data_2jwa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jwa _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 120.866 0.277 . . . . 73.319999999999993 112.385 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.0 mt -52.69 -29.37 26.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.886 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -62.76 -32.54 73.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.108 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -57.72 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.89 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mm -51.31 -44.6 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 75.450000000000003 111.14 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.7 mt -67.13 -44.88 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.200000000000003 111.17 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -61.16 -41.74 97.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 53.229999999999997 110.862 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.9 78.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 111.159 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.68 -45.01 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.439999999999998 111.099 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.1 -48.25 88.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.530000000000001 111.075 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.82 -47.31 91.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.239999999999995 112.488 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.2 mt -65.41 -30.54 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 75.219999999999999 111.139 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.17 -45.22 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.140000000000001 110.978 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.35 -37.55 87.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 75.040000000000006 110.928 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.3 t -62.8 -56.85 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.319999999999993 111.169 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.8 t -52.06 -50.33 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.116 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.46 -38.72 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 111.151 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -49.6 70.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 73.25 110.904 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.9 -45.08 87.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.755 -0.736 . . . . 74.129999999999995 112.43 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.12 -48.95 85.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 71.400000000000006 111.124 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -60.57 -53.82 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 73.340000000000003 111.149 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.1 -53.32 44.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 74.349999999999994 110.888 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.9 -57.73 12.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 65.400000000000006 112.449 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 72.109999999999999 111.138 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.83 0.263 . . . . 63.149999999999999 112.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.4 mt -52.58 -29.71 27.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 72.219999999999999 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.7 m -62.25 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 111.221 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -57.73 5.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 64.349999999999994 110.868 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 51.0 mm -51.38 -44.67 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.25 111.151 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 64.0 mt -67.09 -44.79 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 111.128 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 59.3 p -61.15 -41.85 97.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 70.120000000000005 110.902 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.85 78.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 71.430000000000007 111.073 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 97.1 t -54.58 -44.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 111.134 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.16 -48.55 87.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 75.409999999999997 111.173 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -62.09 -47.29 90.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 74.510000000000005 112.436 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.22 -30.24 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 111.077 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.16 -45.32 66.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.340000000000003 110.929 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.2 -37.81 88.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 70.549999999999997 110.897 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.67 -56.84 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 71.430000000000007 111.177 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 84.7 t -52.22 -49.96 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 70.319999999999993 111.129 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.3 t -55.47 -38.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 75.349999999999994 111.117 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.29 -49.8 70.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 75.299999999999997 110.855 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.89 87.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 72.340000000000003 112.473 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.19 -48.89 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 72.510000000000005 111.095 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.71 -53.95 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 111.121 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.38 -53.86 45.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 75.219999999999999 110.862 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -57.91 12.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 64.530000000000001 112.485 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.93 -39.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 74.129999999999995 111.135 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.09 -58.41 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 110.877 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.68 -31.54 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 73.430000000000007 111.081 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -67.62 -50.9 55.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.914 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 75.420000000000002 110.896 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.823 0.259 . . . . 75.109999999999999 112.333 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.19 -38.64 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.230000000000004 110.939 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -52.3 -30.88 30.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 73.040000000000006 111.102 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -68.89 -57.5 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 64.25 110.844 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.31 -44.62 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 74.230000000000004 111.157 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.5 mm -67.26 -45.07 86.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 74.040000000000006 111.118 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.3 p -60.88 -41.77 96.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 110.879 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -48.31 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 74.409999999999997 111.13 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -54.41 -43.56 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 111.083 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.4 t -61.54 -47.49 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 72.329999999999998 111.16 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.24 -53.17 48.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 74.239999999999995 112.501 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -61.94 -29.44 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 74.310000000000002 111.151 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.8 tp -70.51 -50.61 35.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.349999999999994 110.936 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.1 -37.22 79.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.310000000000002 110.976 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.74 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.163 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.74 -48.96 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 74.049999999999997 111.188 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.2 t -55.74 -39.05 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 72.109999999999999 111.122 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -49.8 70.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 74.310000000000002 110.896 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.76 -44.89 86.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 75.409999999999997 112.493 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.17 -49.02 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 74.140000000000001 111.165 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.51 -54.07 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 72.409999999999997 111.112 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.93 -53.54 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.420000000000002 110.891 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.8 -58.47 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 70.219999999999999 112.488 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 74.319999999999993 111.184 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.82 0.258 . . . . 73.409999999999997 112.377 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.0 mt -51.74 -38.35 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.91 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 18.9 m -51.96 -30.88 26.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 70.140000000000001 111.085 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.8 t -68.92 -57.57 5.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 70.310000000000002 110.87 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.32 -44.65 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 71.109999999999999 111.139 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.29 -45.05 86.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 70.530000000000001 111.125 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.3 p -60.89 -41.61 96.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.430000000000007 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.4 76.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 71.540000000000006 111.048 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.41 -43.46 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 75.329999999999998 111.116 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.63 -47.71 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 111.127 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.58 -53.21 47.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 72.120000000000005 112.558 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 29.8 mm -62.81 -28.03 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 72.230000000000004 111.115 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 12.8 tp -70.0 -51.06 35.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.933 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.34 -37.59 81.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.953 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.39 -58.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 111.129 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 91.9 t -51.67 -48.68 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 75.239999999999995 111.144 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.69 -39.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 111.155 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.07 -50.11 69.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 110.908 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.78 -44.47 86.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 70.340000000000003 112.536 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.29 -49.04 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 72.239999999999995 111.12 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.7 -53.93 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 111.14 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -52.69 -53.87 41.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 74.420000000000002 110.877 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.18 -58.95 9.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 51.340000000000003 112.462 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.96 -39.73 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 74.340000000000003 111.121 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.8 -61.1 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.903 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 78.4 mt -52.8 -39.09 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 72.230000000000004 111.129 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -62.39 -47.28 84.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 74.230000000000004 110.961 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 45.8 mtp85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 110.886 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.768 0.237 . . . . 75.409999999999997 112.353 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -23.47 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 62.340000000000003 110.918 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.6 m -55.91 -33.37 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 65.209999999999994 111.154 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -67.51 -57.97 5.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 73.219999999999999 110.87 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mm -51.46 -44.87 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 111.154 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.18 -43.48 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 74.209999999999994 111.171 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -62.27 -41.49 98.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 72.409999999999997 110.857 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.76 77.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 42.229999999999997 111.089 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.64 -40.58 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.149999999999999 111.158 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.92 -47.48 90.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 70.150000000000006 111.1 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.25 92.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 62.219999999999999 112.474 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.81 -27.46 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.842 0.353 . . . . 74.340000000000003 111.038 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.13 -46.61 61.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 72.209999999999994 110.895 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -38.36 90.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.15 -55.15 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 75.450000000000003 111.15 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.4 t -53.52 -48.94 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 75.299999999999997 111.093 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.7 t -55.92 -38.67 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 71.219999999999999 111.104 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.21 -49.97 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 72.519999999999996 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.66 87.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.843 -0.694 . . . . 74.150000000000006 112.45 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.31 -48.85 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 72.040000000000006 111.146 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -58.16 -54.04 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.152 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -51.93 -53.65 38.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 75.299999999999997 110.852 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.38 10.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.728 -0.749 . . . . 72.349999999999994 112.471 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 70.319999999999993 111.149 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 CA-C-O 120.852 0.272 . . . . 74.200000000000003 112.434 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -23.27 36.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 73.030000000000001 110.92 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 30.8 m -58.11 -33.35 69.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 111.211 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -67.32 -57.71 6.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.239999999999995 110.873 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 49.0 mm -51.52 -45.19 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 74.319999999999993 111.189 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 79.3 mt -67.21 -43.32 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 74.519999999999996 111.133 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 3.8 m -62.05 -41.68 98.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 75.010000000000005 110.863 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 73.5 111.157 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 96.7 t -55.27 -40.62 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 75.019999999999996 111.135 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.05 -47.57 89.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 74.319999999999993 111.136 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.6 -45.87 93.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 65.400000000000006 112.476 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.69 -26.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 73.219999999999999 111.144 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.93 -47.03 61.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 110.922 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -38.32 90.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.430000000000007 110.902 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.13 -54.86 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 74.209999999999994 111.189 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 92.5 t -53.58 -48.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 73.030000000000001 111.164 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.86 -39.43 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.040000000000006 111.157 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.49 -49.72 70.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 73.299999999999997 110.914 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.35 88.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 73.329999999999998 112.465 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.4 -49.07 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 74.299999999999997 111.133 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.42 -54.03 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 75.140000000000001 111.097 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -52.33 -53.61 42.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 73.150000000000006 110.871 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.14 -58.8 9.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 44.299999999999997 112.532 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.7 mm -57.21 -39.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 75.239999999999995 111.168 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.47 -59.88 4.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 110.943 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 76.4 mt -53.21 -44.16 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 75.409999999999997 111.111 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -59.72 -45.51 91.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 71.209999999999994 110.949 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.239999999999995 110.862 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.816 0.257 . . . . 75.239999999999995 112.305 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.97 -33.66 38.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 64.230000000000004 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 m -52.38 -33.43 43.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.167 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -58.64 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.881 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.46 -43.44 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 111.116 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.29 -44.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 71.400000000000006 111.098 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 p -62.08 -40.89 97.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.349999999999994 110.883 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.87 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 63.32 111.092 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.1 -47.43 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 72.5 111.135 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.65 -48.17 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 111.104 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.17 -49.21 81.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 61.520000000000003 112.494 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.56 -31.87 54.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.378 . . . . 65.510000000000005 111.127 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.77 -47.12 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 110.969 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.93 -38.53 88.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 55.32 110.885 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.09 -57.25 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 71.019999999999996 111.07 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.8 t -51.63 -48.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 74.120000000000005 111.14 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -55.53 -41.23 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.450000000000003 111.115 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.26 -49.54 73.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 72.400000000000006 110.894 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.25 -44.35 89.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.742 -0.742 . . . . 71.420000000000002 112.505 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.28 -48.97 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 64.120000000000005 111.138 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.52 -54.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.219999999999999 111.148 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -52.06 -53.7 39.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 72.109999999999999 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.38 10.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 70.120000000000005 112.522 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.129999999999995 111.112 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.774 0.239 . . . . 71.010000000000005 112.283 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.53 37.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 63.210000000000001 110.96 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.4 m -52.31 -33.32 41.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 70.239999999999995 111.11 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -58.74 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 72.230000000000004 110.86 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.43 -43.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 74.420000000000002 111.118 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.34 -44.88 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 111.078 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 34.8 p -62.2 -40.92 97.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 65.540000000000006 110.818 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.9 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 63.140000000000001 111.064 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.07 -47.41 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 74.129999999999995 111.13 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.7 t -57.69 -48.19 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 111.109 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.23 -49.01 83.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.675 -0.774 . . . . 64.219999999999999 112.517 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.61 -32.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 74.430000000000007 111.101 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.05 -47.19 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 64.319999999999993 110.905 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.3 -38.59 87.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 75.340000000000003 110.941 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.65 -57.34 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 74.510000000000005 111.101 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 93.0 t -51.62 -48.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 111.163 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.7 t -55.67 -40.6 61.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 74.340000000000003 111.171 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.29 -49.25 74.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.140000000000001 110.95 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.17 -44.66 88.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.738 . . . . 41.130000000000003 112.472 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.27 -48.94 85.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 73.109999999999999 111.171 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.43 -54.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.125 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -52.65 -53.83 41.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.904 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.8 9.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 53.210000000000001 112.482 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.11 -39.71 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 75.299999999999997 111.155 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.62 -55.38 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 63.0 110.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.67 -50.82 78.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.099999999999994 111.127 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -41.43 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.420000000000002 110.911 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 73.310000000000002 110.935 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.81 0.254 . . . . 75.239999999999995 112.314 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -36.22 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 74.019999999999996 110.88 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -51.63 -37.37 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 71.219999999999999 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -61.94 -59.37 5.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.150000000000006 110.907 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -51.43 -47.55 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 74.109999999999999 111.124 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.1 mm -64.23 -40.01 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.109999999999999 111.186 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -47.52 83.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.848 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.63 -49.62 68.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 72.230000000000004 111.035 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -50.69 -40.14 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.239999999999995 111.091 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.31 -42.94 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 74.099999999999994 111.12 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.16 63.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 60.32 112.523 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.02 -29.9 48.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.939 0.399 . . . . 73.120000000000005 111.184 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.71 -46.92 64.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.951 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -38.66 91.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.49 -56.72 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 65.400000000000006 111.122 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.7 t -52.58 -48.73 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 71.120000000000005 111.133 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.55 -38.59 50.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 75.530000000000001 111.156 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -50.47 68.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 73.549999999999997 110.866 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.59 85.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.755 -0.735 . . . . 71.329999999999998 112.452 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.06 -49.11 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 75.299999999999997 111.109 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.3 t -57.86 -54.21 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.112 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.09 -53.56 40.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.908 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -58.25 10.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.798 -0.715 . . . . 75.530000000000001 112.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.369 . . . . 73.430000000000007 111.129 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.735 0.223 . . . . 74.549999999999997 112.373 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -36.49 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.908 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 13.3 m -51.57 -37.42 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.230000000000004 111.115 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -61.98 -59.24 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 45.100000000000001 110.888 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.52 -47.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 111.092 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.32 -40.06 87.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 111.175 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -47.53 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 70.349999999999994 110.801 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.57 68.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 65.519999999999996 111.088 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 96.6 t -50.83 -40.12 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 75.010000000000005 111.126 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.25 -42.86 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.319999999999993 111.138 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.21 63.58 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.668 -0.777 . . . . 75.239999999999995 112.513 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 63.6 mt -66.05 -29.86 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 75.420000000000002 111.113 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.78 -46.93 64.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 63.329999999999998 110.967 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -38.6 91.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 73.420000000000002 110.903 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.61 -56.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 60.409999999999997 111.088 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 87.9 t -52.5 -48.87 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 75.549999999999997 111.091 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 96.1 t -55.59 -38.67 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 72.219999999999999 111.102 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -50.42 68.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.349999999999994 110.915 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.64 85.42 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.654 -0.784 . . . . 51.200000000000003 112.487 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.12 -49.3 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 75.129999999999995 111.062 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.6 t -58.67 -54.03 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 111.148 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -52.72 -53.79 42.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.200000000000003 110.913 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.11 -58.66 10.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 64.510000000000005 112.427 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.3 -39.84 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 74.230000000000004 111.166 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.11 -58.95 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.400000000000006 110.884 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 77.1 mt -53.29 -40.27 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 111.165 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -65.3 -49.69 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 74.120000000000005 110.886 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.818 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.809 0.254 . . . . 65.230000000000004 112.342 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -51.93 -33.48 37.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 75.450000000000003 110.905 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.7 m -51.75 -31.36 26.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 111.183 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -57.5 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 110.875 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.31 -44.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 75.409999999999997 111.104 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.27 -44.97 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 75.400000000000006 111.142 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.5 p -60.9 -41.74 96.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 75.219999999999999 110.861 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.24 76.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 63.219999999999999 111.056 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.45 -43.39 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 71.239999999999995 111.156 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.66 -47.62 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 70.030000000000001 111.082 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.12 -52.97 50.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 73.430000000000007 112.488 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.8 mm -62.58 -30.78 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.84 0.352 . . . . 71.129999999999995 111.127 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.54 -51.54 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 73.120000000000005 110.932 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -37.05 73.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 74.25 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -63.09 -60.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 111.088 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.64 -47.37 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 111.141 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.56 -38.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 111.16 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -49.94 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.922 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -44.92 86.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.818 -0.705 . . . . 72.420000000000002 112.482 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.08 -49.04 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 74.230000000000004 111.136 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.62 -54.09 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 111.091 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.03 -53.63 39.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.869 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.27 10.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.752 . . . . 53.130000000000003 112.469 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 75.340000000000003 111.122 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.753 0.23 . . . . 75.239999999999995 112.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.35 -34.84 59.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 72.510000000000005 110.884 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 19.9 m -52.57 -31.23 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 71.200000000000003 111.138 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 45.0 t -68.7 -57.28 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 110.86 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.43 -44.67 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 71.349999999999994 111.148 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 36.5 mm -67.34 -45.01 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 64.519999999999996 111.111 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.5 p -60.73 -41.91 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.099999999999994 110.851 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.36 76.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 111.101 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.3 -43.37 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 74.349999999999994 111.198 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.74 -47.52 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 75.439999999999998 111.082 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.14 -52.84 50.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 74.420000000000002 112.487 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 30.2 mm -62.27 -30.42 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 64.129999999999995 111.067 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.6 -51.73 32.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.040000000000006 110.892 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -37.16 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 110.884 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.69 -59.74 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 111.17 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.65 -47.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 111.116 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 89.1 t -56.48 -39.1 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 75.030000000000001 111.082 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -50.03 70.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 53.350000000000001 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.62 -44.94 86.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.754 -0.736 . . . . 63.210000000000001 112.478 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.1 -48.92 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 71.209999999999994 111.174 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.94 -54.08 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 63.0 111.155 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -52.75 -53.91 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 75.349999999999994 110.865 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -58.68 10.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.708 -0.758 . . . . 53.329999999999998 112.499 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.22 -39.65 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 75.129999999999995 111.127 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.14 -60.32 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 72.129999999999995 110.94 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 77.0 mt -52.2 -35.15 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.230000000000004 111.128 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -68.2 -54.24 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 63.140000000000001 110.912 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 74.200000000000003 110.879 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 120.847 0.27 . . . . 72.219999999999999 112.369 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -37.87 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 72.439999999999998 110.932 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.1 m -51.72 -32.16 29.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 72.209999999999994 111.144 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -67.46 -57.79 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 70.409999999999997 110.856 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.7 mt -51.4 -44.61 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 71.329999999999998 111.101 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.24 -44.44 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 74.549999999999997 111.137 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.3 p -61.38 -41.68 97.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.209999999999994 110.897 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.01 77.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 75.530000000000001 111.047 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.63 -43.78 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 72.310000000000002 111.135 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.6 t -61.38 -47.65 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 73.540000000000006 111.108 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.9 -50.1 71.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 73.120000000000005 112.484 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.3 -33.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 72.310000000000002 111.146 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.32 -49.18 58.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.978 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -57.94 -38.6 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 110.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.11 -58.23 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 111.151 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.61 -47.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 72.549999999999997 111.132 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.65 -38.27 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 75.140000000000001 111.168 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.36 -49.79 70.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 64.120000000000005 110.913 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.26 -44.19 89.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.789 -0.72 . . . . 65.25 112.462 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.55 -48.72 86.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 75.230000000000004 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -57.52 -54.03 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 71.040000000000006 111.108 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.84 -53.37 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.863 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.88 -58.06 11.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 64.049999999999997 112.478 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 74.099999999999994 111.127 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.231 0.137 0 CA-C-O 120.791 0.246 . . . . 74.409999999999997 112.354 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.88 -39.12 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 110.908 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 86.2 m -52.57 -32.03 38.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 70.299999999999997 111.053 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 5.0 t -67.43 -57.63 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 55.219999999999999 110.87 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 80.8 mt -51.41 -44.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 75.010000000000005 111.12 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.19 -44.39 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 111.098 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.5 p -61.37 -41.66 97.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 70.129999999999995 110.849 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.92 77.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 75.450000000000003 111.154 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 98.4 t -54.74 -43.74 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 70.430000000000007 111.113 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.43 -47.96 91.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.140000000000001 111.157 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.7 -49.08 82.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 74.040000000000006 112.44 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 72.8 mt -64.43 -32.3 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 71.230000000000004 111.183 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.85 -49.31 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 72.200000000000003 110.918 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.38 -38.53 77.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 110.938 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.17 -58.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 111.07 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.19 -48.27 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 73.450000000000003 111.156 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.37 -39.03 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.010000000000005 111.081 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.49 -49.74 70.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 74.420000000000002 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.6 87.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 73.340000000000003 112.491 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.37 -49.12 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 74.420000000000002 111.159 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.9 t -59.22 -53.85 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 73.120000000000005 111.121 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -52.05 -53.43 42.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.911 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.1 -58.37 10.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 70.519999999999996 112.489 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.62 -40.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.838 0.351 . . . . 75.439999999999998 111.135 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.06 -59.57 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 74.200000000000003 110.91 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 75.5 mt -52.5 -35.32 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 111.163 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -66.99 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 75.140000000000001 110.858 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.858 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.465 -0.165 0 CA-C-O 120.864 0.277 . . . . 73.230000000000004 112.399 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 -38.67 58.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 75.019999999999996 110.896 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.2 m -62.42 -32.42 73.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 111.133 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.67 -57.38 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 73.540000000000006 110.839 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.5 mt -51.53 -44.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.085 -0.507 . . . . 75.299999999999997 111.138 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.59 -44.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.467 . . . . 75.219999999999999 111.163 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -61.14 -41.16 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 110.871 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.49 74.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 72.219999999999999 111.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.22 -44.37 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 111.15 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.85 -48.36 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 111.098 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.56 -46.89 93.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 75.400000000000006 112.569 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.7 mt -65.53 -31.18 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 74.049999999999997 111.146 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tp -69.55 -46.15 67.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 73.409999999999997 110.873 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.89 -37.78 88.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.961 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.51 -57.1 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 70.439999999999998 111.164 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.1 t -51.62 -50.28 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 111.115 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.3 t -55.11 -39.35 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 73.049999999999997 111.156 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -49.64 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -45.15 85.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 71.239999999999995 112.512 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.5 t -59.1 -49.13 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.419 . . . . 72.109999999999999 111.137 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.09 -53.8 43.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 111.144 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.96 -53.71 38.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 74.030000000000001 110.896 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.84 -58.73 9.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 72.400000000000006 112.488 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 72.540000000000006 111.167 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.203 0 CA-C-O 120.821 0.259 . . . . 70.25 112.355 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.81 -38.77 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 74.450000000000003 110.871 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.9 m -61.52 -32.01 72.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 111.156 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -57.29 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.230000000000004 110.858 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 72.2 mt -51.5 -44.38 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 65.25 111.169 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.57 -44.93 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 73.129999999999995 111.175 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 59.6 p -61.13 -41.07 96.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 74.549999999999997 110.866 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.38 74.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 71.430000000000007 111.075 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 98.6 t -54.28 -44.34 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 72.319999999999993 111.159 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.83 -48.78 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 71.019999999999996 111.129 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.8 -47.71 88.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 75.129999999999995 112.502 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 78.5 mt -66.26 -30.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 111.166 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 10.4 tp -70.12 -46.09 65.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 75.019999999999996 110.973 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.19 -38.63 91.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.882 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.02 -57.15 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 73.299999999999997 111.117 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 80.8 t -51.73 -49.8 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 70.329999999999998 111.126 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.06 -39.47 50.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 111.166 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -49.9 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 70.450000000000003 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.75 87.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 65.010000000000005 112.477 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.09 -48.97 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.948 0.404 . . . . 64.230000000000004 111.145 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.57 -54.0 39.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 73.200000000000003 111.191 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -52.35 -53.84 39.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 74.340000000000003 110.873 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.25 -59.23 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.662 -0.78 . . . . 74.409999999999997 112.481 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -56.59 -39.76 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 73.349999999999994 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.75 -60.4 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 74.140000000000001 110.831 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 75.0 mt -52.25 -35.31 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 75.230000000000004 111.136 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -67.9 -59.02 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.923 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 71.230000000000004 110.851 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.84 0.267 . . . . 74.129999999999995 112.369 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mt -52.83 -36.68 59.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 110.846 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.3 m -51.84 -35.16 43.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 71.510000000000005 111.179 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -56.93 10.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.200000000000003 110.934 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.0 mt -51.36 -46.51 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 73.109999999999999 111.099 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 mm -65.98 -43.87 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.409999999999997 111.083 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 p -61.16 -43.07 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 71.540000000000006 110.822 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.7 80.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 75.030000000000001 111.138 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.64 -47.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 111.13 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.01 -47.03 91.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 75.510000000000005 111.106 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.75 -54.4 38.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 73.120000000000005 112.42 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -61.56 -30.06 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 75.519999999999996 111.134 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.9 tp -69.47 -49.72 52.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.230000000000004 110.906 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -37.52 79.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 110.932 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.46 -58.78 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.120000000000005 111.147 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.99 -47.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 111.123 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.18 -38.83 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 64.200000000000003 111.195 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.89 -49.87 70.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 72.519999999999996 110.974 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.38 88.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 53.240000000000002 112.492 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -59.32 -48.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 72.140000000000001 111.179 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -57.69 -54.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.230000000000004 111.097 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -51.9 -53.32 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 71.540000000000006 110.917 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -57.89 11.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 74.030000000000001 112.502 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.89 0.376 . . . . 75.109999999999999 111.167 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.735 0.223 . . . . 74.329999999999998 112.311 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 mt -52.86 -36.38 58.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 110.923 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 40.3 m -51.74 -35.17 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 111.173 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -56.95 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.409999999999997 110.834 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 4.0 mt -51.35 -46.55 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 70.329999999999998 111.123 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 37.8 mm -65.88 -43.81 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 64.120000000000005 111.116 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 45.4 p -61.15 -43.1 99.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.430000000000007 110.921 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.6 80.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.518 . . . . 75.519999999999996 111.071 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 95.5 t -53.64 -47.8 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 64.319999999999993 111.132 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.9 -47.1 90.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 71.299999999999997 111.101 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.53 -54.41 38.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 75.400000000000006 112.535 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.87 -30.83 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 73.219999999999999 111.198 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 12.0 tp -70.21 -49.52 49.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 72.219999999999999 110.909 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -37.31 80.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.519999999999996 110.916 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.92 -59.06 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 65.25 111.098 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 91.0 t -51.84 -48.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 111.144 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 88.7 t -56.8 -38.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.62 -48.94 72.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.12 88.47 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 64.200000000000003 112.505 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.41 -49.17 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 74.450000000000003 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.67 -53.55 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 111.129 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -51.86 -53.13 44.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 110.866 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.99 -57.98 11.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 54.020000000000003 112.495 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.1 -41.04 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.372 . . . . 71.420000000000002 111.126 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.74 -61.44 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 110.874 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.5 mm -56.58 -30.98 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 111.114 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -68.9 -61.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 72.540000000000006 110.897 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 75.349999999999994 110.88 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.759 0.233 . . . . 71.219999999999999 112.336 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.13 -33.7 65.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.224 -0.444 . . . . 63.329999999999998 110.834 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.3 m -52.24 -32.17 35.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 72.540000000000006 111.144 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.6 m -67.8 -58.07 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.845 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -51.28 -44.45 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 111.146 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.7 mt -67.36 -44.38 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 63.329999999999998 111.135 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -61.61 -41.26 97.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 72.129999999999995 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.52 -48.04 76.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.549999999999997 111.094 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.3 t -54.77 -43.88 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.549999999999997 111.181 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.16 -48.23 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 54.43 111.111 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.5 -48.0 87.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 70.329999999999998 112.467 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.1 mt -66.38 -31.66 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.376 . . . . 75.310000000000002 111.18 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 tp -69.67 -44.84 69.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.957 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -38.74 92.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 74.299999999999997 110.871 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.03 -57.04 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 70.209999999999994 111.126 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -51.82 -50.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 72.450000000000003 111.093 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.6 t -54.98 -38.71 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 65.120000000000005 111.074 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tp -64.08 -50.16 69.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 74.409999999999997 110.936 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.91 86.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.831 -0.699 . . . . 63.409999999999997 112.418 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.01 -48.93 85.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 63.229999999999997 111.151 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.92 -54.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 111.185 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -52.0 -53.66 39.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 74.25 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.58 10.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 54.030000000000001 112.526 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.377 . . . . 64.439999999999998 111.085 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.827 0.261 . . . . 64.420000000000002 112.297 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.41 -33.94 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.25 110.962 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 95.5 m -52.69 -32.21 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 111.175 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -67.7 -58.05 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 65.340000000000003 110.813 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.3 mm -51.27 -44.53 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 111.157 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.3 -44.37 87.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.5 111.157 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.2 p -61.68 -41.09 97.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 62.039999999999999 110.904 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.04 76.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 70.319999999999993 111.125 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 99.3 t -54.77 -43.91 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 72.400000000000006 111.153 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.18 -48.37 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 111.11 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.84 -47.6 89.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.724 -0.75 . . . . 64.0 112.563 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.76 -30.97 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 73.120000000000005 111.12 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 16.2 tp -69.97 -45.04 68.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 74.329999999999998 110.907 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 74.200000000000003 110.975 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.06 -56.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 75.540000000000006 111.144 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.85 -50.4 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 62.229999999999997 111.149 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -54.9 -38.83 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 74.450000000000003 111.112 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.98 -50.19 69.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 110.954 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.77 86.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 74.230000000000004 112.484 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 74.230000000000004 111.153 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.74 -53.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 63.399999999999999 111.128 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.69 -53.83 42.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 63.210000000000001 110.872 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -59.03 9.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 43.420000000000002 112.51 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.88 -39.71 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.952 0.406 . . . . 75.540000000000006 111.144 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.48 -61.37 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 74.140000000000001 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.44 -31.5 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 75.450000000000003 111.133 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -67.22 -56.95 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 71.409999999999997 110.943 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 72.219999999999999 110.856 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.86 0.275 . . . . 61.229999999999997 112.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.48 -26.03 40.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.299999999999997 110.869 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 m -62.27 -32.37 73.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 74.310000000000002 111.079 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -57.94 5.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 63.229999999999997 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.38 -44.5 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 111.089 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.3 mt -67.01 -44.79 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 70.430000000000007 111.152 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 p -61.28 -42.1 98.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 63.299999999999997 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.57 80.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 73.530000000000001 111.13 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -54.81 -45.07 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.230000000000004 111.149 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.12 -48.57 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 74.420000000000002 111.12 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.92 -48.09 87.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 72.030000000000001 112.474 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.91 -34.21 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 74.540000000000006 111.116 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.76 -48.72 58.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 110.942 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -36.86 73.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 70.140000000000001 110.956 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.3 -58.0 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.184 -0.462 . . . . 73.010000000000005 111.123 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.5 t -52.32 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.134 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.9 t -57.53 -41.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 72.0 111.108 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.78 -46.33 90.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 70.439999999999998 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.38 -40.14 97.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 34.530000000000001 112.477 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.31 -48.53 87.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 72.239999999999995 111.139 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.04 -52.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 111.163 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -52.65 -53.73 43.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.430000000000007 110.906 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.56 10.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 71.120000000000005 112.459 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 72.230000000000004 111.102 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.848 0.27 . . . . 65.109999999999999 112.36 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -26.24 38.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.967 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 2.8 m -62.2 -32.33 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 75.510000000000005 111.186 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -57.94 5.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 64.549999999999997 110.893 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 2.8 mp -51.37 -44.49 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 71.030000000000001 111.151 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.03 -44.83 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 75.310000000000002 111.16 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 58.5 p -61.19 -42.0 97.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 73.439999999999998 110.954 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.65 80.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 74.519999999999996 111.044 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.77 -45.06 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 111.119 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.14 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 64.549999999999997 111.131 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.89 -48.11 87.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 74.510000000000005 112.49 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.41 -33.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 70.439999999999998 111.193 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.14 -48.66 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 72.219999999999999 110.934 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.13 74.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.908 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.99 -57.93 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.549999999999997 111.102 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 79.1 t -52.04 -46.83 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 74.230000000000004 111.095 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 95.3 t -57.18 -42.41 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 111.152 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.34 -46.04 91.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 73.349999999999994 110.91 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.82 96.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 75.239999999999995 112.443 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.56 -48.56 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 73.349999999999994 111.189 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.1 -52.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 75.140000000000001 111.081 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -52.59 -53.64 43.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 110.897 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.39 -59.25 9.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 52.43 112.524 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 70.4 mt -56.79 -39.22 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 74.409999999999997 111.128 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.7 mt -58.51 -60.27 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 71.319999999999993 110.883 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 26.3 mm -55.97 -30.96 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 111.101 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -71.07 -60.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.409999999999997 110.829 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 75.400000000000006 110.825 -179.954 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.851 0.271 . . . . 74.400000000000006 112.339 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.17 -33.13 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 74.099999999999994 110.913 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -51.81 -32.28 30.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 111.147 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -57.75 5.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.329999999999998 110.898 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.55 -44.71 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 72.329999999999998 111.104 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mm -67.0 -44.33 88.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 73.420000000000002 111.124 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -61.77 -41.53 97.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 71.310000000000002 110.884 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -47.51 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 111.045 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -55.01 -45.58 76.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 75.319999999999993 111.132 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.71 -48.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 72.530000000000001 111.214 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.53 -48.36 86.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 64.510000000000005 112.516 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.83 -35.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.813 0.34 . . . . 74.129999999999995 111.107 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.78 -46.83 67.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 75.299999999999997 110.909 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -39.47 83.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 110.895 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.72 -55.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 111.078 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.31 -46.98 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 111.121 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.76 -40.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 111.117 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.92 -48.82 77.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.209999999999994 110.936 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.99 90.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 63.219999999999999 112.51 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.03 -48.69 85.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 74.340000000000003 111.117 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.23 -54.21 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 71.450000000000003 111.159 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -52.11 -53.84 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 73.319999999999993 110.93 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.87 -58.96 9.28 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.731 -0.747 . . . . 73.030000000000001 112.484 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 70.219999999999999 111.097 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.23 0.122 0 CA-C-O 120.815 0.256 . . . . 74.239999999999995 112.375 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.6 -34.57 51.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 75.430000000000007 110.937 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 28.4 m -52.93 -32.16 44.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 61.219999999999999 111.147 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.73 -57.32 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 60.43 110.799 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 61.3 mt -51.5 -45.07 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 111.187 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 37.3 mm -66.87 -44.36 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 73.340000000000003 111.13 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.9 p -61.62 -41.58 97.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.25 110.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.63 78.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.230000000000004 111.159 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 97.8 t -54.73 -45.51 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 111.048 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.96 -48.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 72.109999999999999 111.094 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.47 -48.69 84.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 73.409999999999997 112.482 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.62 -35.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 74.430000000000007 111.116 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.76 -46.88 67.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.873 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.81 -38.98 83.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 71.400000000000006 110.822 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.76 -56.02 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 75.25 111.161 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 57.2 t -53.05 -47.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 70.120000000000005 111.198 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.55 -40.56 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 72.209999999999994 111.131 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.04 -48.81 77.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.901 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.25 -45.19 88.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 74.420000000000002 112.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.15 -48.85 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 74.25 111.095 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.3 t -57.78 -54.05 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 75.329999999999998 111.154 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -52.1 -53.84 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 110.896 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -59.29 9.06 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 70.239999999999995 112.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.64 -39.72 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.375 . . . . 73.319999999999993 111.102 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -60.02 -60.63 3.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.3 mm -57.75 -31.63 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.010000000000005 111.085 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -68.14 -59.92 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 75.230000000000004 110.851 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.400000000000006 110.897 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.466 -0.254 . . . . 44.049999999999997 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.0 p -129.85 68.36 80.61 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.647 0.737 . . . . 75.209999999999994 110.921 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 102.89 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.669 2.246 . . . . 74.219999999999999 112.326 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.67 129.49 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 44.310000000000002 111.104 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.02 29.75 6.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 74.200000000000003 110.895 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.29 161.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 110.87 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.98 -179.89 5.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.902 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -176.11 34.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.400000000000006 111.098 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.67 160.57 44.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 72.049999999999997 110.852 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -42.65 3.23 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.671 2.247 . . . . 73.319999999999993 112.385 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.0 mt -52.69 -29.37 26.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.886 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -62.76 -32.54 73.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.108 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -57.72 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.89 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mm -51.31 -44.6 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 75.450000000000003 111.14 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.7 mt -67.13 -44.88 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.200000000000003 111.17 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -61.16 -41.74 97.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 53.229999999999997 110.862 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.9 78.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 111.159 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.68 -45.01 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.439999999999998 111.099 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.1 -48.25 88.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.530000000000001 111.075 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.82 -47.31 91.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.239999999999995 112.488 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.2 mt -65.41 -30.54 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 75.219999999999999 111.139 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.17 -45.22 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.140000000000001 110.978 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.35 -37.55 87.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 75.040000000000006 110.928 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.3 t -62.8 -56.85 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.319999999999993 111.169 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.8 t -52.06 -50.33 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.116 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.46 -38.72 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 111.151 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -49.6 70.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 73.25 110.904 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.9 -45.08 87.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.755 -0.736 . . . . 74.129999999999995 112.43 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.12 -48.95 85.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 71.400000000000006 111.124 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -60.57 -53.82 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 73.340000000000003 111.149 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.1 -53.32 44.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 74.349999999999994 110.888 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.9 -57.73 12.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 65.400000000000006 112.449 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.34 -40.49 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 72.109999999999999 111.138 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -57.88 -57.3 13.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 74.140000000000001 110.95 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.6 mt -58.83 -31.03 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.439999999999998 111.137 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -66.86 -51.12 59.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 75.200000000000003 110.926 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -64.59 -45.89 85.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.299999999999997 110.918 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.0 mtt-85 -63.5 -28.09 69.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.876 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.2 -175.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.939 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.98 167.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 54.439999999999998 110.929 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 mttt 60.33 85.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 75.140000000000001 110.853 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.75 66.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 72.019999999999996 111.126 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -177.09 78.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 74.409999999999997 110.902 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 63.310000000000002 110.89 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.466 -0.254 . . . . 74.25 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 7.9 p -129.8 68.41 80.62 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 73.030000000000001 110.86 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 102.93 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 74.420000000000002 112.383 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.52 129.21 5.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 74.0 111.067 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.21 29.83 6.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.420000000000002 110.905 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.36 161.17 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 72.219999999999999 110.941 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.71 179.55 5.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.109999999999999 110.856 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -176.79 34.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 74.049999999999997 111.089 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.33 160.55 45.14 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.69 0.757 . . . . 75.519999999999996 110.862 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -42.01 3.69 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.666 2.244 . . . . 63.149999999999999 112.366 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.4 mt -52.58 -29.71 27.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 72.219999999999999 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.7 m -62.25 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 111.221 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -57.73 5.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 64.349999999999994 110.868 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 51.0 mm -51.38 -44.67 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.25 111.151 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 64.0 mt -67.09 -44.79 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 111.128 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 59.3 p -61.15 -41.85 97.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 70.120000000000005 110.902 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.85 78.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 71.430000000000007 111.073 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 97.1 t -54.58 -44.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 111.134 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.16 -48.55 87.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 75.409999999999997 111.173 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -62.09 -47.29 90.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 74.510000000000005 112.436 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.22 -30.24 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 111.077 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.16 -45.32 66.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.340000000000003 110.929 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.2 -37.81 88.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 70.549999999999997 110.897 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.67 -56.84 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 71.430000000000007 111.177 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 84.7 t -52.22 -49.96 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 70.319999999999993 111.129 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.3 t -55.47 -38.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 75.349999999999994 111.117 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.29 -49.8 70.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 75.299999999999997 110.855 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.89 87.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 72.340000000000003 112.473 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.19 -48.89 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 72.510000000000005 111.095 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.71 -53.95 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 111.121 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.38 -53.86 45.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 75.219999999999999 110.862 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -57.91 12.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 64.530000000000001 112.485 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.93 -39.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 74.129999999999995 111.135 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.09 -58.41 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 110.877 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.68 -31.54 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 73.430000000000007 111.081 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -67.62 -50.9 55.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.914 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -64.21 -45.93 86.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 75.420000000000002 110.896 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -63.51 -28.59 70.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 75.439999999999998 110.908 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.03 -175.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 75.430000000000007 110.896 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.48 167.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 74.230000000000004 110.939 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 1.4 mttt 60.4 86.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 74.430000000000007 110.911 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.6 66.45 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 73.340000000000003 111.144 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -176.94 78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 70.030000000000001 110.871 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 74.310000000000002 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.441 -0.263 . . . . 74.299999999999997 112.441 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 50.0 m 54.49 68.64 2.54 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 72.129999999999995 110.843 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -28.9 24.45 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.687 2.258 . . . . 75.340000000000003 112.291 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.63 177.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.510000000000005 111.086 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.08 81.05 1.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.400000000000006 110.896 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -128.88 33.2 4.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 72.519999999999996 110.901 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -165.43 133.81 3.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 75.519999999999996 110.831 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.06 101.29 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.43 160.61 25.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.699 0.762 . . . . 74.430000000000007 110.88 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -15.11 37.08 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.688 2.259 . . . . 75.109999999999999 112.333 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.19 -38.64 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.230000000000004 110.939 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -52.3 -30.88 30.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 73.040000000000006 111.102 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -68.89 -57.5 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 64.25 110.844 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.31 -44.62 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 74.230000000000004 111.157 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.5 mm -67.26 -45.07 86.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 74.040000000000006 111.118 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.3 p -60.88 -41.77 96.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 110.879 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -48.31 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 74.409999999999997 111.13 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -54.41 -43.56 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 111.083 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.4 t -61.54 -47.49 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 72.329999999999998 111.16 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.24 -53.17 48.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 74.239999999999995 112.501 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -61.94 -29.44 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 74.310000000000002 111.151 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.8 tp -70.51 -50.61 35.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.349999999999994 110.936 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.1 -37.22 79.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.310000000000002 110.976 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.74 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.163 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.74 -48.96 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 74.049999999999997 111.188 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.2 t -55.74 -39.05 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 72.109999999999999 111.122 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -49.8 70.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 74.310000000000002 110.896 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.76 -44.89 86.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 75.409999999999997 112.493 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.17 -49.02 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 74.140000000000001 111.165 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.51 -54.07 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 72.409999999999997 111.112 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.93 -53.54 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.420000000000002 110.891 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.8 -58.47 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 70.219999999999999 112.488 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.68 -40.11 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 74.319999999999993 111.184 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -58.81 -60.06 4.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.25 110.928 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 78.1 mt -51.87 -39.45 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.540000000000006 111.093 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -62.98 -48.1 80.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 110.872 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 -64.79 -47.01 79.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.878 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -31.04 71.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 74.140000000000001 110.86 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.0 -175.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 70.439999999999998 110.947 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.94 -68.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 74.409999999999997 110.936 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -167.23 143.25 4.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 75.510000000000005 110.901 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.54 66.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 75.25 111.124 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -126.39 105.27 8.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 110.926 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 72.409999999999997 110.916 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.423 -0.271 . . . . 70.129999999999995 112.423 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 50.4 m 54.48 68.62 2.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.581 0.705 . . . . 74.319999999999993 110.856 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -29.01 24.57 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.7 2.266 . . . . 74.319999999999993 112.312 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . 59.53 177.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 72.340000000000003 111.073 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.89 80.83 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 73.329999999999998 110.836 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -129.03 33.53 4.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 110.877 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -164.95 134.09 3.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 72.540000000000006 110.816 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -162.81 101.48 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 72.109999999999999 111.117 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.3 160.6 25.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.68 0.753 . . . . 75.209999999999994 110.822 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -13.77 35.09 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.701 2.267 . . . . 73.409999999999997 112.377 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.0 mt -51.74 -38.35 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.91 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 18.9 m -51.96 -30.88 26.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 70.140000000000001 111.085 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.8 t -68.92 -57.57 5.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 70.310000000000002 110.87 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.32 -44.65 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 71.109999999999999 111.139 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.29 -45.05 86.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 70.530000000000001 111.125 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.3 p -60.89 -41.61 96.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.430000000000007 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.4 76.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 71.540000000000006 111.048 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.41 -43.46 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 75.329999999999998 111.116 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.63 -47.71 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 111.127 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.58 -53.21 47.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 72.120000000000005 112.558 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 29.8 mm -62.81 -28.03 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 72.230000000000004 111.115 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 12.8 tp -70.0 -51.06 35.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.933 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.34 -37.59 81.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.953 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.39 -58.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 111.129 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 91.9 t -51.67 -48.68 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 75.239999999999995 111.144 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.69 -39.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 111.155 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.07 -50.11 69.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 110.908 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.78 -44.47 86.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 70.340000000000003 112.536 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.29 -49.04 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 72.239999999999995 111.12 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.7 -53.93 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 111.14 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -52.69 -53.87 41.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 74.420000000000002 110.877 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.18 -58.95 9.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 51.340000000000003 112.462 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.96 -39.73 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 74.340000000000003 111.121 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.8 -61.1 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.903 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 78.4 mt -52.8 -39.09 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 72.230000000000004 111.129 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -62.39 -47.28 84.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 74.230000000000004 110.961 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 45.8 mtp85 -63.76 -47.29 81.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 110.886 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -31.4 72.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.893 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.99 -175.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.540000000000006 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -105.67 -69.03 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 110.926 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -167.25 143.43 4.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 72.510000000000005 110.863 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.3 mt -115.44 66.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.113 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -126.57 105.2 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 73.030000000000001 110.83 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 72.019999999999996 110.964 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.465 -0.254 . . . . 74.310000000000002 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.74 160.51 19.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.65 0.738 . . . . 72.129999999999995 110.937 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 124.83 11.48 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.245 . . . . 72.129999999999995 112.347 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.44 155.9 43.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.438 . . . . 73.409999999999997 111.115 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 175.73 5.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 65.219999999999999 110.876 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.04 174.86 10.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 74.040000000000006 110.939 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.99 -71.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 71.510000000000005 110.954 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.75 56.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 72.010000000000005 111.034 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -139.44 68.34 38.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.546 0.688 . . . . 73.239999999999995 110.883 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.64 -11.28 30.66 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.713 2.276 . . . . 75.409999999999997 112.353 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -23.47 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 62.340000000000003 110.918 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.6 m -55.91 -33.37 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 65.209999999999994 111.154 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -67.51 -57.97 5.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 73.219999999999999 110.87 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mm -51.46 -44.87 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 111.154 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.18 -43.48 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 74.209999999999994 111.171 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -62.27 -41.49 98.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 72.409999999999997 110.857 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.76 77.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 42.229999999999997 111.089 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.64 -40.58 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.149999999999999 111.158 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.92 -47.48 90.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 70.150000000000006 111.1 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.25 92.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 62.219999999999999 112.474 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.81 -27.46 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.842 0.353 . . . . 74.340000000000003 111.038 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.13 -46.61 61.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 72.209999999999994 110.895 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -38.36 90.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.15 -55.15 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 75.450000000000003 111.15 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.4 t -53.52 -48.94 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 75.299999999999997 111.093 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.7 t -55.92 -38.67 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 71.219999999999999 111.104 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.21 -49.97 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 72.519999999999996 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.66 87.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.843 -0.694 . . . . 74.150000000000006 112.45 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.31 -48.85 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 72.040000000000006 111.146 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -58.16 -54.04 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.152 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -51.93 -53.65 38.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 75.299999999999997 110.852 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.38 10.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.728 -0.749 . . . . 72.349999999999994 112.471 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.65 -40.12 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 70.319999999999993 111.149 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.5 mt -58.91 -59.36 5.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 74.129999999999995 110.921 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.7 mt -52.77 -44.76 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 72.400000000000006 111.081 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -60.73 -45.82 92.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 71.239999999999995 110.906 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -62.2 -44.89 95.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 110.84 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -65.33 -43.14 91.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 74.120000000000005 110.896 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.97 -35.99 36.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 73.420000000000002 110.868 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.83 102.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 73.030000000000001 110.874 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.31 148.07 30.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.903 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.46 66.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 74.420000000000002 111.097 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 52.45 80.38 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 75.519999999999996 110.838 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.865 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.576 -0.209 . . . . 72.439999999999998 112.576 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.64 160.54 18.64 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.621 0.724 . . . . 73.219999999999999 110.921 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 124.78 11.4 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.717 2.278 . . . . 74.329999999999998 112.328 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.65 155.9 43.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 73.200000000000003 111.066 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.31 175.17 5.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.871 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.76 175.43 9.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 74.409999999999997 110.904 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 -71.63 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.129999999999995 110.819 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.42 54.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 41.119999999999997 111.106 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 19.8 p -141.31 68.55 26.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.654 0.74 . . . . 73.230000000000004 110.81 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.65 -11.5 31.11 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.707 2.271 . . . . 74.200000000000003 112.434 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -23.27 36.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 73.030000000000001 110.92 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 30.8 m -58.11 -33.35 69.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 111.211 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -67.32 -57.71 6.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.239999999999995 110.873 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 49.0 mm -51.52 -45.19 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 74.319999999999993 111.189 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 79.3 mt -67.21 -43.32 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 74.519999999999996 111.133 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 3.8 m -62.05 -41.68 98.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 75.010000000000005 110.863 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 73.5 111.157 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 96.7 t -55.27 -40.62 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 75.019999999999996 111.135 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.05 -47.57 89.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 74.319999999999993 111.136 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.6 -45.87 93.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 65.400000000000006 112.476 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.69 -26.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 73.219999999999999 111.144 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.93 -47.03 61.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 110.922 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -38.32 90.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.430000000000007 110.902 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.13 -54.86 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 74.209999999999994 111.189 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 92.5 t -53.58 -48.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 73.030000000000001 111.164 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.86 -39.43 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.040000000000006 111.157 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.49 -49.72 70.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 73.299999999999997 110.914 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.35 88.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 73.329999999999998 112.465 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.4 -49.07 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 74.299999999999997 111.133 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.42 -54.03 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 75.140000000000001 111.097 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -52.33 -53.61 42.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 73.150000000000006 110.871 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.14 -58.8 9.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 44.299999999999997 112.532 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.7 mm -57.21 -39.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 75.239999999999995 111.168 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.47 -59.88 4.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 110.943 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 76.4 mt -53.21 -44.16 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 75.409999999999997 111.111 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -59.72 -45.51 91.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 71.209999999999994 110.949 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -61.77 -45.43 93.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.239999999999995 110.862 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -66.09 -43.25 87.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 73.140000000000001 110.825 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -35.72 33.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 75.530000000000001 110.935 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.39 102.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 110.883 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 148.31 30.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 71.349999999999994 110.916 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.8 mt -115.35 66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 73.150000000000006 111.112 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 52.56 80.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 74.519999999999996 110.902 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 75.010000000000005 110.851 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.488 -0.245 . . . . 73.129999999999995 112.488 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.17 160.53 30.81 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.599 0.714 . . . . 75.530000000000001 110.888 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 120.61 7.37 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.703 2.269 . . . . 72.439999999999998 112.309 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.63 117.43 7.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 111.057 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.7 -51.08 5.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 74.209999999999994 110.939 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -98.99 105.26 17.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 70.129999999999995 110.938 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.89 122.43 7.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 75.319999999999993 110.895 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.87 81.38 2.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 73.25 111.151 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -135.85 70.52 64.49 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 75.129999999999995 110.868 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -31.32 20.5 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.681 2.254 . . . . 75.239999999999995 112.305 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.97 -33.66 38.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 64.230000000000004 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 m -52.38 -33.43 43.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.167 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -58.64 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.881 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.46 -43.44 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 111.116 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.29 -44.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 71.400000000000006 111.098 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 p -62.08 -40.89 97.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.349999999999994 110.883 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.87 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 63.32 111.092 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.1 -47.43 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 72.5 111.135 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.65 -48.17 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 111.104 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.17 -49.21 81.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 61.520000000000003 112.494 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.56 -31.87 54.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.378 . . . . 65.510000000000005 111.127 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.77 -47.12 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 110.969 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.93 -38.53 88.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 55.32 110.885 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.09 -57.25 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 71.019999999999996 111.07 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.8 t -51.63 -48.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 74.120000000000005 111.14 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -55.53 -41.23 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.450000000000003 111.115 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.26 -49.54 73.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 72.400000000000006 110.894 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.25 -44.35 89.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.742 -0.742 . . . . 71.420000000000002 112.505 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.28 -48.97 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 64.120000000000005 111.138 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.52 -54.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.219999999999999 111.148 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -52.06 -53.7 39.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 72.109999999999999 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.38 10.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 70.120000000000005 112.522 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.79 -39.96 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.129999999999995 111.112 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.8 mt -59.13 -55.16 38.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 73.219999999999999 110.974 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.49 -50.01 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 63.520000000000003 111.19 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.81 -40.79 66.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 72.409999999999997 110.91 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -64.57 -51.58 62.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 64.450000000000003 110.841 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -62.13 -31.78 72.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 75.340000000000003 110.851 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 123.57 9.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 75.310000000000002 110.855 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.41 -172.13 1.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 64.25 110.889 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 164.37 2.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 75.439999999999998 110.977 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 mt -115.47 66.32 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 73.25 111.156 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.04 81.2 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.150000000000006 110.852 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.530000000000001 110.868 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.454 -0.258 . . . . 75.439999999999998 112.454 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.19 160.56 30.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.6 0.714 . . . . 74.140000000000001 110.921 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 120.73 7.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.622 2.215 . . . . 74.140000000000001 112.376 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -147.58 117.34 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 74.129999999999995 111.121 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.8 -51.08 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.540000000000006 110.884 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -98.93 105.22 17.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 110.887 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.91 122.45 7.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 75.140000000000001 110.829 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.94 81.51 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 64.200000000000003 111.114 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -135.92 70.56 63.96 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.679 0.752 . . . . 72.129999999999995 110.883 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -31.39 20.44 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.659 2.239 . . . . 71.010000000000005 112.283 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.53 37.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 63.210000000000001 110.96 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.4 m -52.31 -33.32 41.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 70.239999999999995 111.11 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -58.74 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 72.230000000000004 110.86 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.43 -43.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 74.420000000000002 111.118 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.34 -44.88 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 111.078 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 34.8 p -62.2 -40.92 97.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 65.540000000000006 110.818 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.9 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 63.140000000000001 111.064 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.07 -47.41 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 74.129999999999995 111.13 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.7 t -57.69 -48.19 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 111.109 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.23 -49.01 83.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.675 -0.774 . . . . 64.219999999999999 112.517 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.61 -32.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 74.430000000000007 111.101 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.05 -47.19 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 64.319999999999993 110.905 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.3 -38.59 87.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 75.340000000000003 110.941 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.65 -57.34 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 74.510000000000005 111.101 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 93.0 t -51.62 -48.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 111.163 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.7 t -55.67 -40.6 61.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 74.340000000000003 111.171 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.29 -49.25 74.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.140000000000001 110.95 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.17 -44.66 88.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.738 . . . . 41.130000000000003 112.472 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.27 -48.94 85.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 73.109999999999999 111.171 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.43 -54.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.125 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -52.65 -53.83 41.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.904 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.8 9.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 53.210000000000001 112.482 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.11 -39.71 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 75.299999999999997 111.155 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.62 -55.38 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 63.0 110.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.67 -50.82 78.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.099999999999994 111.127 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -41.43 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.420000000000002 110.911 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -64.99 -51.57 60.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 73.310000000000002 110.935 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -61.84 -31.98 72.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 74.319999999999993 110.865 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.14 122.95 8.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 75.239999999999995 110.888 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.89 -172.21 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 72.299999999999997 110.874 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 164.5 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 74.400000000000006 110.999 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.3 mt -115.36 66.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 74.25 111.126 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.08 81.11 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 73.549999999999997 110.883 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 110.943 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.478 -0.249 . . . . 74.25 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -142.22 160.52 54.59 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.606 0.717 . . . . 61.340000000000003 110.888 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -179.74 3.11 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.733 2.289 . . . . 74.439999999999998 112.367 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.07 93.97 0.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 65.310000000000002 111.091 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -108.68 109.41 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 72.530000000000001 110.949 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.25 170.23 10.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 74.299999999999997 110.888 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 36.59 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 74.439999999999998 110.828 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.46 135.97 35.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.081 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m 63.15 72.66 0.56 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.632 0.73 . . . . 74.030000000000001 110.87 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -17.15 37.56 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.637 2.225 . . . . 75.239999999999995 112.314 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -36.22 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 74.019999999999996 110.88 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -51.63 -37.37 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 71.219999999999999 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -61.94 -59.37 5.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.150000000000006 110.907 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -51.43 -47.55 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 74.109999999999999 111.124 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.1 mm -64.23 -40.01 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.109999999999999 111.186 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -47.52 83.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.848 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.63 -49.62 68.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 72.230000000000004 111.035 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -50.69 -40.14 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.239999999999995 111.091 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.31 -42.94 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 74.099999999999994 111.12 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.16 63.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 60.32 112.523 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.02 -29.9 48.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.939 0.399 . . . . 73.120000000000005 111.184 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.71 -46.92 64.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.951 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -38.66 91.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.49 -56.72 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 65.400000000000006 111.122 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.7 t -52.58 -48.73 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 71.120000000000005 111.133 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.55 -38.59 50.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 75.530000000000001 111.156 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -50.47 68.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 73.549999999999997 110.866 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.59 85.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.755 -0.735 . . . . 71.329999999999998 112.452 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.06 -49.11 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 75.299999999999997 111.109 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.3 t -57.86 -54.21 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.112 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.09 -53.56 40.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.908 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -58.25 10.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.798 -0.715 . . . . 75.530000000000001 112.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.7 mt -57.96 -40.03 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.369 . . . . 73.430000000000007 111.129 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.6 mt -58.96 -59.05 6.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 74.230000000000004 110.912 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.7 mt -53.47 -39.98 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 111.183 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -65.12 -48.8 72.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 110.921 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -50.34 69.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 73.230000000000004 110.888 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.58 -39.39 93.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 75.150000000000006 110.879 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.89 134.19 25.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 110.939 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.54 -64.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.924 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.23 126.19 47.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.916 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.3 mt -115.58 66.38 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 75.549999999999997 111.096 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 60.17 98.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 75.200000000000003 110.892 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 mttp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 65.430000000000007 110.922 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.534 -0.226 . . . . 75.209999999999994 112.534 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -142.11 160.57 54.7 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.618 0.723 . . . . 74.109999999999999 110.876 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 -179.61 3.0 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.705 2.27 . . . . 75.329999999999998 112.388 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.9 94.04 0.45 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 111.069 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -108.69 109.53 20.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 71.109999999999999 110.877 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.19 170.38 10.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 72.530000000000001 110.889 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.51 36.36 1.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 72.140000000000001 110.831 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.55 135.9 35.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 70.519999999999996 111.157 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 2.0 m 63.29 72.96 0.53 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 72.230000000000004 110.805 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -17.27 37.76 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.735 2.29 . . . . 74.549999999999997 112.373 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -36.49 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.908 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 13.3 m -51.57 -37.42 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.230000000000004 111.115 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -61.98 -59.24 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 45.100000000000001 110.888 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.52 -47.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 111.092 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.32 -40.06 87.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 111.175 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -47.53 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 70.349999999999994 110.801 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.57 68.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 65.519999999999996 111.088 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 96.6 t -50.83 -40.12 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 75.010000000000005 111.126 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.25 -42.86 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.319999999999993 111.138 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.21 63.58 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.668 -0.777 . . . . 75.239999999999995 112.513 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 63.6 mt -66.05 -29.86 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 75.420000000000002 111.113 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.78 -46.93 64.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 63.329999999999998 110.967 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -38.6 91.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 73.420000000000002 110.903 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.61 -56.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 60.409999999999997 111.088 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 87.9 t -52.5 -48.87 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 75.549999999999997 111.091 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 96.1 t -55.59 -38.67 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 72.219999999999999 111.102 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -50.42 68.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.349999999999994 110.915 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.64 85.42 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.654 -0.784 . . . . 51.200000000000003 112.487 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.12 -49.3 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 75.129999999999995 111.062 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.6 t -58.67 -54.03 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 111.148 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -52.72 -53.79 42.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.200000000000003 110.913 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.11 -58.66 10.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 64.510000000000005 112.427 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.3 -39.84 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 74.230000000000004 111.166 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.11 -58.95 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.400000000000006 110.884 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 77.1 mt -53.29 -40.27 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 111.165 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -65.3 -49.69 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 74.120000000000005 110.886 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.08 -50.81 69.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.818 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.74 -39.42 94.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 73.25 110.875 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -50.87 133.8 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 110.895 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.83 -64.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.901 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.18 126.32 48.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.914 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.5 66.39 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 64.140000000000001 111.077 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 60.1 98.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 110.897 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.5 mttp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 63.119999999999997 110.855 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.496 -0.242 . . . . 73.049999999999997 112.496 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.9 m -141.49 70.88 26.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.607 0.718 . . . . 71.140000000000001 110.906 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.78 157.52 60.06 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.68 2.253 . . . . 75.420000000000002 112.315 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.87 90.12 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 72.409999999999997 111.075 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -133.86 178.59 6.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 72.349999999999994 110.919 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.25 -63.62 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 75.200000000000003 110.929 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 58.18 179.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.882 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.65 -175.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 65.0 111.063 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.09 160.53 42.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.656 0.741 . . . . 72.519999999999996 110.857 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -17.23 37.73 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.711 2.274 . . . . 65.230000000000004 112.342 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -51.93 -33.48 37.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 75.450000000000003 110.905 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.7 m -51.75 -31.36 26.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 111.183 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -57.5 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 110.875 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.31 -44.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 75.409999999999997 111.104 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.27 -44.97 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 75.400000000000006 111.142 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.5 p -60.9 -41.74 96.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 75.219999999999999 110.861 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.24 76.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 63.219999999999999 111.056 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.45 -43.39 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 71.239999999999995 111.156 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.66 -47.62 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 70.030000000000001 111.082 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.12 -52.97 50.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 73.430000000000007 112.488 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.8 mm -62.58 -30.78 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.84 0.352 . . . . 71.129999999999995 111.127 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.54 -51.54 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 73.120000000000005 110.932 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -37.05 73.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 74.25 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -63.09 -60.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 111.088 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.64 -47.37 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 111.141 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.56 -38.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 111.16 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -49.94 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.922 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -44.92 86.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.818 -0.705 . . . . 72.420000000000002 112.482 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.08 -49.04 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 74.230000000000004 111.136 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.62 -54.09 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 111.091 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.03 -53.63 39.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.869 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.27 10.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.752 . . . . 53.130000000000003 112.469 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt -57.86 -40.2 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 75.340000000000003 111.122 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.6 mt -58.8 -60.06 4.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.912 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.8 mt -52.0 -35.17 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 71.530000000000001 111.137 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -68.28 -55.38 12.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.87 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.03 -36.32 77.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.876 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -65.45 -42.44 92.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 75.140000000000001 110.863 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 54.46 25.38 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 73.019999999999996 110.887 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.12 126.18 26.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 71.530000000000001 110.885 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -128.91 52.92 1.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 75.530000000000001 110.876 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.4 mt -115.48 66.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 74.329999999999998 111.066 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.29 66.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.299999999999997 110.924 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 110.852 179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.491 -0.244 . . . . 61.140000000000001 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 71.7 m -141.59 70.97 25.81 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.634 0.73 . . . . 73.120000000000005 110.864 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 157.28 60.95 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 63.009999999999998 112.343 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -126.05 90.17 3.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.120000000000005 111.083 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -133.57 178.18 7.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 71.019999999999996 110.904 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.73 -63.81 0.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 73.239999999999995 110.926 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 58.06 179.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 74.0 110.899 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . 62.89 -174.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 73.540000000000006 111.118 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.66 160.49 44.29 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.647 0.737 . . . . 75.439999999999998 110.858 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.41 37.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.738 2.292 . . . . 75.239999999999995 112.338 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.35 -34.84 59.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 72.510000000000005 110.884 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 19.9 m -52.57 -31.23 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 71.200000000000003 111.138 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 45.0 t -68.7 -57.28 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 110.86 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.43 -44.67 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 71.349999999999994 111.148 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 36.5 mm -67.34 -45.01 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 64.519999999999996 111.111 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.5 p -60.73 -41.91 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.099999999999994 110.851 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.36 76.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 111.101 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.3 -43.37 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 74.349999999999994 111.198 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.74 -47.52 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 75.439999999999998 111.082 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.14 -52.84 50.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 74.420000000000002 112.487 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 30.2 mm -62.27 -30.42 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 64.129999999999995 111.067 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.6 -51.73 32.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.040000000000006 110.892 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -37.16 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 110.884 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.69 -59.74 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 111.17 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.65 -47.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 111.116 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 89.1 t -56.48 -39.1 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 75.030000000000001 111.082 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -50.03 70.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 53.350000000000001 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.62 -44.94 86.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.754 -0.736 . . . . 63.210000000000001 112.478 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.1 -48.92 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 71.209999999999994 111.174 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.94 -54.08 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 63.0 111.155 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -52.75 -53.91 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 75.349999999999994 110.865 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -58.68 10.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.708 -0.758 . . . . 53.329999999999998 112.499 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.22 -39.65 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 75.129999999999995 111.127 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.14 -60.32 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 72.129999999999995 110.94 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 77.0 mt -52.2 -35.15 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.230000000000004 111.128 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -68.2 -54.24 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 63.140000000000001 110.912 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -35.53 72.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 74.200000000000003 110.879 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -64.73 -42.59 95.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 74.040000000000006 110.824 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 54.28 25.53 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 72.549999999999997 110.841 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.7 125.75 25.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 74.299999999999997 110.928 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -129.22 53.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.889 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 27.3 mt -115.34 66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 71.310000000000002 111.109 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.31 66.83 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.847 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 71.349999999999994 110.869 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.488 -0.245 . . . . 42.399999999999999 112.488 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.6 p -148.62 156.53 41.79 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.591 0.71 . . . . 75.209999999999994 110.912 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 165.66 30.29 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.696 2.264 . . . . 74.120000000000005 112.34 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -167.24 168.02 13.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 70.319999999999993 111.15 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.82 140.12 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.929 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -119.23 176.35 5.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 110.884 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.61 136.59 57.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 71.510000000000005 110.798 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.33 122.48 6.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 50.539999999999999 111.08 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.5 p -127.15 73.31 77.05 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.621 0.724 . . . . 65.409999999999997 110.859 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -17.78 37.43 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.71 2.273 . . . . 72.219999999999999 112.369 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -37.87 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 72.439999999999998 110.932 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.1 m -51.72 -32.16 29.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 72.209999999999994 111.144 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -67.46 -57.79 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 70.409999999999997 110.856 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.7 mt -51.4 -44.61 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 71.329999999999998 111.101 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.24 -44.44 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 74.549999999999997 111.137 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.3 p -61.38 -41.68 97.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.209999999999994 110.897 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.01 77.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 75.530000000000001 111.047 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.63 -43.78 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 72.310000000000002 111.135 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.6 t -61.38 -47.65 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 73.540000000000006 111.108 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.9 -50.1 71.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 73.120000000000005 112.484 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.3 -33.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 72.310000000000002 111.146 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.32 -49.18 58.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.978 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -57.94 -38.6 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 110.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.11 -58.23 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 111.151 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.61 -47.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 72.549999999999997 111.132 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.65 -38.27 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 75.140000000000001 111.168 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.36 -49.79 70.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 64.120000000000005 110.913 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.26 -44.19 89.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.789 -0.72 . . . . 65.25 112.462 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.55 -48.72 86.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 75.230000000000004 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -57.52 -54.03 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 71.040000000000006 111.108 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.84 -53.37 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.863 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.88 -58.06 11.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 64.049999999999997 112.478 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -58.03 -40.32 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 74.099999999999994 111.127 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.3 mt -57.66 -59.19 5.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.540000000000006 110.889 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.5 mt -52.36 -37.26 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 71.310000000000002 111.142 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -68.95 -63.5 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 73.310000000000002 110.888 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.98 -31.21 28.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 74.430000000000007 110.89 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -63.4 -50.44 69.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 74.239999999999995 110.877 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.77 88.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.877 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.18 159.54 31.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 73.310000000000002 110.874 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.61 114.25 23.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 75.219999999999999 110.933 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 mt -114.3 65.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 75.140000000000001 111.139 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 55.33 84.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 71.439999999999998 110.879 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.8 mttt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 110.878 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.5 -0.24 . . . . 63.43 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 4.6 p -148.58 156.45 41.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.53 0.681 . . . . 75.120000000000005 110.879 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.65 165.62 30.23 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 74.409999999999997 112.363 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.33 167.96 13.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 65.150000000000006 111.112 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.95 140.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.442 . . . . 74.310000000000002 110.934 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -119.31 176.56 5.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.864 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.18 135.84 56.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 73.319999999999993 110.869 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.06 123.23 6.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 70.239999999999995 111.089 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 63.0 p -126.34 72.39 72.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 72.209999999999994 110.838 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -16.74 37.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.634 2.223 . . . . 74.409999999999997 112.354 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.88 -39.12 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 110.908 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 86.2 m -52.57 -32.03 38.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 70.299999999999997 111.053 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 5.0 t -67.43 -57.63 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 55.219999999999999 110.87 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 80.8 mt -51.41 -44.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 75.010000000000005 111.12 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.19 -44.39 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 111.098 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.5 p -61.37 -41.66 97.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 70.129999999999995 110.849 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.92 77.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 75.450000000000003 111.154 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 98.4 t -54.74 -43.74 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 70.430000000000007 111.113 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.43 -47.96 91.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.140000000000001 111.157 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.7 -49.08 82.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 74.040000000000006 112.44 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 72.8 mt -64.43 -32.3 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 71.230000000000004 111.183 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.85 -49.31 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 72.200000000000003 110.918 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.38 -38.53 77.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 110.938 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.17 -58.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 111.07 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.19 -48.27 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 73.450000000000003 111.156 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 91.8 t -56.37 -39.03 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.010000000000005 111.081 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.49 -49.74 70.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 74.420000000000002 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.6 87.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 73.340000000000003 112.491 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.37 -49.12 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 74.420000000000002 111.159 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 45.9 t -59.22 -53.85 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 73.120000000000005 111.121 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -52.05 -53.43 42.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.911 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.1 -58.37 10.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 70.519999999999996 112.489 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.62 -40.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.838 0.351 . . . . 75.439999999999998 111.135 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.06 -59.57 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 74.200000000000003 110.91 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 75.5 mt -52.5 -35.32 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 111.163 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -66.99 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 75.140000000000001 110.858 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -35.0 61.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.858 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -67.22 -49.22 65.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.439999999999998 110.875 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.61 88.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.530000000000001 110.955 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.96 159.27 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 72.420000000000002 110.913 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.15 112.07 19.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 64.329999999999998 110.917 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 25.9 mt -115.75 64.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 75.140000000000001 111.181 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 54.0 84.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 75.349999999999994 110.873 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 40.6 mttt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 74.319999999999993 110.909 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.496 -0.241 . . . . 72.310000000000002 112.496 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.96 160.54 37.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.591 0.71 . . . . 73.510000000000005 110.901 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 94.07 0.53 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.716 2.277 . . . . 74.349999999999994 112.344 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.6 119.01 23.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 71.319999999999993 111.062 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -142.87 75.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.907 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -146.46 138.99 25.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 73.510000000000005 110.932 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.31 146.07 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 110.886 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.15 31.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 111.066 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.25 160.53 27.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.625 0.726 . . . . 64.299999999999997 110.821 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -17.64 37.24 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.708 2.272 . . . . 73.230000000000004 112.399 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 -38.67 58.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 75.019999999999996 110.896 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.2 m -62.42 -32.42 73.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 111.133 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.67 -57.38 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 73.540000000000006 110.839 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.5 mt -51.53 -44.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.085 -0.507 . . . . 75.299999999999997 111.138 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.59 -44.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.467 . . . . 75.219999999999999 111.163 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -61.14 -41.16 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 110.871 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.49 74.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 72.219999999999999 111.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.22 -44.37 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 111.15 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.85 -48.36 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 111.098 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.56 -46.89 93.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 75.400000000000006 112.569 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.7 mt -65.53 -31.18 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 74.049999999999997 111.146 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tp -69.55 -46.15 67.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 73.409999999999997 110.873 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.89 -37.78 88.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.961 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.51 -57.1 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 70.439999999999998 111.164 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.1 t -51.62 -50.28 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 111.115 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.3 t -55.11 -39.35 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 73.049999999999997 111.156 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -49.64 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -45.15 85.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 71.239999999999995 112.512 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.5 t -59.1 -49.13 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.419 . . . . 72.109999999999999 111.137 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.09 -53.8 43.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 111.144 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.96 -53.71 38.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 74.030000000000001 110.896 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.84 -58.73 9.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 72.400000000000006 112.488 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.48 -39.75 70.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 72.540000000000006 111.167 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.8 mt -59.62 -59.5 5.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 75.439999999999998 110.894 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.9 mt -51.72 -34.76 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 75.400000000000006 111.081 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -67.29 -59.97 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.120000000000005 110.916 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -55.64 -25.72 40.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 74.219999999999999 110.895 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -66.75 -22.88 66.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 75.219999999999999 110.893 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -50.56 146.31 5.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 62.439999999999998 110.96 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 63.34 44.93 5.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.439999999999998 110.91 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -68.25 165.44 18.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 72.010000000000005 110.894 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.4 mm -92.58 56.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 111.187 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -110.92 59.1 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.340000000000003 110.859 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 72.25 110.94 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.488 -0.245 . . . . 75.540000000000006 112.488 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.02 160.55 37.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.591 0.71 . . . . 74.109999999999999 110.914 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 94.05 0.53 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.716 2.277 . . . . 72.129999999999995 112.379 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -128.62 119.29 24.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 61.119999999999997 111.071 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -142.53 75.21 1.48 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.218 -0.446 . . . . 73.200000000000003 110.876 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -146.68 139.57 25.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.496 . . . . 74.450000000000003 110.913 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.83 145.88 1.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.858 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -173.4 31.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 72.450000000000003 111.077 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.25 160.58 27.06 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.679 0.752 . . . . 64.540000000000006 110.846 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -16.39 37.34 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.667 2.245 . . . . 70.25 112.355 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.81 -38.77 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 74.450000000000003 110.871 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.9 m -61.52 -32.01 72.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 111.156 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -57.29 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.230000000000004 110.858 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 72.2 mt -51.5 -44.38 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 65.25 111.169 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.57 -44.93 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 73.129999999999995 111.175 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 59.6 p -61.13 -41.07 96.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 74.549999999999997 110.866 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.38 74.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 71.430000000000007 111.075 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 98.6 t -54.28 -44.34 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 72.319999999999993 111.159 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.83 -48.78 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 71.019999999999996 111.129 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.8 -47.71 88.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 75.129999999999995 112.502 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 78.5 mt -66.26 -30.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 111.166 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 10.4 tp -70.12 -46.09 65.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 75.019999999999996 110.973 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.19 -38.63 91.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.882 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.02 -57.15 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 73.299999999999997 111.117 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 80.8 t -51.73 -49.8 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 70.329999999999998 111.126 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.06 -39.47 50.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 111.166 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -49.9 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 70.450000000000003 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.75 87.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 65.010000000000005 112.477 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.09 -48.97 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.948 0.404 . . . . 64.230000000000004 111.145 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.57 -54.0 39.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 73.200000000000003 111.191 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -52.35 -53.84 39.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 74.340000000000003 110.873 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.25 -59.23 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.662 -0.78 . . . . 74.409999999999997 112.481 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -56.59 -39.76 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 73.349999999999994 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.75 -60.4 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 74.140000000000001 110.831 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 75.0 mt -52.25 -35.31 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 75.230000000000004 111.136 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -67.9 -59.02 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.923 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -55.57 -25.69 39.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 71.230000000000004 110.851 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -66.28 -23.39 66.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.209999999999994 110.872 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -50.65 146.29 5.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 110.918 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 63.22 45.55 5.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.915 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.7 165.58 16.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.856 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 20.7 mm -92.62 56.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 75.099999999999994 111.156 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -111.08 59.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.811 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 74.400000000000006 110.861 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.537 -0.225 . . . . 42.310000000000002 112.537 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 66.4 m 53.76 71.98 1.25 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 74.209999999999994 110.885 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 177.26 5.77 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.605 2.204 . . . . 72.310000000000002 112.345 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.91 149.75 34.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 111.077 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.21 138.71 19.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 75.329999999999998 110.914 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.87 148.74 50.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.839 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.59 82.46 6.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.902 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.12 40.67 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 71.25 111.107 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 p -134.28 72.03 71.58 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.693 0.758 . . . . 72.120000000000005 110.853 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -22.01 32.47 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.671 2.247 . . . . 74.129999999999995 112.369 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mt -52.83 -36.68 59.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 110.846 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.3 m -51.84 -35.16 43.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 71.510000000000005 111.179 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -56.93 10.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.200000000000003 110.934 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.0 mt -51.36 -46.51 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 73.109999999999999 111.099 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 mm -65.98 -43.87 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.409999999999997 111.083 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 p -61.16 -43.07 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 71.540000000000006 110.822 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.7 80.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 75.030000000000001 111.138 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.64 -47.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 111.13 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.01 -47.03 91.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 75.510000000000005 111.106 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.75 -54.4 38.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 73.120000000000005 112.42 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -61.56 -30.06 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 75.519999999999996 111.134 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.9 tp -69.47 -49.72 52.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.230000000000004 110.906 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -37.52 79.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 110.932 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.46 -58.78 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.120000000000005 111.147 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.99 -47.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 111.123 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.18 -38.83 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 64.200000000000003 111.195 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.89 -49.87 70.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 72.519999999999996 110.974 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.38 88.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 53.240000000000002 112.492 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -59.32 -48.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 72.140000000000001 111.179 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -57.69 -54.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.230000000000004 111.097 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -51.9 -53.32 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 71.540000000000006 110.917 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -57.89 11.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 74.030000000000001 112.502 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -58.23 -40.3 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.89 0.376 . . . . 75.109999999999999 111.167 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.6 mt -57.71 -59.93 4.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.549999999999997 110.892 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 mm -56.34 -31.65 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 111.168 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -69.62 -58.55 3.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 70.409999999999997 110.901 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -55.16 -34.35 63.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.129999999999995 110.816 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -60.56 -41.44 94.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.5 110.845 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 51.76 88.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 70.200000000000003 110.886 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.04 126.32 8.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.010000000000005 110.931 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -129.26 38.41 3.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 73.140000000000001 110.913 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.9 mt -114.65 66.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 71.0 111.143 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.73 102.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 110.843 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.875 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.55 -0.22 . . . . 74.340000000000003 112.55 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 66.6 m 53.78 71.95 1.25 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.643 0.735 . . . . 75.230000000000004 110.867 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 177.13 5.85 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.778 2.319 . . . . 74.340000000000003 112.309 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -113.8 149.68 34.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 72.25 111.147 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.25 138.76 19.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 75.129999999999995 110.916 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.77 148.87 50.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 72.209999999999994 110.876 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.46 82.26 6.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.933 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.16 40.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 54.509999999999998 111.118 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 4.6 p -134.3 72.39 70.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.643 0.735 . . . . 74.340000000000003 110.798 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -22.21 32.28 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.67 2.247 . . . . 74.329999999999998 112.311 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 mt -52.86 -36.38 58.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 110.923 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 40.3 m -51.74 -35.17 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 111.173 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -56.95 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.409999999999997 110.834 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 4.0 mt -51.35 -46.55 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 70.329999999999998 111.123 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 37.8 mm -65.88 -43.81 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 64.120000000000005 111.116 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 45.4 p -61.15 -43.1 99.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.430000000000007 110.921 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.6 80.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.518 . . . . 75.519999999999996 111.071 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 95.5 t -53.64 -47.8 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 64.319999999999993 111.132 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.9 -47.1 90.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 71.299999999999997 111.101 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.53 -54.41 38.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 75.400000000000006 112.535 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.87 -30.83 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 73.219999999999999 111.198 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 12.0 tp -70.21 -49.52 49.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 72.219999999999999 110.909 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -37.31 80.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.519999999999996 110.916 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.92 -59.06 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 65.25 111.098 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 91.0 t -51.84 -48.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 111.144 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 88.7 t -56.8 -38.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.62 -48.94 72.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.12 88.47 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 64.200000000000003 112.505 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.41 -49.17 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 74.450000000000003 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.67 -53.55 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 111.129 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -51.86 -53.13 44.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 110.866 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.99 -57.98 11.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 54.020000000000003 112.495 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.1 -41.04 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.372 . . . . 71.420000000000002 111.126 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.74 -61.44 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 110.874 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.5 mm -56.58 -30.98 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 111.114 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -68.9 -61.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 72.540000000000006 110.897 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -58.66 -38.73 78.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 75.349999999999994 110.88 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -64.97 -40.57 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.150000000000006 110.839 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 51.78 88.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 73.439999999999998 110.916 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.53 127.1 7.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 74.040000000000006 110.934 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -128.67 37.28 4.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 71.049999999999997 110.929 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.0 mt -115.55 65.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 74.120000000000005 111.182 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.3 102.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 70.25 110.917 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 75.030000000000001 110.957 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.491 -0.243 . . . . 72.510000000000005 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 24.6 t -149.19 69.94 9.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 73.319999999999993 110.822 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 116.93 4.8 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 74.219999999999999 112.327 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.91 -34.75 59.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 62.450000000000003 111.086 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.7 35.91 22.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.839 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.27 -28.36 29.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 75.299999999999997 110.96 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 58.48 40.6 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 71.409999999999997 110.93 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.8 55.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 111.124 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.2 m -122.23 73.15 37.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.715 0.769 . . . . 74.420000000000002 110.889 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -22.43 31.94 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.684 2.256 . . . . 71.219999999999999 112.336 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.13 -33.7 65.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.224 -0.444 . . . . 63.329999999999998 110.834 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.3 m -52.24 -32.17 35.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 72.540000000000006 111.144 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.6 m -67.8 -58.07 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.845 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -51.28 -44.45 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 111.146 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.7 mt -67.36 -44.38 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 63.329999999999998 111.135 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -61.61 -41.26 97.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 72.129999999999995 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.52 -48.04 76.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.549999999999997 111.094 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.3 t -54.77 -43.88 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.549999999999997 111.181 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.16 -48.23 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 54.43 111.111 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.5 -48.0 87.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 70.329999999999998 112.467 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.1 mt -66.38 -31.66 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.376 . . . . 75.310000000000002 111.18 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 tp -69.67 -44.84 69.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.957 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -38.74 92.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 74.299999999999997 110.871 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.03 -57.04 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 70.209999999999994 111.126 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -51.82 -50.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 72.450000000000003 111.093 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.6 t -54.98 -38.71 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 65.120000000000005 111.074 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tp -64.08 -50.16 69.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 74.409999999999997 110.936 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.91 86.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.831 -0.699 . . . . 63.409999999999997 112.418 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.01 -48.93 85.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 63.229999999999997 111.151 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.92 -54.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 111.185 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -52.0 -53.66 39.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 74.25 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.58 10.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 54.030000000000001 112.526 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.58 -39.97 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.377 . . . . 64.439999999999998 111.085 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.32 -60.21 4.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 71.25 110.94 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.4 mm -58.97 -31.21 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 111.093 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -67.19 -56.99 7.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 110.913 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -58.62 -41.94 87.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 72.219999999999999 110.876 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -63.35 -39.44 94.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 73.310000000000002 110.89 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -36.72 39.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 71.409999999999997 110.9 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -67.71 -55.64 12.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 62.229999999999997 110.897 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.23 158.97 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.409999999999997 110.919 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.36 66.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 75.430000000000007 111.135 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.83 56.76 6.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.540000000000006 110.821 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 71.340000000000003 110.864 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.479 -0.248 . . . . 61.020000000000003 112.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 24.4 t -149.11 69.91 9.91 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.571 0.7 . . . . 74.030000000000001 110.951 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 116.93 4.79 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.664 2.243 . . . . 74.120000000000005 112.329 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.9 -34.6 59.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 63.340000000000003 111.117 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.64 35.85 22.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 72.349999999999994 110.93 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.38 -28.39 28.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 110.884 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 58.28 40.54 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 74.329999999999998 110.859 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.85 54.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 73.120000000000005 111.105 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 7.3 m -122.56 72.89 41.09 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.683 0.754 . . . . 75.030000000000001 110.76 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -22.75 31.28 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.709 2.272 . . . . 64.420000000000002 112.297 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.41 -33.94 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.25 110.962 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 95.5 m -52.69 -32.21 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 111.175 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -67.7 -58.05 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 65.340000000000003 110.813 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.3 mm -51.27 -44.53 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 111.157 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.3 -44.37 87.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.5 111.157 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.2 p -61.68 -41.09 97.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 62.039999999999999 110.904 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.04 76.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 70.319999999999993 111.125 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 99.3 t -54.77 -43.91 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 72.400000000000006 111.153 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.18 -48.37 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 111.11 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.84 -47.6 89.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.724 -0.75 . . . . 64.0 112.563 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.76 -30.97 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 73.120000000000005 111.12 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 16.2 tp -69.97 -45.04 68.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 74.329999999999998 110.907 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 74.200000000000003 110.975 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.06 -56.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 75.540000000000006 111.144 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.85 -50.4 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 62.229999999999997 111.149 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -54.9 -38.83 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 74.450000000000003 111.112 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.98 -50.19 69.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 110.954 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.77 86.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 74.230000000000004 112.484 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 74.230000000000004 111.153 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.74 -53.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 63.399999999999999 111.128 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.69 -53.83 42.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 63.210000000000001 110.872 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -59.03 9.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 43.420000000000002 112.51 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.88 -39.71 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.952 0.406 . . . . 75.540000000000006 111.144 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.48 -61.37 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 74.140000000000001 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.44 -31.5 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 75.450000000000003 111.133 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -67.22 -56.95 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 71.409999999999997 110.943 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -58.5 -42.26 87.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 72.219999999999999 110.856 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -63.76 -39.87 95.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 110.895 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -37.06 42.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 110.922 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -67.9 -55.94 10.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 71.340000000000003 110.882 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.25 159.25 8.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 74.310000000000002 110.89 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.7 mt -115.34 66.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 111.121 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.95 56.54 6.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 75.310000000000002 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 75.120000000000005 110.892 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.479 -0.248 . . . . 74.530000000000001 112.479 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.7 m -137.41 72.41 51.37 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.483 0.659 . . . . 75.319999999999993 110.894 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -179.93 3.26 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.613 2.209 . . . . 75.450000000000003 112.377 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.42 92.72 8.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 74.430000000000007 111.083 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -158.06 127.0 5.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 74.239999999999995 110.916 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.46 112.44 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 71.230000000000004 110.916 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 118.4 10.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.909 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.14 53.47 2.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 111.075 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.86 160.54 43.57 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.647 0.737 . . . . 74.329999999999998 110.908 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -47.11 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.693 2.262 . . . . 61.229999999999997 112.378 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.48 -26.03 40.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.299999999999997 110.869 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 m -62.27 -32.37 73.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 74.310000000000002 111.079 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -57.94 5.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 63.229999999999997 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.38 -44.5 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 111.089 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.3 mt -67.01 -44.79 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 70.430000000000007 111.152 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 p -61.28 -42.1 98.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 63.299999999999997 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.57 80.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 73.530000000000001 111.13 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -54.81 -45.07 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.230000000000004 111.149 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.12 -48.57 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 74.420000000000002 111.12 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.92 -48.09 87.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 72.030000000000001 112.474 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.91 -34.21 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 74.540000000000006 111.116 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.76 -48.72 58.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 110.942 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -36.86 73.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 70.140000000000001 110.956 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.3 -58.0 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.184 -0.462 . . . . 73.010000000000005 111.123 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.5 t -52.32 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.134 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.9 t -57.53 -41.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 72.0 111.108 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.78 -46.33 90.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 70.439999999999998 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.38 -40.14 97.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 34.530000000000001 112.477 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.31 -48.53 87.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 72.239999999999995 111.139 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.04 -52.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 111.163 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -52.65 -53.73 43.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.430000000000007 110.906 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.56 10.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 71.120000000000005 112.459 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.68 -39.71 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 72.230000000000004 111.102 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.8 mt -60.4 -61.18 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.230000000000004 110.936 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.4 mm -55.64 -31.22 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 75.409999999999997 111.111 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -71.58 -62.91 1.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 70.409999999999997 110.913 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -52.61 -30.96 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 110.849 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.31 -55.87 6.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 74.530000000000001 110.915 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 51.62 88.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 73.239999999999995 110.898 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -179.24 -173.13 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.540000000000006 110.911 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -79.06 -177.76 5.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 110.872 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.52 66.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 111.189 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 52.04 71.38 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 75.319999999999993 110.801 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 75.040000000000006 110.965 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.461 -0.255 . . . . 74.310000000000002 112.461 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 72.7 m -137.49 72.57 50.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.578 0.704 . . . . 73.010000000000005 110.861 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -179.95 3.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.728 2.285 . . . . 54.229999999999997 112.336 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.4 92.82 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.439999999999998 111.084 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -158.1 126.96 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.5 110.924 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.36 112.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.877 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 118.36 10.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 75.329999999999998 110.855 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.22 53.38 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.099999999999994 111.09 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.77 160.52 43.88 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.647 0.736 . . . . 72.049999999999997 110.884 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -46.96 1.05 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.688 2.259 . . . . 65.109999999999999 112.36 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -26.24 38.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.967 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 2.8 m -62.2 -32.33 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 75.510000000000005 111.186 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -57.94 5.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 64.549999999999997 110.893 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 2.8 mp -51.37 -44.49 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 71.030000000000001 111.151 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.03 -44.83 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 75.310000000000002 111.16 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 58.5 p -61.19 -42.0 97.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 73.439999999999998 110.954 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.65 80.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 74.519999999999996 111.044 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.77 -45.06 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 111.119 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.14 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 64.549999999999997 111.131 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.89 -48.11 87.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 74.510000000000005 112.49 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.41 -33.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 70.439999999999998 111.193 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.14 -48.66 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 72.219999999999999 110.934 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.13 74.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.908 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.99 -57.93 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.549999999999997 111.102 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 79.1 t -52.04 -46.83 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 74.230000000000004 111.095 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 95.3 t -57.18 -42.41 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 111.152 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.34 -46.04 91.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 73.349999999999994 110.91 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.82 96.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 75.239999999999995 112.443 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.56 -48.56 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 73.349999999999994 111.189 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.1 -52.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 75.140000000000001 111.081 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -52.59 -53.64 43.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 110.897 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.39 -59.25 9.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 52.43 112.524 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 70.4 mt -56.79 -39.22 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 74.409999999999997 111.128 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.7 mt -58.51 -60.27 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 71.319999999999993 110.883 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 26.3 mm -55.97 -30.96 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 111.101 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -71.07 -60.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.409999999999997 110.829 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -52.01 -30.12 23.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 75.400000000000006 110.825 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.94 -56.32 6.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 71.129999999999995 110.875 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 51.77 88.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.878 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -178.46 -173.86 0.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.99 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -79.77 -178.24 6.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.975 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.63 66.43 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 75.310000000000002 111.08 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 52.11 71.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 73.439999999999998 110.854 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 72.430000000000007 110.873 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.476 -0.25 . . . . 72.319999999999993 112.476 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.6 t -130.23 68.8 81.57 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.63 0.729 . . . . 70.200000000000003 110.901 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -45.4 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.697 2.265 . . . . 72.409999999999997 112.343 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.0 150.81 37.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 63.299999999999997 111.081 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -112.85 63.9 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 72.140000000000001 110.895 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.65 -177.69 6.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 65.140000000000001 110.915 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -158.61 80.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 65.519999999999996 110.912 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.74 141.5 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 70.329999999999998 111.106 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.55 160.54 37.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.749 0.785 . . . . 75.230000000000004 110.783 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -27.81 26.25 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.734 2.289 . . . . 74.400000000000006 112.339 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.17 -33.13 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 74.099999999999994 110.913 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -51.81 -32.28 30.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 111.147 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -57.75 5.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.329999999999998 110.898 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.55 -44.71 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 72.329999999999998 111.104 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mm -67.0 -44.33 88.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 73.420000000000002 111.124 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -61.77 -41.53 97.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 71.310000000000002 110.884 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -47.51 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 111.045 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -55.01 -45.58 76.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 75.319999999999993 111.132 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.71 -48.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 72.530000000000001 111.214 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.53 -48.36 86.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 64.510000000000005 112.516 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.83 -35.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.813 0.34 . . . . 74.129999999999995 111.107 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.78 -46.83 67.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 75.299999999999997 110.909 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -39.47 83.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 110.895 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.72 -55.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 111.078 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.31 -46.98 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 111.121 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.76 -40.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 111.117 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.92 -48.82 77.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.209999999999994 110.936 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.99 90.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 63.219999999999999 112.51 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.03 -48.69 85.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 74.340000000000003 111.117 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.23 -54.21 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 71.450000000000003 111.159 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -52.11 -53.84 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 73.319999999999993 110.93 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.87 -58.96 9.28 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.731 -0.747 . . . . 73.030000000000001 112.484 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.0 mm -57.22 -39.49 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 70.219999999999999 111.097 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -60.44 -60.63 3.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 110.963 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.2 mm -57.69 -32.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 63.549999999999997 111.197 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -68.86 -60.24 2.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 71.0 110.965 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -52.59 -37.2 57.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 110.904 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -53.55 38.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.239999999999995 110.875 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.09 -175.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 75.420000000000002 110.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.92 -174.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 72.25 110.885 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt 58.64 95.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 110.9 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 mt -115.46 66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 74.329999999999998 111.135 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -174.57 55.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.25 110.833 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 74.030000000000001 110.921 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.458 -0.257 . . . . 64.219999999999999 112.458 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 2.6 t -130.27 68.73 81.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 72.129999999999995 110.935 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 -45.37 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.672 2.248 . . . . 74.129999999999995 112.363 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.09 150.63 37.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.349999999999994 111.084 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -113.03 64.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.120000000000005 110.881 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.43 -177.43 6.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 75.400000000000006 110.916 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -158.28 81.08 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 75.319999999999993 110.871 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -152.49 142.68 22.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 72.349999999999994 111.138 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.3 160.53 35.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.695 0.759 . . . . 72.519999999999996 110.877 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -28.27 25.68 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.714 2.276 . . . . 74.239999999999995 112.375 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.6 -34.57 51.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 75.430000000000007 110.937 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 28.4 m -52.93 -32.16 44.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 61.219999999999999 111.147 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.73 -57.32 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 60.43 110.799 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 61.3 mt -51.5 -45.07 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 111.187 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . . . . . . . . . 37.3 mm -66.87 -44.36 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 73.340000000000003 111.13 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.9 p -61.62 -41.58 97.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.25 110.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.63 78.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.230000000000004 111.159 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 97.8 t -54.73 -45.51 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 111.048 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.96 -48.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 72.109999999999999 111.094 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.47 -48.69 84.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 73.409999999999997 112.482 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.62 -35.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 74.430000000000007 111.116 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.76 -46.88 67.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.873 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.81 -38.98 83.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 71.400000000000006 110.822 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.76 -56.02 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 75.25 111.161 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 57.2 t -53.05 -47.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 70.120000000000005 111.198 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.55 -40.56 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 72.209999999999994 111.131 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.04 -48.81 77.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.901 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.25 -45.19 88.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 74.420000000000002 112.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.15 -48.85 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 74.25 111.095 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 46.3 t -57.78 -54.05 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 75.329999999999998 111.154 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -52.1 -53.84 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 110.896 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -59.29 9.06 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 70.239999999999995 112.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.64 -39.72 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.375 . . . . 73.319999999999993 111.102 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -60.02 -60.63 3.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.3 mm -57.75 -31.63 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.010000000000005 111.085 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -68.14 -59.92 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 75.230000000000004 110.851 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -52.98 -37.17 61.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.400000000000006 110.897 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -52.72 50.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 72.319999999999993 110.92 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 54.05 -175.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.879 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.42 -174.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.928 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt 58.57 95.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.893 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.8 mt -115.51 66.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 75.239999999999995 111.114 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -174.54 55.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 74.219999999999999 110.863 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 73.540000000000006 110.898 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 120.866 0.277 . . . . 70.34 112.385 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.0 mt -52.69 -29.37 26.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.886 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -62.76 -32.54 73.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 63.11 111.108 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -57.72 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.89 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.8 mm -51.31 -44.6 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 72.32 111.14 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 59' ' ' VAL . 63.7 mt -67.13 -44.88 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.2 111.17 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -61.16 -41.74 97.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 51.01 110.862 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.9 78.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.31 111.159 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.4 t -54.68 -45.01 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 61.41 111.099 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 55' ' ' ILE . 96.0 t -60.1 -48.25 88.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.53 111.075 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.71 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.82 -47.31 91.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.24 112.488 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 65' ' ' VAL . 81.2 mt -65.41 -30.54 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 75.22 111.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -70.17 -45.22 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.31 110.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.35 -37.55 87.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 65.41 110.928 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.3 t -62.8 -56.85 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 60.32 111.169 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 61' ' ' ILE . 84.8 t -52.06 -50.33 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.22 111.116 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' HG23 ' A' ' 70' ' ' VAL . 90.8 t -55.46 -38.72 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 53.13 111.151 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -49.6 70.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 64.41 110.904 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.9 -45.08 87.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.755 -0.736 . . . . 73.15 112.43 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.12 -48.95 85.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 71.31 111.124 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.8 t -60.57 -53.82 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 65.25 111.149 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.1 -53.32 44.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 74.12 110.888 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.9 -57.73 12.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 61.45 112.449 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 72.11 111.138 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.83 0.263 . . . . 62.4 112.366 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.4 mt -52.58 -29.71 27.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 45.45 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.7 m -62.25 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.221 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -57.73 5.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 52.33 110.868 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 158' ' ' VAL . 51.0 mm -51.38 -44.67 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.44 111.151 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.469 ' O ' HG23 ' B' ' 159' ' ' VAL . 64.0 mt -67.09 -44.79 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 74.22 111.128 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 59.3 p -61.15 -41.85 97.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 44.43 110.902 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.85 78.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 61.34 111.073 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 154' ' ' ILE . 97.1 t -54.58 -44.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 63.52 111.134 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 155' ' ' ILE . 96.7 t -60.16 -48.55 87.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.173 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.705 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -62.09 -47.29 90.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 52.54 112.436 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.54 ' O ' HG23 ' B' ' 165' ' ' VAL . 81.0 mt -66.22 -30.24 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 60.41 111.077 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.652 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -70.16 -45.32 66.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.929 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.2 -37.81 88.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 61.04 110.897 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 160' ' ' GLY . 93.7 t -62.67 -56.84 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 71.43 111.177 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 161' ' ' ILE . 84.7 t -52.22 -49.96 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 70.32 111.129 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.672 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.3 t -55.47 -38.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 75.35 111.117 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.29 -49.8 70.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 75.2 110.855 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.89 87.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 72.34 112.473 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.19 -48.89 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 25.3 111.095 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.4 t -59.71 -53.95 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.121 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -53.38 -53.86 45.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 74.51 110.862 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -57.91 12.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 54.21 112.485 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.93 -39.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 70.42 111.135 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.09 -58.41 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.42 110.877 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.601 HD11 ' CE2' ' B' ' 171' ' ' PHE . 64.6 mt -59.68 -31.54 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 73.24 111.081 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -67.62 -50.9 55.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.914 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 75.42 110.896 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.823 0.259 . . . . 74.33 112.333 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.19 -38.64 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 50.4 110.939 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.682 HG23 ' HA ' ' B' ' 152' ' ' THR . 19.3 m -52.3 -30.88 30.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 25.4 111.102 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -68.89 -57.5 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 60.41 110.844 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.9 mm -51.31 -44.62 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 60.23 111.157 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.5 mm -67.26 -45.07 86.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 73.21 111.118 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.3 p -60.88 -41.77 96.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 65.0 110.879 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -48.31 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 74.41 111.13 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.7 t -54.41 -43.56 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 72.42 111.083 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 55' ' ' ILE . 86.4 t -61.54 -47.49 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 72.33 111.16 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.694 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.24 -53.17 48.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 74.24 112.501 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 mm -61.94 -29.44 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 72.54 111.151 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.8 tp -70.51 -50.61 35.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.12 110.936 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD23 HG21 ' B' ' 164' ' ' VAL . 7.5 tp -60.1 -37.22 79.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 61.32 110.976 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 60' ' ' GLY . 93.4 t -62.74 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 72.41 111.163 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 61' ' ' ILE . 92.0 t -51.74 -48.96 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 65.43 111.188 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.697 ' O ' HG23 ' A' ' 70' ' ' VAL . 86.2 t -55.74 -39.05 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 72.11 111.122 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -49.8 70.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.896 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.76 -44.89 86.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 75.41 112.493 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.17 -49.02 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 74.14 111.165 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.9 t -58.51 -54.07 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 65.13 111.112 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.93 -53.54 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.891 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.8 -58.47 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 51.11 112.488 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 74.32 111.184 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.82 0.258 . . . . 73.41 112.377 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.0 mt -51.74 -38.35 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 75.13 110.91 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.682 ' HA ' HG23 ' A' ' 52' ' ' THR . 18.9 m -51.96 -30.88 26.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 70.14 111.085 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.8 t -68.92 -57.57 5.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 54.21 110.87 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.9 mm -51.32 -44.65 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 70.02 111.139 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.495 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.6 mm -67.29 -45.05 86.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 65.41 111.125 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.3 p -60.89 -41.61 96.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.4 76.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 65.14 111.048 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.0 t -54.41 -43.46 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.02 111.116 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 155' ' ' ILE . 87.2 t -61.63 -47.71 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.44 111.127 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.676 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.58 -53.21 47.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 72.12 112.558 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.597 ' O ' HG23 ' B' ' 165' ' ' VAL . 29.8 mm -62.81 -28.03 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 64.12 111.115 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.624 ' O ' HG23 ' B' ' 166' ' ' VAL . 12.8 tp -70.0 -51.06 35.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.933 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 64' ' ' VAL . 7.5 tp -60.34 -37.59 81.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.953 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.676 HG23 ' O ' ' B' ' 160' ' ' GLY . 90.1 t -62.39 -58.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.23 111.129 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 161' ' ' ILE . 91.9 t -51.67 -48.68 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 73.13 111.144 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.707 ' O ' HG23 ' B' ' 170' ' ' VAL . 85.3 t -55.69 -39.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 71.01 111.155 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.07 -50.11 69.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.908 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.78 -44.47 86.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 70.34 112.536 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.29 -49.04 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 55.33 111.12 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.9 t -57.7 -53.93 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.31 111.14 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.7 t80 -52.69 -53.87 41.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.877 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.18 -58.95 9.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 51.34 112.462 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.96 -39.73 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 65.03 111.121 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.8 -61.1 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 61.4 110.903 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' B' ' 171' ' ' PHE . 78.4 mt -52.8 -39.09 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 72.23 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -62.39 -47.28 84.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 74.23 110.961 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 45.8 mtp85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 70.52 110.886 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.768 0.237 . . . . 64.41 112.353 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -23.47 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 61.33 110.918 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.653 HG21 HD12 ' B' ' 155' ' ' ILE . 31.6 m -55.91 -33.37 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 65.21 111.154 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -67.51 -57.97 5.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 35.25 110.87 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 58' ' ' VAL . 49.2 mm -51.46 -44.87 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.4 111.154 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.626 ' CD1' HG21 ' B' ' 152' ' ' THR . 79.0 mt -67.18 -43.48 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 64.33 111.171 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.698 ' HB3' HG21 ' B' ' 159' ' ' VAL . 3.8 m -62.27 -41.49 98.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 72.41 110.857 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.76 77.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 42.23 111.089 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 54' ' ' ILE . 94.9 t -55.64 -40.58 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.15 111.158 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' B' ' 156' ' ' SER . 92.3 t -63.92 -47.48 90.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 65.14 111.1 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.691 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.54 -46.25 92.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 62.22 112.474 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 65' ' ' VAL . 80.5 mt -66.81 -27.46 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.842 0.353 . . . . 71.53 111.038 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.658 ' O ' HG23 ' A' ' 66' ' ' VAL . 2.1 tt -71.13 -46.61 61.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 65.32 110.895 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -38.36 90.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.2 t -62.15 -55.15 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 64.53 111.15 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 61' ' ' ILE . 94.4 t -53.52 -48.94 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 75.3 111.093 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 70' ' ' VAL . 94.7 t -55.92 -38.67 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 63.31 111.104 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.21 -49.97 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.66 87.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.843 -0.694 . . . . 74.15 112.45 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.31 -48.85 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 72.04 111.146 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.5 t -58.16 -54.04 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 75.43 111.152 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -51.93 -53.65 38.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.852 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.38 10.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.728 -0.749 . . . . 72.35 112.471 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 62.21 111.149 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 CA-C-O 120.852 0.272 . . . . 74.2 112.434 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -23.27 36.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 52.52 110.92 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.626 HG21 ' CD1' ' A' ' 55' ' ' ILE . 30.8 m -58.11 -33.35 69.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.211 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -67.32 -57.71 6.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 65.11 110.873 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 158' ' ' VAL . 49.0 mm -51.52 -45.19 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 74.32 111.189 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.653 HD12 HG21 ' A' ' 52' ' ' THR . 79.3 mt -67.21 -43.32 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.133 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.725 ' HB3' HG21 ' A' ' 59' ' ' VAL . 3.8 m -62.05 -41.68 98.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.33 110.863 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 45.41 111.157 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.7 t -55.27 -40.62 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 70.21 111.135 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.698 HG21 ' HB3' ' A' ' 56' ' ' SER . 93.7 t -64.05 -47.57 89.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 61.34 111.136 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.704 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -63.6 -45.87 93.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 65.4 112.476 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.661 ' O ' HG23 ' B' ' 165' ' ' VAL . 81.0 mt -66.69 -26.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 64.22 111.144 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.65 ' O ' HG23 ' B' ' 166' ' ' VAL . 2.1 tt -70.93 -47.03 61.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.922 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.406 ' O ' HD13 ' B' ' 163' ' ' LEU . 0.2 OUTLIER -64.65 -38.32 90.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.902 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 160' ' ' GLY . 93.3 t -62.13 -54.86 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 64.33 111.189 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.661 HG23 ' O ' ' B' ' 161' ' ' ILE . 92.5 t -53.58 -48.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 73.03 111.164 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.706 ' O ' HG23 ' B' ' 170' ' ' VAL . 90.8 t -55.86 -39.43 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.157 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.49 -49.72 70.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 45.42 110.914 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.35 88.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 73.33 112.465 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.4 -49.07 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 51.15 111.133 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.0 t -58.42 -54.03 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 65.14 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.708 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.33 -53.61 42.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 73.15 110.871 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.14 -58.8 9.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 35.5 112.532 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.7 mm -57.21 -39.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 75.24 111.168 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.47 -59.88 4.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 75.03 110.943 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.708 HD11 ' CE2' ' B' ' 171' ' ' PHE . 76.4 mt -53.21 -44.16 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 72.33 111.111 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -59.72 -45.51 91.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 64.32 110.949 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.862 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.816 0.257 . . . . 75.24 112.305 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.97 -33.66 38.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 42.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.788 HG21 HD12 ' B' ' 155' ' ' ILE . 14.2 m -52.38 -33.43 43.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.11 111.167 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -58.64 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.881 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.5 mm -51.46 -43.44 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 73.34 111.116 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.782 HD12 HG21 ' B' ' 152' ' ' THR . 80.2 mt -67.29 -44.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 71.33 111.098 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 p -62.08 -40.89 97.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 72.23 110.883 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.87 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 45.35 111.092 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.5 t -56.1 -47.43 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 72.5 111.135 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 55' ' ' ILE . 84.1 t -57.65 -48.17 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 44.15 111.104 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.706 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -60.17 -49.21 81.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 44.01 112.494 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 65' ' ' VAL . 78.3 mt -63.56 -31.87 54.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.378 . . . . 65.51 111.127 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.66 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -69.77 -47.12 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.969 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.93 -38.53 88.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 50.43 110.885 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.0 t -62.09 -57.25 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 62.3 111.07 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.8 t -51.63 -48.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 74.12 111.14 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 70' ' ' VAL . 92.9 t -55.53 -41.23 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.45 111.115 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.26 -49.54 73.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 54.52 110.894 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.25 -44.35 89.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.742 -0.742 . . . . 71.42 112.505 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 65' ' ' VAL . 83.9 t -59.28 -48.97 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 44.25 111.138 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.6 t -57.52 -54.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.22 111.148 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -52.06 -53.7 39.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 72.11 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.38 10.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.522 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.13 111.112 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.774 0.239 . . . . 63.32 112.283 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.53 37.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 63.03 110.96 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.782 HG21 HD12 ' A' ' 55' ' ' ILE . 14.4 m -52.31 -33.32 41.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 70.24 111.11 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -58.74 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 72.23 110.86 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.5 mm -51.43 -43.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 74.42 111.118 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.788 HD12 HG21 ' A' ' 52' ' ' THR . 80.4 mt -67.34 -44.88 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 70.12 111.078 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 34.8 p -62.2 -40.92 97.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 65.54 110.818 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.9 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 51.31 111.064 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.5 t -56.07 -47.41 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 155' ' ' ILE . 84.7 t -57.69 -48.19 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.109 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.714 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -60.23 -49.01 83.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.675 -0.774 . . . . 64.22 112.517 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.544 ' O ' HG23 ' B' ' 165' ' ' VAL . 78.3 mt -63.61 -32.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 74.43 111.101 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.651 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -70.05 -47.19 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 64.32 110.905 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 163' ' ' LEU . 1.7 tt -61.3 -38.59 87.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 64.3 110.941 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 160' ' ' GLY . 94.7 t -62.65 -57.34 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.43 111.101 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 161' ' ' ILE . 93.0 t -51.62 -48.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.13 111.163 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.686 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.7 t -55.67 -40.6 61.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 74.21 111.171 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.29 -49.25 74.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.95 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.17 -44.66 88.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.738 . . . . 41.13 112.472 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.27 -48.94 85.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 73.11 111.171 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.686 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -57.43 -54.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.44 111.125 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.587 ' CZ ' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.65 -53.83 41.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.8 9.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 53.21 112.482 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.11 -39.71 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 72.33 111.155 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.62 -55.38 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 51.43 110.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.587 HD11 ' CZ ' ' B' ' 171' ' ' PHE . 73.0 mt -61.67 -50.82 78.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.1 111.127 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -41.43 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.911 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 73.31 110.935 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.81 0.254 . . . . 72.02 112.314 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -36.22 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 74.02 110.88 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -51.63 -37.37 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.02 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -61.94 -59.37 5.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 55.25 110.907 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.678 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.3 mm -51.43 -47.55 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 74.11 111.124 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 59' ' ' VAL . 40.1 mm -64.23 -40.01 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.02 111.186 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.685 ' OG ' HG21 ' B' ' 159' ' ' VAL . 0.1 OUTLIER -58.38 -47.52 83.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 65.1 110.848 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.63 -49.62 68.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 64.2 111.035 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.9 t -50.69 -40.14 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.24 111.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 55' ' ' ILE . 62.0 t -69.31 -42.94 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 64.11 111.12 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.58 -50.16 63.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 60.32 112.523 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 65' ' ' VAL . 63.4 mt -66.02 -29.9 48.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.939 0.399 . . . . 71.14 111.184 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.665 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -69.71 -46.92 64.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 65.25 110.951 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -38.66 91.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 72.44 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.1 t -61.49 -56.72 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 53.22 111.122 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 61' ' ' ILE . 87.7 t -52.58 -48.73 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 64.24 111.133 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 70' ' ' VAL . 92.2 t -55.55 -38.59 50.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 75.53 111.156 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -50.47 68.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 64.53 110.866 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.59 85.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.755 -0.735 . . . . 71.33 112.452 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.06 -49.11 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 73.24 111.109 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.3 t -57.86 -54.21 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.23 111.112 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.09 -53.56 40.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.908 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -58.25 10.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.798 -0.715 . . . . 75.53 112.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.369 . . . . 65.21 111.129 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.735 0.223 . . . . 74.4 112.373 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -36.49 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 71.12 110.908 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 13.3 m -51.57 -37.42 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.115 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -61.98 -59.24 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 45.1 110.888 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.687 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.1 mm -51.52 -47.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 73.14 111.092 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.692 ' O ' HG23 ' B' ' 159' ' ' VAL . 39.8 mm -64.32 -40.06 87.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -58.39 -47.53 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 60.42 110.801 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.57 68.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 51.14 111.088 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.6 t -50.83 -40.12 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 72.52 111.126 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.692 HG23 ' O ' ' B' ' 155' ' ' ILE . 62.1 t -69.25 -42.86 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.32 111.138 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.703 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -63.58 -50.21 63.58 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.668 -0.777 . . . . 75.24 112.513 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.548 ' O ' HG23 ' B' ' 165' ' ' VAL . 63.6 mt -66.05 -29.86 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 75.42 111.113 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.663 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -69.78 -46.93 64.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 63.33 110.967 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -38.6 91.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 73.42 110.903 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 160' ' ' GLY . 94.1 t -61.61 -56.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 55.43 111.088 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 161' ' ' ILE . 87.9 t -52.5 -48.87 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 75.55 111.091 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.685 ' O ' HG23 ' B' ' 170' ' ' VAL . 96.1 t -55.59 -38.67 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 61.35 111.102 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -50.42 68.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 62.14 110.915 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.64 85.42 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.654 -0.784 . . . . 51.2 112.487 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.12 -49.3 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 62.43 111.062 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.685 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.6 t -58.67 -54.03 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 70.11 111.148 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.649 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -52.72 -53.79 42.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.913 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.11 -58.66 10.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 64.51 112.427 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.3 -39.84 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 74.23 111.166 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 174' ' ' LEU . 19.1 mt -59.11 -58.95 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.4 110.884 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.649 HD11 ' CE2' ' B' ' 171' ' ' PHE . 77.1 mt -53.29 -40.27 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.187 -0.46 . . . . 61.02 111.165 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -65.3 -49.69 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 71.41 110.886 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.818 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.809 0.254 . . . . 62.43 112.342 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -51.93 -33.48 37.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 73.15 110.905 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.683 HG23 ' HA ' ' B' ' 152' ' ' THR . 18.7 m -51.75 -31.36 26.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.183 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -57.5 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.875 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.1 mm -51.31 -44.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 62.4 111.104 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.6 mm -67.27 -44.97 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.142 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.5 p -60.9 -41.74 96.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.861 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.24 76.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 63.22 111.056 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.0 t -54.45 -43.39 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 71.24 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 55' ' ' ILE . 86.9 t -61.66 -47.62 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 51.44 111.082 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.712 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.12 -52.97 50.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 73.43 112.488 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 65' ' ' VAL . 29.8 mm -62.58 -30.78 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.84 0.352 . . . . 64.13 111.127 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.6 tp -69.54 -51.54 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 72.15 110.932 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -37.05 73.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.4 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 60' ' ' GLY . 93.8 t -63.09 -60.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.31 111.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.6 t -51.64 -47.37 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 74.32 111.141 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.68 ' O ' HG23 ' A' ' 70' ' ' VAL . 91.8 t -56.56 -38.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 64.31 111.16 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -49.94 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.922 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -44.92 86.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.818 -0.705 . . . . 72.42 112.482 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.08 -49.04 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 72.04 111.136 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.8 t -59.62 -54.09 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 50.45 111.091 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.03 -53.63 39.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.869 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.27 10.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.752 . . . . 32.21 112.469 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 75.34 111.122 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.753 0.23 . . . . 70.12 112.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.35 -34.84 59.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 64.32 110.884 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.683 ' HA ' HG23 ' A' ' 52' ' ' THR . 19.9 m -52.57 -31.23 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 64.23 111.138 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 45.0 t -68.7 -57.28 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 54.25 110.86 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.1 mm -51.43 -44.67 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 51.12 111.148 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.499 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.5 mm -67.34 -45.01 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 60.21 111.111 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.5 p -60.73 -41.91 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.851 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.36 76.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.101 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.3 t -54.3 -43.37 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 50.02 111.198 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.499 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.1 t -61.74 -47.52 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 53.34 111.082 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.71 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.14 -52.84 50.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 74.42 112.487 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.482 ' O ' HG23 ' B' ' 165' ' ' VAL . 30.2 mm -62.27 -30.42 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 62.31 111.067 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.643 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.6 tp -69.6 -51.73 32.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.04 110.892 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -37.16 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.03 110.884 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.71 HG23 ' O ' ' B' ' 160' ' ' GLY . 88.6 t -62.69 -59.74 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.17 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 161' ' ' ILE . 89.7 t -51.65 -47.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 74.02 111.116 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.689 ' O ' HG23 ' B' ' 170' ' ' VAL . 89.1 t -56.48 -39.1 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.082 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -50.03 70.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 53.35 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.62 -44.94 86.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.754 -0.736 . . . . 63.21 112.478 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.1 -48.92 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 52.4 111.174 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.689 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.7 t -58.94 -54.08 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 52.14 111.155 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -52.75 -53.91 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 75.35 110.865 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -58.68 10.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.708 -0.758 . . . . 51.41 112.499 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.22 -39.65 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 74.34 111.127 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.14 -60.32 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 42.01 110.94 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.548 HD11 ' CE2' ' B' ' 171' ' ' PHE . 77.0 mt -52.2 -35.15 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 61.14 111.128 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -68.2 -54.24 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 51.14 110.912 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 74.2 110.879 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 120.847 0.27 . . . . 62.13 112.369 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -37.87 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 72.44 110.932 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.559 HG23 ' HA ' ' B' ' 152' ' ' THR . 79.1 m -51.72 -32.16 29.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 72.21 111.144 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -67.46 -57.79 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 62.44 110.856 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 80.7 mt -51.4 -44.61 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 65.22 111.101 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.7 mm -67.24 -44.44 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 64.52 111.137 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.3 p -61.38 -41.68 97.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.21 110.897 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.01 77.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 71.12 111.047 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.3 t -54.63 -43.78 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 51.04 111.135 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 55' ' ' ILE . 85.6 t -61.38 -47.65 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 73.54 111.108 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.9 -50.1 71.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 72.34 112.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' HG23 ' A' ' 65' ' ' VAL . 72.4 mt -64.3 -33.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 72.31 111.146 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.3 tt -69.32 -49.18 58.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.978 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -57.94 -38.6 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 54.54 110.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.4 t -63.11 -58.23 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 64.34 111.151 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 61' ' ' ILE . 58.3 t -52.61 -47.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 72.55 111.132 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.723 ' O ' HG23 ' A' ' 70' ' ' VAL . 96.5 t -56.65 -38.27 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 75.14 111.168 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.36 -49.79 70.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 41.14 110.913 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.26 -44.19 89.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.789 -0.72 . . . . 65.25 112.462 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.55 -48.72 86.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 75.23 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.2 t -57.52 -54.03 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 71.04 111.108 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.84 -53.37 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.863 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.88 -58.06 11.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 64.05 112.478 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 64.11 111.127 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.231 0.137 0 CA-C-O 120.791 0.246 . . . . 74.41 112.354 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.88 -39.12 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 42.25 110.908 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.559 ' HA ' HG23 ' A' ' 52' ' ' THR . 86.2 m -52.57 -32.03 38.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 70.3 111.053 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 5.0 t -67.43 -57.63 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 53.14 110.87 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 80.8 mt -51.41 -44.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 75.01 111.12 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.8 mm -67.19 -44.39 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.098 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.5 p -61.37 -41.66 97.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 70.13 110.849 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.92 77.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 51.33 111.154 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.4 t -54.74 -43.74 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 63.41 111.113 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.0 t -61.43 -47.96 91.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.14 111.157 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.694 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -60.7 -49.08 82.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 71.12 112.44 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 165' ' ' VAL . 72.8 mt -64.43 -32.3 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 42.21 111.183 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.654 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.3 tt -69.85 -49.31 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 63.41 110.918 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.38 -38.53 77.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 52.14 110.938 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 160' ' ' GLY . 97.7 t -63.17 -58.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 63.4 111.07 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 161' ' ' ILE . 58.0 t -52.19 -48.27 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 73.45 111.156 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.683 ' O ' HG23 ' B' ' 170' ' ' VAL . 91.8 t -56.37 -39.03 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.01 111.081 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.49 -49.74 70.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 71.41 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.6 87.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.491 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.37 -49.12 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 74.42 111.159 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.683 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.9 t -59.22 -53.85 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 51.24 111.121 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.729 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.3 t80 -52.05 -53.43 42.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.1 -58.37 10.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 70.52 112.489 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.62 -40.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.838 0.351 . . . . 75.44 111.135 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.06 -59.57 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 51.15 110.91 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.729 HD11 ' CE2' ' B' ' 171' ' ' PHE . 75.5 mt -52.5 -35.32 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.32 111.163 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -66.99 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 75.14 110.858 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.33 110.858 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.465 -0.165 0 CA-C-O 120.864 0.277 . . . . 73.23 112.399 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 -38.67 58.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 75.02 110.896 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.575 HG21 ' CD1' ' B' ' 155' ' ' ILE . 22.2 m -62.42 -32.42 73.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 65.1 111.133 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.67 -57.38 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 72.15 110.839 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 72.5 mt -51.53 -44.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.085 -0.507 . . . . 75.3 111.138 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.576 ' CD1' HG21 ' B' ' 152' ' ' THR . 65.2 mt -67.59 -44.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.467 . . . . 71.34 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB2' HG21 ' B' ' 159' ' ' VAL . 59.5 p -61.14 -41.16 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.871 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.49 74.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 72.01 111.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.7 t -54.22 -44.37 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 71.15 111.15 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' ILE . 90.0 t -60.85 -48.36 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 71.11 111.098 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.56 -46.89 93.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 71.32 112.569 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 65' ' ' VAL . 80.7 mt -65.53 -31.18 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 70.24 111.146 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 66' ' ' VAL . 10.3 tp -69.55 -46.15 67.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 73.41 110.873 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD22 ' CG2' ' B' ' 164' ' ' VAL . 1.2 tt -62.89 -37.78 88.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 62.41 110.961 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.4 t -62.51 -57.1 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 61.33 111.164 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 61' ' ' ILE . 80.1 t -51.62 -50.28 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.115 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 70' ' ' VAL . 90.3 t -55.11 -39.35 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 51.4 111.156 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -49.64 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -45.15 85.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 71.24 112.512 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.5 t -59.1 -49.13 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.419 . . . . 62.23 111.137 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.5 t -60.09 -53.8 43.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 51.13 111.144 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.96 -53.71 38.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 71.34 110.896 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.84 -58.73 9.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 72.4 112.488 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 72.54 111.167 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.203 0 CA-C-O 120.821 0.259 . . . . 70.25 112.355 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.81 -38.77 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 60.13 110.871 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.576 HG21 ' CD1' ' A' ' 55' ' ' ILE . 22.9 m -61.52 -32.01 72.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 73.41 111.156 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -57.29 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.858 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 72.2 mt -51.5 -44.38 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 52.21 111.169 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.575 ' CD1' HG21 ' A' ' 52' ' ' THR . 65.6 mt -67.57 -44.93 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 71.2 111.175 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.405 ' HB2' HG21 ' A' ' 59' ' ' VAL . 59.6 p -61.13 -41.07 96.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 74.55 110.866 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.38 74.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 71.43 111.075 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.6 t -54.28 -44.34 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 62.03 111.159 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 155' ' ' ILE . 92.6 t -60.83 -48.78 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 63.42 111.129 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -61.8 -47.71 88.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 75.13 112.502 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 78.5 mt -66.26 -30.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 72.41 111.166 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.657 ' O ' HG23 ' B' ' 166' ' ' VAL . 10.4 tp -70.12 -46.09 65.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.973 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.19 -38.63 91.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 72.42 110.882 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.6 t -62.02 -57.15 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 45.42 111.117 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 161' ' ' ILE . 80.8 t -51.73 -49.8 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.11 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.687 ' O ' HG23 ' B' ' 170' ' ' VAL . 92.1 t -55.06 -39.47 50.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 64.53 111.166 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -49.9 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 61.43 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.75 87.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 65.01 112.477 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.09 -48.97 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.948 0.404 . . . . 53.43 111.145 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -58.57 -54.0 39.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 73.2 111.191 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.704 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.35 -53.84 39.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.873 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.25 -59.23 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.662 -0.78 . . . . 51.41 112.481 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -56.59 -39.76 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 61.42 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.75 -60.4 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.831 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.704 HD11 ' CE2' ' B' ' 171' ' ' PHE . 75.0 mt -52.25 -35.31 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 65.14 111.136 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -67.9 -59.02 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.14 110.923 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.851 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.84 0.267 . . . . 64.23 112.369 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HA ' HD12 ' A' ' 54' ' ' ILE . 9.1 mt -52.83 -36.68 59.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 72.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.607 ' HA ' HG23 ' B' ' 152' ' ' THR . 40.3 m -51.84 -35.16 43.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 62.12 111.179 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -56.93 10.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.13 110.934 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.717 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.0 mt -51.36 -46.51 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 64.12 111.099 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 59' ' ' VAL . 37.8 mm -65.98 -43.87 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.41 111.083 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 p -61.16 -43.07 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 71.54 110.822 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.7 80.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 73.41 111.138 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 54' ' ' ILE . 95.6 t -53.64 -47.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 72.33 111.13 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 55' ' ' ILE . 97.9 t -59.01 -47.03 91.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.106 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -58.75 -54.4 38.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 72.44 112.42 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 mm -61.56 -30.06 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 71.1 111.134 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.663 ' O ' HG23 ' A' ' 66' ' ' VAL . 11.9 tp -69.47 -49.72 52.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.23 110.906 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -37.52 79.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.932 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 60' ' ' GLY . 90.3 t -62.46 -58.78 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 61.31 111.147 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 61' ' ' ILE . 91.7 t -51.99 -47.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.5 111.123 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 70' ' ' VAL . 93.5 t -56.18 -38.83 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 52.41 111.195 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.89 -49.87 70.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 65.3 110.974 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.38 88.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 33.35 112.492 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -59.32 -48.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 72.14 111.179 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.4 t -57.69 -54.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 63.34 111.097 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -51.9 -53.32 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 71.44 110.917 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -57.89 11.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 65.4 112.502 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.89 0.376 . . . . 75.11 111.167 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.735 0.223 . . . . 74.33 112.311 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 151' ' ' LEU . . . . . 0.555 ' HA ' HD12 ' B' ' 154' ' ' ILE . 9.2 mt -52.86 -36.38 58.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 72.31 110.923 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 52' ' ' THR . 40.3 m -51.74 -35.17 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.173 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -56.95 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.41 110.834 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 4.0 mt -51.35 -46.55 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 63.12 111.123 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.419 ' O ' HG23 ' B' ' 159' ' ' VAL . 37.8 mm -65.88 -43.81 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 61.14 111.116 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 45.4 p -61.15 -43.1 99.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.921 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.6 80.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.518 . . . . 72.42 111.071 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 95.5 t -53.64 -47.8 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 64.32 111.132 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 155' ' ' ILE . 97.2 t -58.9 -47.1 90.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 53.54 111.101 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -58.53 -54.41 38.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 72.21 112.535 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.502 ' O ' HG23 ' B' ' 165' ' ' VAL . 30.4 mm -61.87 -30.83 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 72.34 111.198 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.647 ' O ' HG23 ' B' ' 166' ' ' VAL . 12.0 tp -70.21 -49.52 49.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.909 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -37.31 80.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.916 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.4 t -62.92 -59.06 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 65.25 111.098 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 161' ' ' ILE . 91.0 t -51.84 -48.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.144 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.662 ' O ' HG23 ' B' ' 170' ' ' VAL . 88.7 t -56.8 -38.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 72.44 111.135 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.62 -48.94 72.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.12 88.47 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 50.34 112.505 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.41 -49.17 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 74.45 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.4 t -60.67 -53.55 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 63.45 111.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -51.86 -53.13 44.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 64.02 110.866 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.99 -57.98 11.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 40.11 112.495 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.1 -41.04 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.372 . . . . 63.2 111.126 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.74 -61.44 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.23 110.874 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.5 mm -56.58 -30.98 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.33 111.114 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -68.9 -61.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.897 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 75.35 110.88 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.759 0.233 . . . . 70.33 112.336 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.13 -33.7 65.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.224 -0.444 . . . . 53.01 110.834 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.59 HG21 HD12 ' B' ' 155' ' ' ILE . 95.3 m -52.24 -32.17 35.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 72.32 111.144 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.6 m -67.8 -58.07 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.845 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.3 mm -51.28 -44.45 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.146 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.593 HD12 HG21 ' B' ' 152' ' ' THR . 73.7 mt -67.36 -44.38 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 60.23 111.135 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -61.61 -41.26 97.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 63.02 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.52 -48.04 76.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.51 111.094 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 99.3 t -54.77 -43.88 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.55 111.181 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 55' ' ' ILE . 87.3 t -61.16 -48.23 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 43.24 111.111 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.711 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.5 -48.0 87.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 70.12 112.467 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 65' ' ' VAL . 76.1 mt -66.38 -31.66 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.376 . . . . 70.5 111.18 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.2 tp -69.67 -44.84 69.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 72.24 110.957 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -38.74 92.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 62.13 110.871 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.2 t -62.03 -57.04 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 60.45 111.126 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 61' ' ' ILE . 79.7 t -51.82 -50.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 72.45 111.093 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 70' ' ' VAL . 93.6 t -54.98 -38.71 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 65.12 111.074 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tp -64.08 -50.16 69.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 74.41 110.936 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.91 86.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.831 -0.699 . . . . 63.41 112.418 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.01 -48.93 85.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 63.23 111.151 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.1 t -57.92 -54.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 75.31 111.185 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -52.0 -53.66 39.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 74.25 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.58 10.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 54.03 112.526 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.377 . . . . 64.44 111.085 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.827 0.261 . . . . 62.41 112.297 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.41 -33.94 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.25 110.962 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.593 HG21 HD12 ' A' ' 55' ' ' ILE . 95.5 m -52.69 -32.21 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 75.32 111.175 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -67.7 -58.05 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 65.34 110.813 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.712 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.3 mm -51.27 -44.53 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 74.12 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 52' ' ' THR . 73.5 mt -67.3 -44.37 87.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.5 111.157 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.2 p -61.68 -41.09 97.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 53.51 110.904 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.04 76.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 41.35 111.125 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.712 HG23 ' O ' ' B' ' 154' ' ' ILE . 99.3 t -54.77 -43.91 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 53.54 111.153 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.8 t -61.18 -48.37 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.11 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -61.84 -47.6 89.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.724 -0.75 . . . . 42.01 112.563 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.554 ' O ' HG23 ' B' ' 165' ' ' VAL . 76.8 mt -66.76 -30.97 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 72.42 111.12 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.657 ' O ' HG23 ' B' ' 166' ' ' VAL . 16.2 tp -69.97 -45.04 68.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.907 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 74.2 110.975 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 97.4 t -62.06 -56.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 65.24 111.144 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 161' ' ' ILE . 78.1 t -51.85 -50.4 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 62.23 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.71 ' O ' HG23 ' B' ' 170' ' ' VAL . 93.9 t -54.9 -38.83 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.3 111.112 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.98 -50.19 69.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.954 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.77 86.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 43.1 112.484 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.53 111.153 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.71 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -57.74 -53.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 54.12 111.128 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.69 -53.83 42.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 63.21 110.872 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -59.03 9.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 43.42 112.51 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.88 -39.71 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.952 0.406 . . . . 74.51 111.144 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.48 -61.37 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 73.3 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.44 -31.5 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 75.45 111.133 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -67.22 -56.95 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 65.43 110.943 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 63.24 110.856 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.86 0.275 . . . . 61.23 112.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.48 -26.03 40.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.869 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.508 HG23 HG23 ' B' ' 152' ' ' THR . 2.8 m -62.27 -32.37 73.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 52.01 111.079 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -57.94 5.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 41.24 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.7 mp -51.38 -44.5 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 64.11 111.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 59' ' ' VAL . 66.3 mt -67.01 -44.79 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 70.43 111.152 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 p -61.28 -42.1 98.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 63.3 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.57 80.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 73.53 111.13 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.7 t -54.81 -45.07 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.23 111.149 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 55' ' ' ILE . 98.7 t -60.12 -48.57 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.42 111.12 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.92 -48.09 87.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 65.32 112.474 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 65' ' ' VAL . 76.2 mt -62.91 -34.21 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 74.22 111.116 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.656 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.2 tp -69.76 -48.72 58.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.03 110.942 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -36.86 73.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 53.2 110.956 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.0 t -65.3 -58.0 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.184 -0.462 . . . . 64.13 111.123 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 61' ' ' ILE . 78.5 t -52.32 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 61.11 111.134 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 62' ' ' LEU . 98.9 t -57.53 -41.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 72.0 111.108 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.78 -46.33 90.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 64.23 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.38 -40.14 97.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 34.53 112.477 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 65' ' ' VAL . 88.3 t -62.31 -48.53 87.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 62.21 111.139 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.04 -52.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 72.43 111.163 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -52.65 -53.73 43.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.43 110.906 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.56 10.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 55.52 112.459 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 62.13 111.102 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.848 0.27 . . . . 64.12 112.36 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -26.24 38.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.967 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.508 HG23 HG23 ' A' ' 52' ' ' THR . 2.8 m -62.2 -32.33 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 75.51 111.186 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -57.94 5.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 51.4 110.893 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.706 ' O ' HG23 ' B' ' 158' ' ' VAL . 2.8 mp -51.37 -44.49 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 55.32 111.151 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.462 ' O ' HG23 ' B' ' 159' ' ' VAL . 66.5 mt -67.03 -44.83 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.16 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 58.5 p -61.19 -42.0 97.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 64.53 110.954 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.65 80.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 74.52 111.044 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.2 t -54.77 -45.06 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 74.33 111.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 155' ' ' ILE . 97.7 t -60.14 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 64.41 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.705 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.89 -48.11 87.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.49 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.518 ' O ' HG23 ' B' ' 165' ' ' VAL . 76.6 mt -62.41 -33.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 70.44 111.193 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.639 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.2 tp -70.14 -48.66 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 64.04 110.934 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.13 74.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.01 110.908 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 160' ' ' GLY . 88.3 t -64.99 -57.93 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.55 111.102 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 161' ' ' ILE . 79.1 t -52.04 -46.83 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 74.23 111.095 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.639 HG23 ' O ' ' B' ' 162' ' ' LEU . 95.3 t -57.18 -42.41 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 74.04 111.152 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.34 -46.04 91.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.91 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.82 96.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 44.44 112.443 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 165' ' ' VAL . 87.8 t -62.56 -48.56 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 73.35 111.189 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.1 -52.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 63.45 111.081 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -52.59 -53.64 43.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.14 110.897 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.39 -59.25 9.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 52.43 112.524 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 70.4 mt -56.79 -39.22 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 74.41 111.128 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.7 mt -58.51 -60.27 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 71.32 110.883 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 26.3 mm -55.97 -30.96 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 74.31 111.101 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -71.07 -60.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.34 110.829 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 65.14 110.825 -179.954 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.851 0.271 . . . . 71.41 112.339 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.17 -33.13 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 65.11 110.913 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.584 ' HA ' HG23 ' B' ' 152' ' ' THR . 28.3 m -51.81 -32.28 30.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 74.11 111.147 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -57.75 5.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.898 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 58' ' ' VAL . 61.6 mt -51.55 -44.71 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 61.13 111.104 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 59' ' ' VAL . 37.1 mm -67.0 -44.33 88.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 72.53 111.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -61.77 -41.53 97.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 70.43 110.884 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -47.51 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.02 111.045 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.4 t -55.01 -45.58 76.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 75.32 111.132 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' ILE . 85.0 t -59.71 -48.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 71.03 111.214 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.53 -48.36 86.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 64.51 112.516 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 65' ' ' VAL . 71.0 mt -63.83 -35.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.813 0.34 . . . . 74.13 111.107 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -68.78 -46.83 67.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 75.3 110.909 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.675 HD23 HG21 ' B' ' 164' ' ' VAL . 0.8 OUTLIER -59.35 -39.47 83.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 73.21 110.895 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.8 t -62.72 -55.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.078 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 61' ' ' ILE . 58.8 t -53.31 -46.98 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.121 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.696 ' O ' HG23 ' A' ' 70' ' ' VAL . 96.5 t -56.76 -40.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.117 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.92 -48.82 77.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.21 110.936 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.99 90.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 50.35 112.51 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.03 -48.69 85.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 74.34 111.117 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.1 t -57.23 -54.21 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 53.54 111.159 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -52.11 -53.84 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 73.32 110.93 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.87 -58.96 9.28 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.731 -0.747 . . . . 54.04 112.484 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 53.35 111.097 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.23 0.122 0 CA-C-O 120.815 0.256 . . . . 74.24 112.375 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.6 -34.57 51.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 54.12 110.937 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 52' ' ' THR . 28.4 m -52.93 -32.16 44.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 55.13 111.147 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.73 -57.32 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 60.43 110.799 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 61.3 mt -51.5 -45.07 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 62.3 111.187 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 159' ' ' VAL . 37.3 mm -66.87 -44.36 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 73.23 111.13 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.9 p -61.62 -41.58 97.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.25 110.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.63 78.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.23 111.159 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 97.8 t -54.73 -45.51 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 75.32 111.048 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 155' ' ' ILE . 84.7 t -59.96 -48.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 72.11 111.094 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.714 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.47 -48.69 84.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 73.41 112.482 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.584 ' O ' HG23 ' B' ' 165' ' ' VAL . 71.3 mt -63.62 -35.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 74.43 111.116 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 162' ' ' LEU . . . . . 0.66 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -68.76 -46.88 67.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.873 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.687 HD23 HG21 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -59.81 -38.98 83.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 71.21 110.822 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.4 t -62.76 -56.02 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 74.01 111.161 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 161' ' ' ILE . 57.2 t -53.05 -47.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 70.12 111.198 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.672 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.3 t -56.55 -40.56 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 62.44 111.131 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.04 -48.81 77.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.901 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.25 -45.19 88.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.15 -48.85 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 74.25 111.095 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.3 t -57.78 -54.05 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 52.32 111.154 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -52.1 -53.84 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.896 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -59.29 9.06 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 52.03 112.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.64 -39.72 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.375 . . . . 72.32 111.102 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -60.02 -60.63 3.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 64.42 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.3 mm -57.75 -31.63 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.01 111.085 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -68.14 -59.92 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.4 110.851 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.897 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.466 -0.254 . . . . 43.45 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.0 p -129.85 68.36 80.61 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.647 0.737 . . . . 72.32 110.921 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 102.89 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.669 2.246 . . . . 74.22 112.326 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.67 129.49 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 44.31 111.104 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.02 29.75 6.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 72.32 110.895 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.483 ' C ' HD13 ' B' ' 151' ' ' LEU . 0.0 OUTLIER 63.29 161.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.23 110.87 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.98 -179.89 5.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.902 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -176.11 34.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.4 111.098 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.67 160.57 44.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 72.05 110.852 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -42.65 3.23 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.671 2.247 . . . . 70.34 112.385 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD13 ' C ' ' B' ' 146' ' ' GLN . 26.0 mt -52.69 -29.37 26.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.886 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -62.76 -32.54 73.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 63.11 111.108 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -57.72 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.89 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.8 mm -51.31 -44.6 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 72.32 111.14 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 59' ' ' VAL . 63.7 mt -67.13 -44.88 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.2 111.17 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -61.16 -41.74 97.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 51.01 110.862 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.9 78.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.31 111.159 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.4 t -54.68 -45.01 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 61.41 111.099 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 55' ' ' ILE . 96.0 t -60.1 -48.25 88.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.53 111.075 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.71 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.82 -47.31 91.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.24 112.488 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 65' ' ' VAL . 81.2 mt -65.41 -30.54 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 75.22 111.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -70.17 -45.22 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.31 110.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.35 -37.55 87.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 65.41 110.928 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.3 t -62.8 -56.85 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 60.32 111.169 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 61' ' ' ILE . 84.8 t -52.06 -50.33 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.22 111.116 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' HG23 ' A' ' 70' ' ' VAL . 90.8 t -55.46 -38.72 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 53.13 111.151 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -49.6 70.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 64.41 110.904 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.9 -45.08 87.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.755 -0.736 . . . . 73.15 112.43 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.12 -48.95 85.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 71.31 111.124 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.8 t -60.57 -53.82 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 65.25 111.149 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.4 t80 -52.1 -53.32 44.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 74.12 110.888 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.9 -57.73 12.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 61.45 112.449 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.34 -40.49 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 72.11 111.138 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 74' ' ' LEU . 24.7 mt -57.88 -57.3 13.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 74.14 110.95 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.68 HD11 ' CE2' ' A' ' 71' ' ' PHE . 65.6 mt -58.83 -31.03 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.137 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -66.86 -51.12 59.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 75.2 110.926 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -64.59 -45.89 85.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.3 110.918 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.0 mtt-85 -63.5 -28.09 69.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.876 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.2 -175.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.939 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.98 167.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 53.12 110.929 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 mttt 60.33 85.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 74.24 110.853 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.75 66.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 72.02 111.126 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -177.09 78.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 63.33 110.902 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 63.31 110.89 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.466 -0.254 . . . . 74.25 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 7.9 p -129.8 68.41 80.62 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 73.03 110.86 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 102.93 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 62.42 112.383 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.52 129.21 5.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 74.0 111.067 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.21 29.83 6.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.905 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.479 ' C ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 63.36 161.17 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.941 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 147' ' ' ARG . . . . . 0.406 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -129.71 179.55 5.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.11 110.856 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -176.79 34.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 74.05 111.089 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.33 160.55 45.14 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.69 0.757 . . . . 73.34 110.862 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -42.01 3.69 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.666 2.244 . . . . 62.4 112.366 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' LEU . . . . . 0.483 HD13 ' C ' ' A' ' 46' ' ' GLN . 26.4 mt -52.58 -29.71 27.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 45.45 110.867 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.7 m -62.25 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.221 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -57.73 5.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 52.33 110.868 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 158' ' ' VAL . 51.0 mm -51.38 -44.67 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.44 111.151 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.469 ' O ' HG23 ' B' ' 159' ' ' VAL . 64.0 mt -67.09 -44.79 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 74.22 111.128 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 59.3 p -61.15 -41.85 97.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 44.43 110.902 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.85 78.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 61.34 111.073 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 154' ' ' ILE . 97.1 t -54.58 -44.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 63.52 111.134 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 155' ' ' ILE . 96.7 t -60.16 -48.55 87.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.173 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.705 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -62.09 -47.29 90.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 52.54 112.436 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.54 ' O ' HG23 ' B' ' 165' ' ' VAL . 81.0 mt -66.22 -30.24 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 60.41 111.077 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.652 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -70.16 -45.32 66.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.929 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.2 -37.81 88.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 61.04 110.897 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 160' ' ' GLY . 93.7 t -62.67 -56.84 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 71.43 111.177 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 161' ' ' ILE . 84.7 t -52.22 -49.96 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 70.32 111.129 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.672 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.3 t -55.47 -38.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 75.35 111.117 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.29 -49.8 70.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 75.2 110.855 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.89 87.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 72.34 112.473 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.19 -48.89 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 25.3 111.095 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.4 t -59.71 -53.95 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.121 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -53.38 -53.86 45.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 74.51 110.862 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -57.91 12.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 54.21 112.485 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.93 -39.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 70.42 111.135 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.09 -58.41 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.42 110.877 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.601 HD11 ' CE2' ' B' ' 171' ' ' PHE . 64.6 mt -59.68 -31.54 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 73.24 111.081 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -67.62 -50.9 55.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.914 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -64.21 -45.93 86.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 75.42 110.896 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -63.51 -28.59 70.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.908 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.03 -175.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 64.42 110.896 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.48 167.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 74.23 110.939 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 1.4 mttt 60.4 86.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.911 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.6 66.45 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 73.34 111.144 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -176.94 78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 54.53 110.871 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.441 -0.263 . . . . 74.3 112.441 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 50.0 m 54.49 68.64 2.54 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 61.25 110.843 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -28.9 24.45 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.687 2.258 . . . . 75.34 112.291 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.63 177.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.51 111.086 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.08 81.05 1.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.4 110.896 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -128.88 33.2 4.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 45.13 110.901 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -165.43 133.81 3.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.14 110.831 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.06 101.29 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 75.13 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.43 160.61 25.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.699 0.762 . . . . 72.44 110.88 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -15.11 37.08 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.688 2.259 . . . . 74.33 112.333 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.19 -38.64 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 50.4 110.939 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.682 HG23 ' HA ' ' B' ' 152' ' ' THR . 19.3 m -52.3 -30.88 30.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 25.4 111.102 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -68.89 -57.5 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 60.41 110.844 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.9 mm -51.31 -44.62 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 60.23 111.157 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.5 mm -67.26 -45.07 86.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 73.21 111.118 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.3 p -60.88 -41.77 96.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 65.0 110.879 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -48.31 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 74.41 111.13 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.7 t -54.41 -43.56 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 72.42 111.083 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 55' ' ' ILE . 86.4 t -61.54 -47.49 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 72.33 111.16 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.694 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.24 -53.17 48.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 74.24 112.501 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 mm -61.94 -29.44 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 72.54 111.151 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.8 tp -70.51 -50.61 35.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.12 110.936 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD23 HG21 ' B' ' 164' ' ' VAL . 7.5 tp -60.1 -37.22 79.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 61.32 110.976 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 60' ' ' GLY . 93.4 t -62.74 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 72.41 111.163 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 61' ' ' ILE . 92.0 t -51.74 -48.96 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 65.43 111.188 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.697 ' O ' HG23 ' A' ' 70' ' ' VAL . 86.2 t -55.74 -39.05 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 72.11 111.122 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -49.8 70.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.896 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.76 -44.89 86.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 75.41 112.493 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.17 -49.02 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 74.14 111.165 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.9 t -58.51 -54.07 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 65.13 111.112 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.713 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.5 t80 -51.93 -53.54 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.891 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.8 -58.47 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 51.11 112.488 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.68 -40.11 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 74.32 111.184 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -58.81 -60.06 4.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 72.03 110.928 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.713 HD11 ' CE2' ' A' ' 71' ' ' PHE . 78.1 mt -51.87 -39.45 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.54 111.093 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -62.98 -48.1 80.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 72.43 110.872 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 -64.79 -47.01 79.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 73.12 110.878 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -31.04 71.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 74.14 110.86 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.0 -175.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 60.11 110.947 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.94 -68.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 74.25 110.936 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -167.23 143.25 4.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 72.15 110.901 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.54 66.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 70.03 111.124 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -126.39 105.27 8.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.926 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 44.24 110.916 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.423 -0.271 . . . . 62.43 112.423 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 50.4 m 54.48 68.62 2.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.581 0.705 . . . . 54.25 110.856 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -29.01 24.57 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.7 2.266 . . . . 44.14 112.312 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . 59.53 177.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 63.25 111.073 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.89 80.83 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 54.55 110.836 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -129.03 33.53 4.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 65.23 110.877 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -164.95 134.09 3.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 64.25 110.816 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -162.81 101.48 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 72.11 111.117 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.3 160.6 25.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.68 0.753 . . . . 63.12 110.822 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -13.77 35.09 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.701 2.267 . . . . 73.41 112.377 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.0 mt -51.74 -38.35 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 75.13 110.91 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.682 ' HA ' HG23 ' A' ' 52' ' ' THR . 18.9 m -51.96 -30.88 26.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 70.14 111.085 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.8 t -68.92 -57.57 5.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 54.21 110.87 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.9 mm -51.32 -44.65 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 70.02 111.139 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.495 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.6 mm -67.29 -45.05 86.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 65.41 111.125 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.3 p -60.89 -41.61 96.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.4 76.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 65.14 111.048 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.0 t -54.41 -43.46 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.02 111.116 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 155' ' ' ILE . 87.2 t -61.63 -47.71 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.44 111.127 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.676 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.58 -53.21 47.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 72.12 112.558 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.597 ' O ' HG23 ' B' ' 165' ' ' VAL . 29.8 mm -62.81 -28.03 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 64.12 111.115 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.624 ' O ' HG23 ' B' ' 166' ' ' VAL . 12.8 tp -70.0 -51.06 35.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.933 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 64' ' ' VAL . 7.5 tp -60.34 -37.59 81.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.953 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.676 HG23 ' O ' ' B' ' 160' ' ' GLY . 90.1 t -62.39 -58.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.23 111.129 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 161' ' ' ILE . 91.9 t -51.67 -48.68 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 73.13 111.144 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.707 ' O ' HG23 ' B' ' 170' ' ' VAL . 85.3 t -55.69 -39.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 71.01 111.155 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.07 -50.11 69.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.908 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.78 -44.47 86.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 70.34 112.536 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.29 -49.04 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 55.33 111.12 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.9 t -57.7 -53.93 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.31 111.14 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.7 t80 -52.69 -53.87 41.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.877 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.18 -58.95 9.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 51.34 112.462 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.96 -39.73 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 65.03 111.121 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.8 -61.1 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 61.4 110.903 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' B' ' 171' ' ' PHE . 78.4 mt -52.8 -39.09 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 72.23 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -62.39 -47.28 84.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 74.23 110.961 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 45.8 mtp85 -63.76 -47.29 81.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 70.52 110.886 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -31.4 72.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 64.15 110.893 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.99 -175.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.54 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -105.67 -69.03 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.926 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -167.25 143.43 4.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 72.51 110.863 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.3 mt -115.44 66.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 70.43 111.113 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -126.57 105.2 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 71.21 110.83 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 72.02 110.964 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.465 -0.254 . . . . 74.31 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.74 160.51 19.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.65 0.738 . . . . 72.13 110.937 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 124.83 11.48 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.245 . . . . 72.13 112.347 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.44 155.9 43.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.438 . . . . 73.41 111.115 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 175.73 5.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 64.44 110.876 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.04 174.86 10.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 73.43 110.939 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.99 -71.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 71.51 110.954 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.75 56.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.11 111.034 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -139.44 68.34 38.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.546 0.688 . . . . 73.24 110.883 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.64 -11.28 30.66 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.713 2.276 . . . . 64.41 112.353 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -23.47 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 61.33 110.918 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.653 HG21 HD12 ' B' ' 155' ' ' ILE . 31.6 m -55.91 -33.37 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 65.21 111.154 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -67.51 -57.97 5.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 35.25 110.87 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 58' ' ' VAL . 49.2 mm -51.46 -44.87 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.4 111.154 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.626 ' CD1' HG21 ' B' ' 152' ' ' THR . 79.0 mt -67.18 -43.48 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 64.33 111.171 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.698 ' HB3' HG21 ' B' ' 159' ' ' VAL . 3.8 m -62.27 -41.49 98.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 72.41 110.857 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.76 77.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 42.23 111.089 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 54' ' ' ILE . 94.9 t -55.64 -40.58 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.15 111.158 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' B' ' 156' ' ' SER . 92.3 t -63.92 -47.48 90.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 65.14 111.1 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.691 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.54 -46.25 92.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 62.22 112.474 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 65' ' ' VAL . 80.5 mt -66.81 -27.46 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.842 0.353 . . . . 71.53 111.038 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.658 ' O ' HG23 ' A' ' 66' ' ' VAL . 2.1 tt -71.13 -46.61 61.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 65.32 110.895 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -38.36 90.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.2 t -62.15 -55.15 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 64.53 111.15 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 61' ' ' ILE . 94.4 t -53.52 -48.94 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 75.3 111.093 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 70' ' ' VAL . 94.7 t -55.92 -38.67 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 63.31 111.104 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.21 -49.97 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.66 87.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.843 -0.694 . . . . 74.15 112.45 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.31 -48.85 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 72.04 111.146 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.5 t -58.16 -54.04 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 75.43 111.152 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.4 t80 -51.93 -53.65 38.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.852 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.38 10.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.728 -0.749 . . . . 72.35 112.471 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.65 -40.12 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 62.21 111.149 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.5 mt -58.91 -59.36 5.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 54.14 110.921 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.718 HD11 ' CE2' ' A' ' 71' ' ' PHE . 76.7 mt -52.77 -44.76 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 72.4 111.081 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -60.73 -45.82 92.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 64.25 110.906 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -62.2 -44.89 95.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 65.11 110.84 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -65.33 -43.14 91.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 71.21 110.896 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.97 -35.99 36.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 61.45 110.868 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.83 102.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 72.23 110.874 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.31 148.07 30.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.903 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.46 66.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 73.53 111.097 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 52.45 80.38 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 64.15 110.838 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.865 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.576 -0.209 . . . . 65.23 112.576 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.64 160.54 18.64 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.621 0.724 . . . . 53.23 110.921 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 124.78 11.4 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.717 2.278 . . . . 73.13 112.328 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.65 155.9 43.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 72.21 111.066 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.31 175.17 5.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.871 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.76 175.43 9.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 70.54 110.904 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 -71.63 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.819 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.42 54.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 41.12 111.106 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 19.8 p -141.31 68.55 26.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.654 0.74 . . . . 70.21 110.81 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.65 -11.5 31.11 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.707 2.271 . . . . 74.2 112.434 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -23.27 36.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 52.52 110.92 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.626 HG21 ' CD1' ' A' ' 55' ' ' ILE . 30.8 m -58.11 -33.35 69.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.211 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -67.32 -57.71 6.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 65.11 110.873 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 158' ' ' VAL . 49.0 mm -51.52 -45.19 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 74.32 111.189 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.653 HD12 HG21 ' A' ' 52' ' ' THR . 79.3 mt -67.21 -43.32 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.133 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.725 ' HB3' HG21 ' A' ' 59' ' ' VAL . 3.8 m -62.05 -41.68 98.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.33 110.863 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 45.41 111.157 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.7 t -55.27 -40.62 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 70.21 111.135 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.698 HG21 ' HB3' ' A' ' 56' ' ' SER . 93.7 t -64.05 -47.57 89.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 61.34 111.136 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.704 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -63.6 -45.87 93.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 65.4 112.476 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.661 ' O ' HG23 ' B' ' 165' ' ' VAL . 81.0 mt -66.69 -26.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 64.22 111.144 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.65 ' O ' HG23 ' B' ' 166' ' ' VAL . 2.1 tt -70.93 -47.03 61.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.922 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.406 ' O ' HD13 ' B' ' 163' ' ' LEU . 0.2 OUTLIER -64.65 -38.32 90.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.902 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 160' ' ' GLY . 93.3 t -62.13 -54.86 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 64.33 111.189 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.661 HG23 ' O ' ' B' ' 161' ' ' ILE . 92.5 t -53.58 -48.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 73.03 111.164 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.706 ' O ' HG23 ' B' ' 170' ' ' VAL . 90.8 t -55.86 -39.43 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.157 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.49 -49.72 70.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 45.42 110.914 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.35 88.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 73.33 112.465 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.4 -49.07 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 51.15 111.133 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.0 t -58.42 -54.03 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 65.14 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.708 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.33 -53.61 42.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 73.15 110.871 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.14 -58.8 9.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 35.5 112.532 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.7 mm -57.21 -39.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 75.24 111.168 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.47 -59.88 4.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 75.03 110.943 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.708 HD11 ' CE2' ' B' ' 171' ' ' PHE . 76.4 mt -53.21 -44.16 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 72.33 111.111 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -59.72 -45.51 91.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 64.32 110.949 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -61.77 -45.43 93.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.862 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -66.09 -43.25 87.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 70.2 110.825 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -35.72 33.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 75.53 110.935 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.39 102.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 73.44 110.883 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 148.31 30.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 65.34 110.916 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.8 mt -115.35 66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 65.13 111.112 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 52.56 80.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.5 110.902 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 61.44 110.851 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.488 -0.245 . . . . 50.13 112.488 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.17 160.53 30.81 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.599 0.714 . . . . 75.53 110.888 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 120.61 7.37 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.703 2.269 . . . . 72.44 112.309 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.63 117.43 7.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 54.31 111.057 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.7 -51.08 5.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 74.21 110.939 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -98.99 105.26 17.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 63.22 110.938 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.89 122.43 7.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.895 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.87 81.38 2.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 55.02 111.151 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -135.85 70.52 64.49 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 73.25 110.868 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -31.32 20.5 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.681 2.254 . . . . 75.24 112.305 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.97 -33.66 38.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 42.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.788 HG21 HD12 ' B' ' 155' ' ' ILE . 14.2 m -52.38 -33.43 43.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.11 111.167 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -58.64 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.881 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.5 mm -51.46 -43.44 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 73.34 111.116 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.782 HD12 HG21 ' B' ' 152' ' ' THR . 80.2 mt -67.29 -44.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 71.33 111.098 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 p -62.08 -40.89 97.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 72.23 110.883 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.87 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 45.35 111.092 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.5 t -56.1 -47.43 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 72.5 111.135 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 55' ' ' ILE . 84.1 t -57.65 -48.17 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 44.15 111.104 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.706 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -60.17 -49.21 81.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 44.01 112.494 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 65' ' ' VAL . 78.3 mt -63.56 -31.87 54.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.378 . . . . 65.51 111.127 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.66 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -69.77 -47.12 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.969 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.93 -38.53 88.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 50.43 110.885 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.0 t -62.09 -57.25 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 62.3 111.07 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.8 t -51.63 -48.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 74.12 111.14 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 70' ' ' VAL . 92.9 t -55.53 -41.23 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.45 111.115 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.26 -49.54 73.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 54.52 110.894 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.25 -44.35 89.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.742 -0.742 . . . . 71.42 112.505 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 65' ' ' VAL . 83.9 t -59.28 -48.97 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 44.25 111.138 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.6 t -57.52 -54.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.22 111.148 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.3 t80 -52.06 -53.7 39.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 72.11 110.839 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.38 10.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.522 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.79 -39.96 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.13 111.112 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.8 mt -59.13 -55.16 38.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 70.44 110.974 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.632 HD11 ' CE2' ' A' ' 71' ' ' PHE . 73.0 mt -61.49 -50.01 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 55.25 111.19 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.81 -40.79 66.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 65.14 110.91 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -64.57 -51.58 62.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 61.52 110.841 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -62.13 -31.78 72.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.851 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 123.57 9.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.855 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.41 -172.13 1.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 64.25 110.889 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 164.37 2.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 75.35 110.977 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 mt -115.47 66.32 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 63.52 111.156 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.04 81.2 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 73.55 110.852 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.53 110.868 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.454 -0.258 . . . . 53.11 112.454 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.19 160.56 30.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.6 0.714 . . . . 74.14 110.921 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 120.73 7.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.622 2.215 . . . . 74.14 112.376 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -147.58 117.34 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 74.13 111.121 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.8 -51.08 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.54 110.884 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -98.93 105.22 17.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 71.54 110.887 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.91 122.45 7.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 75.14 110.829 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.94 81.51 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 64.2 111.114 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -135.92 70.56 63.96 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.679 0.752 . . . . 72.13 110.883 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -31.39 20.44 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.659 2.239 . . . . 63.32 112.283 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.53 37.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 63.03 110.96 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.782 HG21 HD12 ' A' ' 55' ' ' ILE . 14.4 m -52.31 -33.32 41.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 70.24 111.11 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -58.74 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 72.23 110.86 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.5 mm -51.43 -43.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 74.42 111.118 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.788 HD12 HG21 ' A' ' 52' ' ' THR . 80.4 mt -67.34 -44.88 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 70.12 111.078 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 34.8 p -62.2 -40.92 97.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 65.54 110.818 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.9 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 51.31 111.064 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.5 t -56.07 -47.41 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 155' ' ' ILE . 84.7 t -57.69 -48.19 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.109 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.714 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -60.23 -49.01 83.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.675 -0.774 . . . . 64.22 112.517 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.544 ' O ' HG23 ' B' ' 165' ' ' VAL . 78.3 mt -63.61 -32.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 74.43 111.101 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.651 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -70.05 -47.19 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 64.32 110.905 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 163' ' ' LEU . 1.7 tt -61.3 -38.59 87.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 64.3 110.941 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 160' ' ' GLY . 94.7 t -62.65 -57.34 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.43 111.101 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 161' ' ' ILE . 93.0 t -51.62 -48.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.13 111.163 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.686 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.7 t -55.67 -40.6 61.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 74.21 111.171 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.29 -49.25 74.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.95 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.17 -44.66 88.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.738 . . . . 41.13 112.472 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.27 -48.94 85.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 73.11 111.171 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.686 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -57.43 -54.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.44 111.125 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.587 ' CZ ' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.65 -53.83 41.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.8 9.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 53.21 112.482 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.11 -39.71 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 72.33 111.155 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.62 -55.38 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 51.43 110.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.587 HD11 ' CZ ' ' B' ' 171' ' ' PHE . 73.0 mt -61.67 -50.82 78.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.1 111.127 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -41.43 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.911 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -64.99 -51.57 60.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 73.31 110.935 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -61.84 -31.98 72.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.865 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.14 122.95 8.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 70.41 110.888 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.89 -172.21 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 61.32 110.874 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 164.5 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 63.22 110.999 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.3 mt -115.36 66.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 74.25 111.126 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.08 81.11 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 54.4 110.883 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.943 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.478 -0.249 . . . . 74.25 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -142.22 160.52 54.59 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.606 0.717 . . . . 54.52 110.888 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -179.74 3.11 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.733 2.289 . . . . 74.44 112.367 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.07 93.97 0.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 65.31 111.091 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -108.68 109.41 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 72.53 110.949 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.25 170.23 10.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.888 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 36.59 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 73.02 110.828 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.46 135.97 35.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.33 111.081 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m 63.15 72.66 0.56 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.632 0.73 . . . . 61.13 110.87 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -17.15 37.56 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.637 2.225 . . . . 72.02 112.314 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -36.22 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 74.02 110.88 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -51.63 -37.37 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.02 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -61.94 -59.37 5.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 55.25 110.907 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.678 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.3 mm -51.43 -47.55 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 74.11 111.124 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 59' ' ' VAL . 40.1 mm -64.23 -40.01 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.02 111.186 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.685 ' OG ' HG21 ' B' ' 159' ' ' VAL . 0.1 OUTLIER -58.38 -47.52 83.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 65.1 110.848 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.63 -49.62 68.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 64.2 111.035 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.9 t -50.69 -40.14 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.24 111.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 55' ' ' ILE . 62.0 t -69.31 -42.94 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 64.11 111.12 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.58 -50.16 63.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 60.32 112.523 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 65' ' ' VAL . 63.4 mt -66.02 -29.9 48.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.939 0.399 . . . . 71.14 111.184 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.665 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -69.71 -46.92 64.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 65.25 110.951 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -38.66 91.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 72.44 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.1 t -61.49 -56.72 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 53.22 111.122 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 61' ' ' ILE . 87.7 t -52.58 -48.73 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 64.24 111.133 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 70' ' ' VAL . 92.2 t -55.55 -38.59 50.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 75.53 111.156 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -50.47 68.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 64.53 110.866 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.59 85.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.755 -0.735 . . . . 71.33 112.452 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.06 -49.11 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 73.24 111.109 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.3 t -57.86 -54.21 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.23 111.112 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.4 t80 -52.09 -53.56 40.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.908 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -58.25 10.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.798 -0.715 . . . . 75.53 112.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.7 mt -57.96 -40.03 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.369 . . . . 65.21 111.129 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.6 mt -58.96 -59.05 6.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 70.21 110.912 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.722 HD11 ' CE2' ' A' ' 71' ' ' PHE . 76.7 mt -53.47 -39.98 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 70.31 111.183 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -65.12 -48.8 72.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 74.0 110.921 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -50.34 69.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 71.41 110.888 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.58 -39.39 93.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 75.15 110.879 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.89 134.19 25.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 70.13 110.939 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.54 -64.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 54.33 110.924 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.23 126.19 47.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 73.52 110.916 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.3 mt -115.58 66.38 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 75.55 111.096 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 60.17 98.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 72.32 110.892 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 mttp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 65.43 110.922 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.534 -0.226 . . . . 63.34 112.534 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -142.11 160.57 54.7 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.618 0.723 . . . . 74.11 110.876 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 -179.61 3.0 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.705 2.27 . . . . 71.41 112.388 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.9 94.04 0.45 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.44 . . . . 73.22 111.069 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -108.69 109.53 20.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 63.24 110.877 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.19 170.38 10.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 44.13 110.889 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.51 36.36 1.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 72.14 110.831 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.55 135.9 35.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 64.22 111.157 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 2.0 m 63.29 72.96 0.53 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 62.12 110.805 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -17.27 37.76 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.735 2.29 . . . . 74.4 112.373 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -36.49 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 71.12 110.908 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 13.3 m -51.57 -37.42 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.115 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -61.98 -59.24 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 45.1 110.888 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.687 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.1 mm -51.52 -47.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 73.14 111.092 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.692 ' O ' HG23 ' B' ' 159' ' ' VAL . 39.8 mm -64.32 -40.06 87.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -58.39 -47.53 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 60.42 110.801 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.57 68.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 51.14 111.088 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.6 t -50.83 -40.12 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 72.52 111.126 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.692 HG23 ' O ' ' B' ' 155' ' ' ILE . 62.1 t -69.25 -42.86 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.32 111.138 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.703 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -63.58 -50.21 63.58 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.668 -0.777 . . . . 75.24 112.513 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.548 ' O ' HG23 ' B' ' 165' ' ' VAL . 63.6 mt -66.05 -29.86 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 75.42 111.113 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.663 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -69.78 -46.93 64.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 63.33 110.967 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -38.6 91.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 73.42 110.903 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 160' ' ' GLY . 94.1 t -61.61 -56.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 55.43 111.088 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 161' ' ' ILE . 87.9 t -52.5 -48.87 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 75.55 111.091 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.685 ' O ' HG23 ' B' ' 170' ' ' VAL . 96.1 t -55.59 -38.67 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 61.35 111.102 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -50.42 68.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 62.14 110.915 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.64 85.42 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.654 -0.784 . . . . 51.2 112.487 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.12 -49.3 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 62.43 111.062 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.685 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.6 t -58.67 -54.03 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 70.11 111.148 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.649 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -52.72 -53.79 42.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.913 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.11 -58.66 10.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 64.51 112.427 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.3 -39.84 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 74.23 111.166 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 174' ' ' LEU . 19.1 mt -59.11 -58.95 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.4 110.884 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.649 HD11 ' CE2' ' B' ' 171' ' ' PHE . 77.1 mt -53.29 -40.27 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.187 -0.46 . . . . 61.02 111.165 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -65.3 -49.69 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 71.41 110.886 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.08 -50.81 69.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.818 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.74 -39.42 94.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 64.45 110.875 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -50.87 133.8 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.43 110.895 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.83 -64.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.901 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.18 126.32 48.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 71.44 110.914 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.5 66.39 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 53.34 111.077 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 60.1 98.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 64.32 110.897 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.5 mttp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 63.12 110.855 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.496 -0.242 . . . . 73.05 112.496 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.9 m -141.49 70.88 26.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.607 0.718 . . . . 60.23 110.906 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.78 157.52 60.06 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.68 2.253 . . . . 64.24 112.315 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.87 90.12 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 72.41 111.075 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -133.86 178.59 6.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 72.35 110.919 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.25 -63.62 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.13 110.929 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 58.18 179.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.882 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.65 -175.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 65.0 111.063 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.09 160.53 42.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.656 0.741 . . . . 44.44 110.857 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -17.23 37.73 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.711 2.274 . . . . 62.43 112.342 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -51.93 -33.48 37.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 73.15 110.905 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.683 HG23 ' HA ' ' B' ' 152' ' ' THR . 18.7 m -51.75 -31.36 26.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.183 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -57.5 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.875 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.1 mm -51.31 -44.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 62.4 111.104 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.6 mm -67.27 -44.97 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.142 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.5 p -60.9 -41.74 96.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.861 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.24 76.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 63.22 111.056 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.0 t -54.45 -43.39 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 71.24 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 55' ' ' ILE . 86.9 t -61.66 -47.62 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 51.44 111.082 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.712 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.12 -52.97 50.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 73.43 112.488 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 65' ' ' VAL . 29.8 mm -62.58 -30.78 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.84 0.352 . . . . 64.13 111.127 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.6 tp -69.54 -51.54 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 72.15 110.932 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -37.05 73.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.4 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 60' ' ' GLY . 93.8 t -63.09 -60.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.31 111.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.6 t -51.64 -47.37 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 74.32 111.141 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.68 ' O ' HG23 ' A' ' 70' ' ' VAL . 91.8 t -56.56 -38.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 64.31 111.16 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -49.94 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.922 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -44.92 86.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.818 -0.705 . . . . 72.42 112.482 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.08 -49.04 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 72.04 111.136 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.8 t -59.62 -54.09 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 50.45 111.091 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.729 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.4 t80 -52.03 -53.63 39.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.869 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.27 10.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.752 . . . . 32.21 112.469 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt -57.86 -40.2 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 75.34 111.122 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.6 mt -58.8 -60.06 4.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.912 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.729 HD11 ' CE2' ' A' ' 71' ' ' PHE . 76.8 mt -52.0 -35.17 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 64.11 111.137 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -68.28 -55.38 12.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.87 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.03 -36.32 77.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.876 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -65.45 -42.44 92.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.863 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 54.46 25.38 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 73.02 110.887 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.12 126.18 26.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 63.14 110.885 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -128.91 52.92 1.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 54.2 110.876 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.4 mt -115.48 66.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 72.14 111.066 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.29 66.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.924 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 72.32 110.852 179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.491 -0.244 . . . . 40.2 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 71.7 m -141.59 70.97 25.81 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.634 0.73 . . . . 73.12 110.864 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 157.28 60.95 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 63.01 112.343 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -126.05 90.17 3.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 71.2 111.083 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -133.57 178.18 7.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 43.42 110.904 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.73 -63.81 0.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 63.52 110.926 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 58.06 179.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 74.0 110.899 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . 62.89 -174.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 73.54 111.118 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.66 160.49 44.29 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.647 0.737 . . . . 74.21 110.858 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.41 37.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.738 2.292 . . . . 70.12 112.338 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.35 -34.84 59.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 64.32 110.884 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.683 ' HA ' HG23 ' A' ' 52' ' ' THR . 19.9 m -52.57 -31.23 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 64.23 111.138 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 45.0 t -68.7 -57.28 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 54.25 110.86 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.1 mm -51.43 -44.67 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 51.12 111.148 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.499 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.5 mm -67.34 -45.01 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 60.21 111.111 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.5 p -60.73 -41.91 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.851 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.36 76.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.101 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.3 t -54.3 -43.37 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 50.02 111.198 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.499 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.1 t -61.74 -47.52 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 53.34 111.082 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.71 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.14 -52.84 50.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 74.42 112.487 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.482 ' O ' HG23 ' B' ' 165' ' ' VAL . 30.2 mm -62.27 -30.42 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 62.31 111.067 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.643 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.6 tp -69.6 -51.73 32.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.04 110.892 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -37.16 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.03 110.884 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.71 HG23 ' O ' ' B' ' 160' ' ' GLY . 88.6 t -62.69 -59.74 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.17 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 161' ' ' ILE . 89.7 t -51.65 -47.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 74.02 111.116 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.689 ' O ' HG23 ' B' ' 170' ' ' VAL . 89.1 t -56.48 -39.1 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.082 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -50.03 70.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 53.35 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.62 -44.94 86.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.754 -0.736 . . . . 63.21 112.478 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.1 -48.92 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 52.4 111.174 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.689 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.7 t -58.94 -54.08 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 52.14 111.155 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -52.75 -53.91 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 75.35 110.865 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -58.68 10.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.708 -0.758 . . . . 51.41 112.499 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.22 -39.65 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 74.34 111.127 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.14 -60.32 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 42.01 110.94 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.548 HD11 ' CE2' ' B' ' 171' ' ' PHE . 77.0 mt -52.2 -35.15 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 61.14 111.128 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -68.2 -54.24 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 51.14 110.912 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -35.53 72.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 74.2 110.879 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -64.73 -42.59 95.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 72.21 110.824 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 54.28 25.53 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 72.55 110.841 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.7 125.75 25.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 70.54 110.928 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -129.22 53.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.889 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 27.3 mt -115.34 66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 71.1 111.109 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.31 66.83 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.31 110.847 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 62.21 110.869 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.488 -0.245 . . . . 42.4 112.488 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.6 p -148.62 156.53 41.79 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.591 0.71 . . . . 75.21 110.912 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 165.66 30.29 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.696 2.264 . . . . 53.23 112.34 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -167.24 168.02 13.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 70.32 111.15 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.82 140.12 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 72.24 110.929 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -119.23 176.35 5.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 64.54 110.884 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.61 136.59 57.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 71.51 110.798 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.33 122.48 6.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 50.54 111.08 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.5 p -127.15 73.31 77.05 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.621 0.724 . . . . 65.41 110.859 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -17.78 37.43 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.71 2.273 . . . . 62.13 112.369 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -37.87 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 72.44 110.932 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.559 HG23 ' HA ' ' B' ' 152' ' ' THR . 79.1 m -51.72 -32.16 29.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 72.21 111.144 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -67.46 -57.79 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 62.44 110.856 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 80.7 mt -51.4 -44.61 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 65.22 111.101 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.7 mm -67.24 -44.44 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 64.52 111.137 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.3 p -61.38 -41.68 97.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.21 110.897 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.01 77.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 71.12 111.047 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.3 t -54.63 -43.78 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 51.04 111.135 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 55' ' ' ILE . 85.6 t -61.38 -47.65 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 73.54 111.108 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.9 -50.1 71.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 72.34 112.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' HG23 ' A' ' 65' ' ' VAL . 72.4 mt -64.3 -33.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 72.31 111.146 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.3 tt -69.32 -49.18 58.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.978 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -57.94 -38.6 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 54.54 110.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.4 t -63.11 -58.23 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 64.34 111.151 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 61' ' ' ILE . 58.3 t -52.61 -47.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 72.55 111.132 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.723 ' O ' HG23 ' A' ' 70' ' ' VAL . 96.5 t -56.65 -38.27 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 75.14 111.168 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.36 -49.79 70.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 41.14 110.913 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.26 -44.19 89.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.789 -0.72 . . . . 65.25 112.462 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.55 -48.72 86.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 75.23 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.2 t -57.52 -54.03 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 71.04 111.108 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.5 t80 -51.84 -53.37 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.863 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.88 -58.06 11.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 64.05 112.478 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -58.03 -40.32 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 64.11 111.127 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.3 mt -57.66 -59.19 5.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.54 110.889 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' A' ' 71' ' ' PHE . 75.5 mt -52.36 -37.26 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 71.31 111.142 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -68.95 -63.5 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 51.2 110.888 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.98 -31.21 28.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 73.31 110.89 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -63.4 -50.44 69.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 72.31 110.877 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.77 88.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.03 110.877 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.18 159.54 31.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 73.31 110.874 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.61 114.25 23.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 75.22 110.933 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 mt -114.3 65.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 75.14 111.139 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 55.33 84.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 63.51 110.879 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.8 mttt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 72.01 110.878 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.5 -0.24 . . . . 63.3 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 4.6 p -148.58 156.45 41.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.53 0.681 . . . . 75.12 110.879 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.65 165.62 30.23 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 74.41 112.363 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.33 167.96 13.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 51.14 111.112 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.95 140.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.442 . . . . 74.31 110.934 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -119.31 176.56 5.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.25 110.864 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.18 135.84 56.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 63.15 110.869 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.06 123.23 6.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 70.24 111.089 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 63.0 p -126.34 72.39 72.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 72.21 110.838 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -16.74 37.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.634 2.223 . . . . 74.41 112.354 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.88 -39.12 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 42.25 110.908 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.559 ' HA ' HG23 ' A' ' 52' ' ' THR . 86.2 m -52.57 -32.03 38.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 70.3 111.053 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 5.0 t -67.43 -57.63 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 53.14 110.87 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 80.8 mt -51.41 -44.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 75.01 111.12 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.8 mm -67.19 -44.39 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.098 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.5 p -61.37 -41.66 97.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 70.13 110.849 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.92 77.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 51.33 111.154 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.4 t -54.74 -43.74 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 63.41 111.113 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.0 t -61.43 -47.96 91.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.14 111.157 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.694 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -60.7 -49.08 82.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 71.12 112.44 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 165' ' ' VAL . 72.8 mt -64.43 -32.3 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 42.21 111.183 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.654 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.3 tt -69.85 -49.31 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 63.41 110.918 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.38 -38.53 77.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 52.14 110.938 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 160' ' ' GLY . 97.7 t -63.17 -58.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 63.4 111.07 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 161' ' ' ILE . 58.0 t -52.19 -48.27 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 73.45 111.156 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.683 ' O ' HG23 ' B' ' 170' ' ' VAL . 91.8 t -56.37 -39.03 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.01 111.081 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.49 -49.74 70.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 71.41 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.6 87.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.491 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.37 -49.12 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 74.42 111.159 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.683 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.9 t -59.22 -53.85 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 51.24 111.121 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.729 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.3 t80 -52.05 -53.43 42.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.1 -58.37 10.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 70.52 112.489 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.62 -40.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.838 0.351 . . . . 75.44 111.135 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.06 -59.57 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 51.15 110.91 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.729 HD11 ' CE2' ' B' ' 171' ' ' PHE . 75.5 mt -52.5 -35.32 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.32 111.163 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -66.99 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 75.14 110.858 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -35.0 61.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.33 110.858 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -67.22 -49.22 65.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.44 110.875 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.61 88.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.955 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.96 159.27 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 54.54 110.913 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.15 112.07 19.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 61.45 110.917 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 25.9 mt -115.75 64.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 53.2 111.181 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 54.0 84.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.873 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 40.6 mttt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.52 110.909 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.496 -0.241 . . . . 60.31 112.496 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.96 160.54 37.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.591 0.71 . . . . 73.51 110.901 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 94.07 0.53 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.716 2.277 . . . . 74.35 112.344 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.6 119.01 23.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 71.32 111.062 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HG3' HD21 ' B' ' 151' ' ' LEU . 40.5 tt0 -142.87 75.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.907 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -146.46 138.99 25.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.13 110.932 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HB3' HD13 ' B' ' 151' ' ' LEU . 0.0 OUTLIER -174.31 146.07 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 63.1 110.886 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.15 31.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 63.23 111.066 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -109.25 160.53 27.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.625 0.726 . . . . 64.3 110.821 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -17.64 37.24 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.708 2.272 . . . . 73.23 112.399 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 49' ' ' SER . 0.8 OUTLIER -52.27 -38.67 58.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 75.02 110.896 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.575 HG21 ' CD1' ' B' ' 155' ' ' ILE . 22.2 m -62.42 -32.42 73.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 65.1 111.133 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.67 -57.38 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 72.15 110.839 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 72.5 mt -51.53 -44.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.085 -0.507 . . . . 75.3 111.138 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.576 ' CD1' HG21 ' B' ' 152' ' ' THR . 65.2 mt -67.59 -44.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.467 . . . . 71.34 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB2' HG21 ' B' ' 159' ' ' VAL . 59.5 p -61.14 -41.16 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.871 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.49 74.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 72.01 111.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.7 t -54.22 -44.37 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 71.15 111.15 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' ILE . 90.0 t -60.85 -48.36 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 71.11 111.098 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.56 -46.89 93.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 71.32 112.569 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 65' ' ' VAL . 80.7 mt -65.53 -31.18 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 70.24 111.146 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 66' ' ' VAL . 10.3 tp -69.55 -46.15 67.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 73.41 110.873 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD22 ' CG2' ' B' ' 164' ' ' VAL . 1.2 tt -62.89 -37.78 88.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 62.41 110.961 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.4 t -62.51 -57.1 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 61.33 111.164 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 61' ' ' ILE . 80.1 t -51.62 -50.28 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.115 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 70' ' ' VAL . 90.3 t -55.11 -39.35 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 51.4 111.156 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -49.64 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -45.15 85.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 71.24 112.512 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.5 t -59.1 -49.13 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.419 . . . . 62.23 111.137 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.5 t -60.09 -53.8 43.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 51.13 111.144 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.743 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.3 t80 -51.96 -53.71 38.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 71.34 110.896 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.84 -58.73 9.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 72.4 112.488 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.48 -39.75 70.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 72.54 111.167 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.8 mt -59.62 -59.5 5.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 70.13 110.894 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.743 HD11 ' CE2' ' A' ' 71' ' ' PHE . 75.9 mt -51.72 -34.76 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 75.14 111.081 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -67.29 -59.97 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.12 110.916 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -55.64 -25.72 40.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 64.32 110.895 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -66.75 -22.88 66.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 72.34 110.893 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -50.56 146.31 5.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 61.2 110.96 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 63.34 44.93 5.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 64.31 110.91 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -68.25 165.44 18.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.894 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.4 mm -92.58 56.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 63.45 111.187 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -110.92 59.1 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 72.21 110.859 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 65.42 110.94 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.488 -0.245 . . . . 75.54 112.488 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.02 160.55 37.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.591 0.71 . . . . 64.35 110.914 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 94.05 0.53 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.716 2.277 . . . . 72.13 112.379 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -128.62 119.29 24.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 43.34 111.071 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' GLU . . . . . 0.475 ' HG3' HD21 ' A' ' 51' ' ' LEU . 40.5 tt0 -142.53 75.21 1.48 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.218 -0.446 . . . . 60.52 110.876 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -146.68 139.57 25.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.496 . . . . 72.12 110.913 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -173.83 145.88 1.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 53.43 110.858 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -173.4 31.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 72.45 111.077 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' SER . . . . . 0.547 ' CB ' HD12 ' B' ' 151' ' ' LEU . 0.2 OUTLIER -109.25 160.58 27.06 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.679 0.752 . . . . 63.11 110.846 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -16.39 37.34 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.667 2.245 . . . . 70.25 112.355 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -51.81 -38.77 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 60.13 110.871 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.576 HG21 ' CD1' ' A' ' 55' ' ' ILE . 22.9 m -61.52 -32.01 72.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 73.41 111.156 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -57.29 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.858 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 72.2 mt -51.5 -44.38 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 52.21 111.169 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.575 ' CD1' HG21 ' A' ' 52' ' ' THR . 65.6 mt -67.57 -44.93 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 71.2 111.175 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.405 ' HB2' HG21 ' A' ' 59' ' ' VAL . 59.6 p -61.13 -41.07 96.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 74.55 110.866 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.38 74.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 71.43 111.075 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.6 t -54.28 -44.34 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 62.03 111.159 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 155' ' ' ILE . 92.6 t -60.83 -48.78 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 63.42 111.129 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -61.8 -47.71 88.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 75.13 112.502 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 78.5 mt -66.26 -30.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 72.41 111.166 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.657 ' O ' HG23 ' B' ' 166' ' ' VAL . 10.4 tp -70.12 -46.09 65.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.973 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.19 -38.63 91.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 72.42 110.882 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.6 t -62.02 -57.15 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 45.42 111.117 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 161' ' ' ILE . 80.8 t -51.73 -49.8 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.11 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.687 ' O ' HG23 ' B' ' 170' ' ' VAL . 92.1 t -55.06 -39.47 50.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 64.53 111.166 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -49.9 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 61.43 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.75 87.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 65.01 112.477 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.09 -48.97 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.948 0.404 . . . . 53.43 111.145 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -58.57 -54.0 39.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 73.2 111.191 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.704 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.35 -53.84 39.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.873 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.25 -59.23 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.662 -0.78 . . . . 51.41 112.481 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -56.59 -39.76 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 61.42 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.75 -60.4 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.831 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.704 HD11 ' CE2' ' B' ' 171' ' ' PHE . 75.0 mt -52.25 -35.31 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 65.14 111.136 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -67.9 -59.02 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.14 110.923 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -55.57 -25.69 39.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.851 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -66.28 -23.39 66.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.872 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -50.65 146.29 5.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 70.22 110.918 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 63.22 45.55 5.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.915 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.7 165.58 16.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 71.22 110.856 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 20.7 mm -92.62 56.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 75.1 111.156 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -111.08 59.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.811 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.861 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.537 -0.225 . . . . 42.31 112.537 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 66.4 m 53.76 71.98 1.25 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 74.21 110.885 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 177.26 5.77 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.605 2.204 . . . . 71.52 112.345 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.91 149.75 34.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.077 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.21 138.71 19.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.914 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.87 148.74 50.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.839 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.59 82.46 6.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.902 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.12 40.67 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 71.25 111.107 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 p -134.28 72.03 71.58 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.693 0.758 . . . . 62.13 110.853 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -22.01 32.47 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.671 2.247 . . . . 64.23 112.369 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HA ' HD12 ' A' ' 54' ' ' ILE . 9.1 mt -52.83 -36.68 59.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 72.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.607 ' HA ' HG23 ' B' ' 152' ' ' THR . 40.3 m -51.84 -35.16 43.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 62.12 111.179 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -56.93 10.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.13 110.934 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.717 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.0 mt -51.36 -46.51 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 64.12 111.099 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 59' ' ' VAL . 37.8 mm -65.98 -43.87 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.41 111.083 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 p -61.16 -43.07 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 71.54 110.822 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.7 80.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 73.41 111.138 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 54' ' ' ILE . 95.6 t -53.64 -47.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 72.33 111.13 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 55' ' ' ILE . 97.9 t -59.01 -47.03 91.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.106 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -58.75 -54.4 38.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 72.44 112.42 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 mm -61.56 -30.06 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 71.1 111.134 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.663 ' O ' HG23 ' A' ' 66' ' ' VAL . 11.9 tp -69.47 -49.72 52.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.23 110.906 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -37.52 79.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.932 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 60' ' ' GLY . 90.3 t -62.46 -58.78 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 61.31 111.147 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 61' ' ' ILE . 91.7 t -51.99 -47.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.5 111.123 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 70' ' ' VAL . 93.5 t -56.18 -38.83 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 52.41 111.195 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.89 -49.87 70.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 65.3 110.974 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.38 88.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 33.35 112.492 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -59.32 -48.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 72.14 111.179 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.4 t -57.69 -54.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 63.34 111.097 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -51.9 -53.32 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 71.44 110.917 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -57.89 11.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 65.4 112.502 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -58.23 -40.3 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.89 0.376 . . . . 75.11 111.167 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.6 mt -57.71 -59.93 4.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.892 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 mm -56.34 -31.65 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.11 111.168 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -69.62 -58.55 3.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 70.41 110.901 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -55.16 -34.35 63.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.03 110.816 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -60.56 -41.44 94.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.845 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 51.76 88.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 70.2 110.886 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.04 126.32 8.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.931 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -129.26 38.41 3.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 73.14 110.913 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.9 mt -114.65 66.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 62.21 111.143 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.73 102.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 62.11 110.843 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 74.34 110.875 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.55 -0.22 . . . . 74.34 112.55 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 66.6 m 53.78 71.95 1.25 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.643 0.735 . . . . 73.55 110.867 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 177.13 5.85 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.778 2.319 . . . . 65.23 112.309 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -113.8 149.68 34.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 72.25 111.147 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.25 138.76 19.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 74.54 110.916 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.77 148.87 50.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 63.53 110.876 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.46 82.26 6.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.933 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.16 40.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 54.51 111.118 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 4.6 p -134.3 72.39 70.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.643 0.735 . . . . 74.34 110.798 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -22.21 32.28 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.67 2.247 . . . . 74.33 112.311 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' LEU . . . . . 0.555 ' HA ' HD12 ' B' ' 154' ' ' ILE . 9.2 mt -52.86 -36.38 58.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 72.31 110.923 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 52' ' ' THR . 40.3 m -51.74 -35.17 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.173 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -56.95 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.41 110.834 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 4.0 mt -51.35 -46.55 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 63.12 111.123 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.419 ' O ' HG23 ' B' ' 159' ' ' VAL . 37.8 mm -65.88 -43.81 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 61.14 111.116 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 45.4 p -61.15 -43.1 99.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.921 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.6 80.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.518 . . . . 72.42 111.071 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 95.5 t -53.64 -47.8 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 64.32 111.132 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 155' ' ' ILE . 97.2 t -58.9 -47.1 90.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 53.54 111.101 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -58.53 -54.41 38.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 72.21 112.535 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.502 ' O ' HG23 ' B' ' 165' ' ' VAL . 30.4 mm -61.87 -30.83 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 72.34 111.198 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.647 ' O ' HG23 ' B' ' 166' ' ' VAL . 12.0 tp -70.21 -49.52 49.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.909 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -37.31 80.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.916 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.4 t -62.92 -59.06 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 65.25 111.098 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 161' ' ' ILE . 91.0 t -51.84 -48.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.144 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.662 ' O ' HG23 ' B' ' 170' ' ' VAL . 88.7 t -56.8 -38.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 72.44 111.135 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.62 -48.94 72.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.12 88.47 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 50.34 112.505 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.41 -49.17 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 74.45 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.4 t -60.67 -53.55 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 63.45 111.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -51.86 -53.13 44.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 64.02 110.866 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.99 -57.98 11.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 40.11 112.495 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.1 -41.04 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.372 . . . . 63.2 111.126 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.74 -61.44 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.23 110.874 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.5 mm -56.58 -30.98 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.33 111.114 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -68.9 -61.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.897 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -58.66 -38.73 78.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 75.35 110.88 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -64.97 -40.57 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.839 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 51.78 88.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 73.44 110.916 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.53 127.1 7.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 74.04 110.934 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -128.67 37.28 4.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 71.05 110.929 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.0 mt -115.55 65.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 63.31 111.182 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.3 102.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 70.25 110.917 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 75.03 110.957 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.491 -0.243 . . . . 72.51 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 24.6 t -149.19 69.94 9.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 73.32 110.822 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 116.93 4.8 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 74.22 112.327 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.91 -34.75 59.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 60.23 111.086 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.7 35.91 22.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 70.23 110.839 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.27 -28.36 29.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 71.24 110.96 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 58.48 40.6 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 71.41 110.93 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.8 55.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 65.33 111.124 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.2 m -122.23 73.15 37.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.715 0.769 . . . . 74.42 110.889 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -22.43 31.94 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.684 2.256 . . . . 70.33 112.336 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.13 -33.7 65.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.224 -0.444 . . . . 53.01 110.834 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.59 HG21 HD12 ' B' ' 155' ' ' ILE . 95.3 m -52.24 -32.17 35.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 72.32 111.144 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.6 m -67.8 -58.07 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.845 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.3 mm -51.28 -44.45 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.146 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.593 HD12 HG21 ' B' ' 152' ' ' THR . 73.7 mt -67.36 -44.38 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 60.23 111.135 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -61.61 -41.26 97.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 63.02 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.52 -48.04 76.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.51 111.094 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 99.3 t -54.77 -43.88 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.55 111.181 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 55' ' ' ILE . 87.3 t -61.16 -48.23 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 43.24 111.111 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.711 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.5 -48.0 87.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 70.12 112.467 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 65' ' ' VAL . 76.1 mt -66.38 -31.66 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.376 . . . . 70.5 111.18 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.2 tp -69.67 -44.84 69.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 72.24 110.957 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -38.74 92.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 62.13 110.871 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.2 t -62.03 -57.04 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 60.45 111.126 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 61' ' ' ILE . 79.7 t -51.82 -50.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 72.45 111.093 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 70' ' ' VAL . 93.6 t -54.98 -38.71 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 65.12 111.074 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tp -64.08 -50.16 69.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 74.41 110.936 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.91 86.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.831 -0.699 . . . . 63.41 112.418 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.01 -48.93 85.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 63.23 111.151 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.1 t -57.92 -54.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 75.31 111.185 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -52.0 -53.66 39.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 74.25 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.58 10.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 54.03 112.526 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.58 -39.97 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.377 . . . . 64.44 111.085 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.32 -60.21 4.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 71.23 110.94 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.4 mm -58.97 -31.21 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 43.23 111.093 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -67.19 -56.99 7.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 73.01 110.913 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -58.62 -41.94 87.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 72.22 110.876 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -63.35 -39.44 94.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 71.33 110.89 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -36.72 39.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 65.43 110.9 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -67.71 -55.64 12.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 55.2 110.897 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.23 158.97 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 63.42 110.919 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.36 66.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 75.12 111.135 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.83 56.76 6.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.54 110.821 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 53.14 110.864 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.479 -0.248 . . . . 61.02 112.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 24.4 t -149.11 69.91 9.91 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.571 0.7 . . . . 74.03 110.951 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 116.93 4.79 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.664 2.243 . . . . 60.53 112.329 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.9 -34.6 59.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 63.34 111.117 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.64 35.85 22.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 72.35 110.93 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.38 -28.39 28.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 74.52 110.884 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 58.28 40.54 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 74.33 110.859 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.85 54.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 73.12 111.105 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 7.3 m -122.56 72.89 41.09 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.683 0.754 . . . . 72.1 110.76 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -22.75 31.28 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.709 2.272 . . . . 62.41 112.297 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.41 -33.94 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.25 110.962 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.593 HG21 HD12 ' A' ' 55' ' ' ILE . 95.5 m -52.69 -32.21 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 75.32 111.175 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -67.7 -58.05 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 65.34 110.813 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.712 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.3 mm -51.27 -44.53 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 74.12 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 52' ' ' THR . 73.5 mt -67.3 -44.37 87.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.5 111.157 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.2 p -61.68 -41.09 97.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 53.51 110.904 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.04 76.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 41.35 111.125 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.712 HG23 ' O ' ' B' ' 154' ' ' ILE . 99.3 t -54.77 -43.91 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 53.54 111.153 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.8 t -61.18 -48.37 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.11 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -61.84 -47.6 89.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.724 -0.75 . . . . 42.01 112.563 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.554 ' O ' HG23 ' B' ' 165' ' ' VAL . 76.8 mt -66.76 -30.97 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 72.42 111.12 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.657 ' O ' HG23 ' B' ' 166' ' ' VAL . 16.2 tp -69.97 -45.04 68.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.907 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 74.2 110.975 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 97.4 t -62.06 -56.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 65.24 111.144 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 161' ' ' ILE . 78.1 t -51.85 -50.4 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 62.23 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.71 ' O ' HG23 ' B' ' 170' ' ' VAL . 93.9 t -54.9 -38.83 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.3 111.112 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.98 -50.19 69.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.954 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.77 86.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 43.1 112.484 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.53 111.153 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.71 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -57.74 -53.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 54.12 111.128 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.69 -53.83 42.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 63.21 110.872 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -59.03 9.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 43.42 112.51 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.88 -39.71 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.952 0.406 . . . . 74.51 111.144 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.48 -61.37 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 73.3 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.44 -31.5 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 75.45 111.133 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -67.22 -56.95 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 65.43 110.943 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -58.5 -42.26 87.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 63.24 110.856 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -63.76 -39.87 95.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 71.55 110.895 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -37.06 42.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 62.44 110.922 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -67.9 -55.94 10.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 71.14 110.882 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.25 159.25 8.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 74.31 110.89 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.7 mt -115.34 66.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 63.23 111.121 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.95 56.54 6.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 73.1 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 75.12 110.892 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.479 -0.248 . . . . 74.53 112.479 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.7 m -137.41 72.41 51.37 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.483 0.659 . . . . 64.43 110.894 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -179.93 3.26 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.613 2.209 . . . . 75.45 112.377 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.42 92.72 8.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 74.43 111.083 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -158.06 127.0 5.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.916 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.46 112.44 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 61.54 110.916 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB2' HD13 ' B' ' 151' ' ' LEU . 0.0 OUTLIER -67.04 118.4 10.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 71.24 110.909 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.14 53.47 2.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 54.41 111.075 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.86 160.54 43.57 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.647 0.737 . . . . 74.33 110.908 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -47.11 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.693 2.262 . . . . 61.23 112.378 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD13 ' HB2' ' B' ' 147' ' ' ARG . 0.5 OUTLIER -55.48 -26.03 40.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.869 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.508 HG23 HG23 ' B' ' 152' ' ' THR . 2.8 m -62.27 -32.37 73.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 52.01 111.079 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -57.94 5.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 41.24 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.7 mp -51.38 -44.5 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 64.11 111.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 59' ' ' VAL . 66.3 mt -67.01 -44.79 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 70.43 111.152 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 p -61.28 -42.1 98.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 63.3 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.57 80.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 73.53 111.13 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.7 t -54.81 -45.07 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.23 111.149 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 55' ' ' ILE . 98.7 t -60.12 -48.57 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.42 111.12 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.92 -48.09 87.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 65.32 112.474 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 65' ' ' VAL . 76.2 mt -62.91 -34.21 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 74.22 111.116 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.656 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.2 tp -69.76 -48.72 58.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.03 110.942 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -36.86 73.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 53.2 110.956 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.0 t -65.3 -58.0 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.184 -0.462 . . . . 64.13 111.123 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 61' ' ' ILE . 78.5 t -52.32 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 61.11 111.134 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 62' ' ' LEU . 98.9 t -57.53 -41.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 72.0 111.108 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.78 -46.33 90.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 64.23 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.38 -40.14 97.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 34.53 112.477 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 65' ' ' VAL . 88.3 t -62.31 -48.53 87.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 62.21 111.139 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG12 ' CD1' ' A' ' 74' ' ' LEU . 56.9 t -65.04 -52.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 72.43 111.163 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -52.65 -53.73 43.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.43 110.906 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.56 10.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 55.52 112.459 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.68 -39.71 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 62.13 111.102 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.405 ' CD1' HG12 ' A' ' 70' ' ' VAL . 24.8 mt -60.4 -61.18 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.23 110.936 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.4 mm -55.64 -31.22 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 75.41 111.111 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -71.58 -62.91 1.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 70.15 110.913 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -52.61 -30.96 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.849 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.31 -55.87 6.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 65.32 110.915 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 51.62 88.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 73.21 110.898 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -179.24 -173.13 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.54 110.911 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -79.06 -177.76 5.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 71.25 110.872 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.52 66.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 61.33 111.189 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 52.04 71.38 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 75.32 110.801 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 75.04 110.965 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.461 -0.255 . . . . 74.31 112.461 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 72.7 m -137.49 72.57 50.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.578 0.704 . . . . 61.53 110.861 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -179.95 3.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.728 2.285 . . . . 45.44 112.336 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.4 92.82 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 52.11 111.084 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -158.1 126.96 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.2 110.924 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.445 ' CA ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -171.36 112.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.877 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 147' ' ' ARG . . . . . 0.55 ' HB2' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -67.04 118.36 10.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 73.23 110.855 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.22 53.38 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 65.15 111.09 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.77 160.52 43.88 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.647 0.736 . . . . 41.03 110.884 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -46.96 1.05 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.688 2.259 . . . . 64.12 112.36 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -55.24 -26.24 38.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.967 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.508 HG23 HG23 ' A' ' 52' ' ' THR . 2.8 m -62.2 -32.33 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 75.51 111.186 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -57.94 5.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 51.4 110.893 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.706 ' O ' HG23 ' B' ' 158' ' ' VAL . 2.8 mp -51.37 -44.49 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 55.32 111.151 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.462 ' O ' HG23 ' B' ' 159' ' ' VAL . 66.5 mt -67.03 -44.83 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.16 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 58.5 p -61.19 -42.0 97.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 64.53 110.954 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.65 80.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 74.52 111.044 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.2 t -54.77 -45.06 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 74.33 111.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 155' ' ' ILE . 97.7 t -60.14 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 64.41 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.705 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.89 -48.11 87.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.49 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.518 ' O ' HG23 ' B' ' 165' ' ' VAL . 76.6 mt -62.41 -33.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 70.44 111.193 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.639 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.2 tp -70.14 -48.66 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 64.04 110.934 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.13 74.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.01 110.908 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 160' ' ' GLY . 88.3 t -64.99 -57.93 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.55 111.102 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 161' ' ' ILE . 79.1 t -52.04 -46.83 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 74.23 111.095 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.639 HG23 ' O ' ' B' ' 162' ' ' LEU . 95.3 t -57.18 -42.41 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 74.04 111.152 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.34 -46.04 91.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.91 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.82 96.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 44.44 112.443 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 165' ' ' VAL . 87.8 t -62.56 -48.56 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 73.35 111.189 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.1 -52.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 63.45 111.081 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -52.59 -53.64 43.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.14 110.897 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.39 -59.25 9.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 52.43 112.524 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 70.4 mt -56.79 -39.22 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 74.41 111.128 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.7 mt -58.51 -60.27 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 71.32 110.883 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 26.3 mm -55.97 -30.96 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 74.31 111.101 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -71.07 -60.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.34 110.829 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -52.01 -30.12 23.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 65.14 110.825 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.94 -56.32 6.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.875 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 51.77 88.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 73.01 110.878 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -178.46 -173.86 0.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 71.04 110.99 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -79.77 -178.24 6.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 55.11 110.975 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.63 66.43 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 75.31 111.08 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 52.11 71.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 72.23 110.854 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 44.14 110.873 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.476 -0.25 . . . . 62.54 112.476 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.6 t -130.23 68.8 81.57 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.63 0.729 . . . . 70.2 110.901 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -45.4 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.697 2.265 . . . . 72.41 112.343 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.0 150.81 37.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 63.25 111.081 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -112.85 63.9 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 61.41 110.895 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.65 -177.69 6.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 62.04 110.915 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -158.61 80.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 65.52 110.912 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.74 141.5 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 70.33 111.106 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.55 160.54 37.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.749 0.785 . . . . 75.23 110.783 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -27.81 26.25 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.734 2.289 . . . . 71.41 112.339 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.17 -33.13 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 65.11 110.913 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.584 ' HA ' HG23 ' B' ' 152' ' ' THR . 28.3 m -51.81 -32.28 30.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 74.11 111.147 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -57.75 5.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.898 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 58' ' ' VAL . 61.6 mt -51.55 -44.71 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 61.13 111.104 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 59' ' ' VAL . 37.1 mm -67.0 -44.33 88.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 72.53 111.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -61.77 -41.53 97.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 70.43 110.884 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -47.51 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.02 111.045 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.4 t -55.01 -45.58 76.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 75.32 111.132 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' ILE . 85.0 t -59.71 -48.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 71.03 111.214 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.53 -48.36 86.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 64.51 112.516 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 65' ' ' VAL . 71.0 mt -63.83 -35.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.813 0.34 . . . . 74.13 111.107 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -68.78 -46.83 67.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 75.3 110.909 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.675 HD23 HG21 ' B' ' 164' ' ' VAL . 0.8 OUTLIER -59.35 -39.47 83.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 73.21 110.895 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.8 t -62.72 -55.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.078 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 61' ' ' ILE . 58.8 t -53.31 -46.98 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.121 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.696 ' O ' HG23 ' A' ' 70' ' ' VAL . 96.5 t -56.76 -40.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.117 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.92 -48.82 77.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.21 110.936 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.99 90.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 50.35 112.51 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.03 -48.69 85.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 74.34 111.117 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.1 t -57.23 -54.21 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 53.54 111.159 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -52.11 -53.84 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 73.32 110.93 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.87 -58.96 9.28 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.731 -0.747 . . . . 54.04 112.484 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.0 mm -57.22 -39.49 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 53.35 111.097 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -60.44 -60.63 3.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.02 110.963 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.2 mm -57.69 -32.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 60.51 111.197 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -68.86 -60.24 2.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 71.0 110.965 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -52.59 -37.2 57.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 70.31 110.904 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -53.55 38.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.24 110.875 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.09 -175.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 75.42 110.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.92 -174.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 72.25 110.885 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt 58.64 95.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 64.13 110.9 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 mt -115.46 66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 62.42 111.135 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -174.57 55.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.24 110.833 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 73.35 110.921 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.458 -0.257 . . . . 35.5 112.458 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 2.6 t -130.27 68.73 81.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 72.13 110.935 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 -45.37 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.672 2.248 . . . . 72.12 112.363 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.09 150.63 37.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.11 111.084 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -113.03 64.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.881 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.43 -177.43 6.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.916 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -158.28 81.08 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 75.32 110.871 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -152.49 142.68 22.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 72.35 111.138 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.3 160.53 35.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.695 0.759 . . . . 72.52 110.877 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -28.27 25.68 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.714 2.276 . . . . 74.24 112.375 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.6 -34.57 51.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 54.12 110.937 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 52' ' ' THR . 28.4 m -52.93 -32.16 44.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 55.13 111.147 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.73 -57.32 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 60.43 110.799 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 61.3 mt -51.5 -45.07 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 62.3 111.187 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 159' ' ' VAL . 37.3 mm -66.87 -44.36 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 73.23 111.13 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.9 p -61.62 -41.58 97.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.25 110.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.63 78.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.23 111.159 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 97.8 t -54.73 -45.51 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 75.32 111.048 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 155' ' ' ILE . 84.7 t -59.96 -48.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 72.11 111.094 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.714 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.47 -48.69 84.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 73.41 112.482 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.584 ' O ' HG23 ' B' ' 165' ' ' VAL . 71.3 mt -63.62 -35.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 74.43 111.116 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.66 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -68.76 -46.88 67.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.873 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.687 HD23 HG21 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -59.81 -38.98 83.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 71.21 110.822 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.4 t -62.76 -56.02 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 74.01 111.161 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 161' ' ' ILE . 57.2 t -53.05 -47.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 70.12 111.198 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.672 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.3 t -56.55 -40.56 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 62.44 111.131 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.04 -48.81 77.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.901 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.25 -45.19 88.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.15 -48.85 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 74.25 111.095 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.3 t -57.78 -54.05 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 52.32 111.154 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -52.1 -53.84 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.896 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -59.29 9.06 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 52.03 112.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.64 -39.72 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.375 . . . . 72.32 111.102 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -60.02 -60.63 3.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 64.42 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.3 mm -57.75 -31.63 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.01 111.085 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -68.14 -59.92 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.4 110.851 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -52.98 -37.17 61.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.897 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -52.72 50.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 72.04 110.92 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 54.05 -175.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.879 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.42 -174.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 75.21 110.928 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt 58.57 95.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.893 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.8 mt -115.51 66.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 75.24 111.114 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -174.54 55.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 61.33 110.863 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.898 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 120.866 0.277 . . . . 70.34 112.385 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.0 mt -52.69 -29.37 26.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.886 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -62.76 -32.54 73.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 63.11 111.108 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -57.72 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.89 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.8 mm -51.31 -44.6 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 72.32 111.14 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 59' ' ' VAL . 63.7 mt -67.13 -44.88 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.2 111.17 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -61.16 -41.74 97.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 51.01 110.862 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.9 78.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.31 111.159 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.4 t -54.68 -45.01 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 61.41 111.099 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 55' ' ' ILE . 96.0 t -60.1 -48.25 88.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.53 111.075 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.71 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.82 -47.31 91.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.24 112.488 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 65' ' ' VAL . 81.2 mt -65.41 -30.54 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 75.22 111.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -70.17 -45.22 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.31 110.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.35 -37.55 87.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 65.41 110.928 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.3 t -62.8 -56.85 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 60.32 111.169 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 61' ' ' ILE . 84.8 t -52.06 -50.33 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.22 111.116 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' HG23 ' A' ' 70' ' ' VAL . 90.8 t -55.46 -38.72 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 53.13 111.151 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -49.6 70.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 64.41 110.904 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.9 -45.08 87.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.755 -0.736 . . . . 73.15 112.43 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.12 -48.95 85.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 71.31 111.124 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.8 t -60.57 -53.82 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 65.25 111.149 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.1 -53.32 44.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 74.12 110.888 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.9 -57.73 12.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 61.45 112.449 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 72.11 111.138 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.83 0.263 . . . . 62.4 112.366 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.4 mt -52.58 -29.71 27.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 45.45 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.7 m -62.25 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.221 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -57.73 5.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 52.33 110.868 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 158' ' ' VAL . 51.0 mm -51.38 -44.67 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.44 111.151 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.469 ' O ' HG23 ' B' ' 159' ' ' VAL . 64.0 mt -67.09 -44.79 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 74.22 111.128 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 59.3 p -61.15 -41.85 97.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 44.43 110.902 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.85 78.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 61.34 111.073 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 154' ' ' ILE . 97.1 t -54.58 -44.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 63.52 111.134 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 155' ' ' ILE . 96.7 t -60.16 -48.55 87.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.173 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.705 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -62.09 -47.29 90.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 52.54 112.436 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.54 ' O ' HG23 ' B' ' 165' ' ' VAL . 81.0 mt -66.22 -30.24 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 60.41 111.077 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.652 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -70.16 -45.32 66.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.929 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.2 -37.81 88.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 61.04 110.897 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 160' ' ' GLY . 93.7 t -62.67 -56.84 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 71.43 111.177 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 161' ' ' ILE . 84.7 t -52.22 -49.96 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 70.32 111.129 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.672 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.3 t -55.47 -38.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 75.35 111.117 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.29 -49.8 70.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 75.2 110.855 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.89 87.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 72.34 112.473 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.19 -48.89 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 25.3 111.095 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.4 t -59.71 -53.95 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.121 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -53.38 -53.86 45.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 74.51 110.862 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -57.91 12.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 54.21 112.485 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.93 -39.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 70.42 111.135 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.09 -58.41 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.42 110.877 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.601 HD11 ' CE2' ' B' ' 171' ' ' PHE . 64.6 mt -59.68 -31.54 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 73.24 111.081 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -67.62 -50.9 55.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.914 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 75.42 110.896 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.823 0.259 . . . . 74.33 112.333 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.19 -38.64 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 50.4 110.939 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.682 HG23 ' HA ' ' B' ' 152' ' ' THR . 19.3 m -52.3 -30.88 30.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 25.4 111.102 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -68.89 -57.5 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 60.41 110.844 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.9 mm -51.31 -44.62 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 60.23 111.157 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.5 mm -67.26 -45.07 86.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 73.21 111.118 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.3 p -60.88 -41.77 96.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 65.0 110.879 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -48.31 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 74.41 111.13 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.7 t -54.41 -43.56 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 72.42 111.083 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 55' ' ' ILE . 86.4 t -61.54 -47.49 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 72.33 111.16 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.694 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.24 -53.17 48.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 74.24 112.501 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 mm -61.94 -29.44 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 72.54 111.151 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.8 tp -70.51 -50.61 35.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.12 110.936 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD23 HG21 ' B' ' 164' ' ' VAL . 7.5 tp -60.1 -37.22 79.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 61.32 110.976 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 60' ' ' GLY . 93.4 t -62.74 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 72.41 111.163 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 61' ' ' ILE . 92.0 t -51.74 -48.96 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 65.43 111.188 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.697 ' O ' HG23 ' A' ' 70' ' ' VAL . 86.2 t -55.74 -39.05 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 72.11 111.122 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -49.8 70.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.896 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.76 -44.89 86.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 75.41 112.493 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.17 -49.02 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 74.14 111.165 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.9 t -58.51 -54.07 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 65.13 111.112 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.93 -53.54 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.891 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.8 -58.47 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 51.11 112.488 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 74.32 111.184 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.82 0.258 . . . . 73.41 112.377 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.0 mt -51.74 -38.35 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 75.13 110.91 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.682 ' HA ' HG23 ' A' ' 52' ' ' THR . 18.9 m -51.96 -30.88 26.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 70.14 111.085 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.8 t -68.92 -57.57 5.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 54.21 110.87 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.9 mm -51.32 -44.65 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 70.02 111.139 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.495 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.6 mm -67.29 -45.05 86.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 65.41 111.125 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.3 p -60.89 -41.61 96.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.4 76.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 65.14 111.048 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.0 t -54.41 -43.46 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.02 111.116 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 155' ' ' ILE . 87.2 t -61.63 -47.71 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.44 111.127 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.676 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.58 -53.21 47.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 72.12 112.558 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.597 ' O ' HG23 ' B' ' 165' ' ' VAL . 29.8 mm -62.81 -28.03 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 64.12 111.115 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.624 ' O ' HG23 ' B' ' 166' ' ' VAL . 12.8 tp -70.0 -51.06 35.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.933 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 64' ' ' VAL . 7.5 tp -60.34 -37.59 81.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.953 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.676 HG23 ' O ' ' B' ' 160' ' ' GLY . 90.1 t -62.39 -58.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.23 111.129 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 161' ' ' ILE . 91.9 t -51.67 -48.68 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 73.13 111.144 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.707 ' O ' HG23 ' B' ' 170' ' ' VAL . 85.3 t -55.69 -39.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 71.01 111.155 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.07 -50.11 69.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.908 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.78 -44.47 86.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 70.34 112.536 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.29 -49.04 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 55.33 111.12 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.9 t -57.7 -53.93 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.31 111.14 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.7 t80 -52.69 -53.87 41.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.877 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.18 -58.95 9.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 51.34 112.462 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.96 -39.73 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 65.03 111.121 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.8 -61.1 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 61.4 110.903 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' B' ' 171' ' ' PHE . 78.4 mt -52.8 -39.09 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 72.23 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -62.39 -47.28 84.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 74.23 110.961 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 45.8 mtp85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 70.52 110.886 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.768 0.237 . . . . 64.41 112.353 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -23.47 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 61.33 110.918 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.653 HG21 HD12 ' B' ' 155' ' ' ILE . 31.6 m -55.91 -33.37 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 65.21 111.154 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -67.51 -57.97 5.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 35.25 110.87 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 58' ' ' VAL . 49.2 mm -51.46 -44.87 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.4 111.154 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.626 ' CD1' HG21 ' B' ' 152' ' ' THR . 79.0 mt -67.18 -43.48 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 64.33 111.171 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.698 ' HB3' HG21 ' B' ' 159' ' ' VAL . 3.8 m -62.27 -41.49 98.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 72.41 110.857 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.76 77.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 42.23 111.089 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 54' ' ' ILE . 94.9 t -55.64 -40.58 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.15 111.158 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' B' ' 156' ' ' SER . 92.3 t -63.92 -47.48 90.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 65.14 111.1 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.691 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.54 -46.25 92.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 62.22 112.474 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 65' ' ' VAL . 80.5 mt -66.81 -27.46 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.842 0.353 . . . . 71.53 111.038 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.658 ' O ' HG23 ' A' ' 66' ' ' VAL . 2.1 tt -71.13 -46.61 61.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 65.32 110.895 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -38.36 90.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.2 t -62.15 -55.15 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 64.53 111.15 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 61' ' ' ILE . 94.4 t -53.52 -48.94 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 75.3 111.093 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 70' ' ' VAL . 94.7 t -55.92 -38.67 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 63.31 111.104 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.21 -49.97 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.66 87.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.843 -0.694 . . . . 74.15 112.45 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.31 -48.85 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 72.04 111.146 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.5 t -58.16 -54.04 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 75.43 111.152 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -51.93 -53.65 38.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.852 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.38 10.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.728 -0.749 . . . . 72.35 112.471 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 62.21 111.149 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 CA-C-O 120.852 0.272 . . . . 74.2 112.434 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -23.27 36.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 52.52 110.92 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.626 HG21 ' CD1' ' A' ' 55' ' ' ILE . 30.8 m -58.11 -33.35 69.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.211 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -67.32 -57.71 6.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 65.11 110.873 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 158' ' ' VAL . 49.0 mm -51.52 -45.19 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 74.32 111.189 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.653 HD12 HG21 ' A' ' 52' ' ' THR . 79.3 mt -67.21 -43.32 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.133 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.725 ' HB3' HG21 ' A' ' 59' ' ' VAL . 3.8 m -62.05 -41.68 98.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.33 110.863 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 45.41 111.157 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.7 t -55.27 -40.62 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 70.21 111.135 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.698 HG21 ' HB3' ' A' ' 56' ' ' SER . 93.7 t -64.05 -47.57 89.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 61.34 111.136 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.704 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -63.6 -45.87 93.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 65.4 112.476 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.661 ' O ' HG23 ' B' ' 165' ' ' VAL . 81.0 mt -66.69 -26.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 64.22 111.144 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.65 ' O ' HG23 ' B' ' 166' ' ' VAL . 2.1 tt -70.93 -47.03 61.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.922 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.406 ' O ' HD13 ' B' ' 163' ' ' LEU . 0.2 OUTLIER -64.65 -38.32 90.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.902 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 160' ' ' GLY . 93.3 t -62.13 -54.86 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 64.33 111.189 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.661 HG23 ' O ' ' B' ' 161' ' ' ILE . 92.5 t -53.58 -48.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 73.03 111.164 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.706 ' O ' HG23 ' B' ' 170' ' ' VAL . 90.8 t -55.86 -39.43 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.157 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.49 -49.72 70.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 45.42 110.914 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.35 88.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 73.33 112.465 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.4 -49.07 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 51.15 111.133 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.0 t -58.42 -54.03 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 65.14 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.708 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.33 -53.61 42.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 73.15 110.871 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.14 -58.8 9.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 35.5 112.532 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.7 mm -57.21 -39.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 75.24 111.168 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.47 -59.88 4.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 75.03 110.943 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.708 HD11 ' CE2' ' B' ' 171' ' ' PHE . 76.4 mt -53.21 -44.16 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 72.33 111.111 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -59.72 -45.51 91.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 64.32 110.949 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.862 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.816 0.257 . . . . 75.24 112.305 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.97 -33.66 38.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 42.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.788 HG21 HD12 ' B' ' 155' ' ' ILE . 14.2 m -52.38 -33.43 43.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.11 111.167 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -58.64 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.881 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.5 mm -51.46 -43.44 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 73.34 111.116 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.782 HD12 HG21 ' B' ' 152' ' ' THR . 80.2 mt -67.29 -44.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 71.33 111.098 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 p -62.08 -40.89 97.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 72.23 110.883 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.87 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 45.35 111.092 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.5 t -56.1 -47.43 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 72.5 111.135 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 55' ' ' ILE . 84.1 t -57.65 -48.17 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 44.15 111.104 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.706 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -60.17 -49.21 81.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 44.01 112.494 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 65' ' ' VAL . 78.3 mt -63.56 -31.87 54.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.378 . . . . 65.51 111.127 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.66 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -69.77 -47.12 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.969 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.93 -38.53 88.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 50.43 110.885 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.0 t -62.09 -57.25 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 62.3 111.07 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.8 t -51.63 -48.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 74.12 111.14 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 70' ' ' VAL . 92.9 t -55.53 -41.23 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.45 111.115 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.26 -49.54 73.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 54.52 110.894 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.25 -44.35 89.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.742 -0.742 . . . . 71.42 112.505 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 65' ' ' VAL . 83.9 t -59.28 -48.97 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 44.25 111.138 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.6 t -57.52 -54.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.22 111.148 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -52.06 -53.7 39.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 72.11 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.38 10.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.522 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.13 111.112 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.774 0.239 . . . . 63.32 112.283 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.53 37.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 63.03 110.96 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.782 HG21 HD12 ' A' ' 55' ' ' ILE . 14.4 m -52.31 -33.32 41.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 70.24 111.11 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -58.74 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 72.23 110.86 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.5 mm -51.43 -43.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 74.42 111.118 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.788 HD12 HG21 ' A' ' 52' ' ' THR . 80.4 mt -67.34 -44.88 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 70.12 111.078 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 34.8 p -62.2 -40.92 97.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 65.54 110.818 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.9 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 51.31 111.064 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.5 t -56.07 -47.41 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 155' ' ' ILE . 84.7 t -57.69 -48.19 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.109 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.714 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -60.23 -49.01 83.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.675 -0.774 . . . . 64.22 112.517 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.544 ' O ' HG23 ' B' ' 165' ' ' VAL . 78.3 mt -63.61 -32.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 74.43 111.101 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.651 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -70.05 -47.19 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 64.32 110.905 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 163' ' ' LEU . 1.7 tt -61.3 -38.59 87.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 64.3 110.941 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 160' ' ' GLY . 94.7 t -62.65 -57.34 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.43 111.101 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 161' ' ' ILE . 93.0 t -51.62 -48.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.13 111.163 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.686 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.7 t -55.67 -40.6 61.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 74.21 111.171 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.29 -49.25 74.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.95 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.17 -44.66 88.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.738 . . . . 41.13 112.472 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.27 -48.94 85.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 73.11 111.171 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.686 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -57.43 -54.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.44 111.125 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.587 ' CZ ' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.65 -53.83 41.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.8 9.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 53.21 112.482 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.11 -39.71 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 72.33 111.155 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.62 -55.38 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 51.43 110.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.587 HD11 ' CZ ' ' B' ' 171' ' ' PHE . 73.0 mt -61.67 -50.82 78.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.1 111.127 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -41.43 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.911 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 73.31 110.935 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.81 0.254 . . . . 72.02 112.314 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -36.22 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 74.02 110.88 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -51.63 -37.37 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.02 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -61.94 -59.37 5.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 55.25 110.907 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.678 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.3 mm -51.43 -47.55 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 74.11 111.124 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 59' ' ' VAL . 40.1 mm -64.23 -40.01 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.02 111.186 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.685 ' OG ' HG21 ' B' ' 159' ' ' VAL . 0.1 OUTLIER -58.38 -47.52 83.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 65.1 110.848 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.63 -49.62 68.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 64.2 111.035 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.9 t -50.69 -40.14 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.24 111.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 55' ' ' ILE . 62.0 t -69.31 -42.94 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 64.11 111.12 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.58 -50.16 63.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 60.32 112.523 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 65' ' ' VAL . 63.4 mt -66.02 -29.9 48.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.939 0.399 . . . . 71.14 111.184 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.665 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -69.71 -46.92 64.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 65.25 110.951 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -38.66 91.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 72.44 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.1 t -61.49 -56.72 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 53.22 111.122 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 61' ' ' ILE . 87.7 t -52.58 -48.73 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 64.24 111.133 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 70' ' ' VAL . 92.2 t -55.55 -38.59 50.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 75.53 111.156 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -50.47 68.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 64.53 110.866 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.59 85.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.755 -0.735 . . . . 71.33 112.452 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.06 -49.11 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 73.24 111.109 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.3 t -57.86 -54.21 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.23 111.112 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.09 -53.56 40.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.908 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -58.25 10.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.798 -0.715 . . . . 75.53 112.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.369 . . . . 65.21 111.129 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.735 0.223 . . . . 74.4 112.373 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -36.49 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 71.12 110.908 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 13.3 m -51.57 -37.42 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.115 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -61.98 -59.24 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 45.1 110.888 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.687 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.1 mm -51.52 -47.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 73.14 111.092 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.692 ' O ' HG23 ' B' ' 159' ' ' VAL . 39.8 mm -64.32 -40.06 87.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -58.39 -47.53 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 60.42 110.801 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.57 68.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 51.14 111.088 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.6 t -50.83 -40.12 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 72.52 111.126 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.692 HG23 ' O ' ' B' ' 155' ' ' ILE . 62.1 t -69.25 -42.86 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.32 111.138 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.703 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -63.58 -50.21 63.58 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.668 -0.777 . . . . 75.24 112.513 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.548 ' O ' HG23 ' B' ' 165' ' ' VAL . 63.6 mt -66.05 -29.86 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 75.42 111.113 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.663 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -69.78 -46.93 64.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 63.33 110.967 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -38.6 91.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 73.42 110.903 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 160' ' ' GLY . 94.1 t -61.61 -56.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 55.43 111.088 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 161' ' ' ILE . 87.9 t -52.5 -48.87 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 75.55 111.091 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.685 ' O ' HG23 ' B' ' 170' ' ' VAL . 96.1 t -55.59 -38.67 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 61.35 111.102 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -50.42 68.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 62.14 110.915 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.64 85.42 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.654 -0.784 . . . . 51.2 112.487 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.12 -49.3 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 62.43 111.062 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.685 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.6 t -58.67 -54.03 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 70.11 111.148 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.649 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -52.72 -53.79 42.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.913 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.11 -58.66 10.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 64.51 112.427 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.3 -39.84 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 74.23 111.166 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 174' ' ' LEU . 19.1 mt -59.11 -58.95 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.4 110.884 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.649 HD11 ' CE2' ' B' ' 171' ' ' PHE . 77.1 mt -53.29 -40.27 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.187 -0.46 . . . . 61.02 111.165 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -65.3 -49.69 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 71.41 110.886 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.818 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.809 0.254 . . . . 62.43 112.342 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -51.93 -33.48 37.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 73.15 110.905 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.683 HG23 ' HA ' ' B' ' 152' ' ' THR . 18.7 m -51.75 -31.36 26.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.183 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -57.5 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.875 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.1 mm -51.31 -44.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 62.4 111.104 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.6 mm -67.27 -44.97 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.142 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.5 p -60.9 -41.74 96.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.861 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.24 76.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 63.22 111.056 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.0 t -54.45 -43.39 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 71.24 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 55' ' ' ILE . 86.9 t -61.66 -47.62 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 51.44 111.082 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.712 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.12 -52.97 50.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 73.43 112.488 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 65' ' ' VAL . 29.8 mm -62.58 -30.78 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.84 0.352 . . . . 64.13 111.127 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.6 tp -69.54 -51.54 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 72.15 110.932 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -37.05 73.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.4 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 60' ' ' GLY . 93.8 t -63.09 -60.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.31 111.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.6 t -51.64 -47.37 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 74.32 111.141 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.68 ' O ' HG23 ' A' ' 70' ' ' VAL . 91.8 t -56.56 -38.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 64.31 111.16 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -49.94 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.922 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -44.92 86.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.818 -0.705 . . . . 72.42 112.482 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.08 -49.04 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 72.04 111.136 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.8 t -59.62 -54.09 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 50.45 111.091 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.03 -53.63 39.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.869 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.27 10.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.752 . . . . 32.21 112.469 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 75.34 111.122 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.753 0.23 . . . . 70.12 112.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.35 -34.84 59.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 64.32 110.884 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.683 ' HA ' HG23 ' A' ' 52' ' ' THR . 19.9 m -52.57 -31.23 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 64.23 111.138 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 45.0 t -68.7 -57.28 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 54.25 110.86 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.1 mm -51.43 -44.67 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 51.12 111.148 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.499 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.5 mm -67.34 -45.01 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 60.21 111.111 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.5 p -60.73 -41.91 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.851 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.36 76.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.101 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.3 t -54.3 -43.37 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 50.02 111.198 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.499 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.1 t -61.74 -47.52 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 53.34 111.082 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.71 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.14 -52.84 50.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 74.42 112.487 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.482 ' O ' HG23 ' B' ' 165' ' ' VAL . 30.2 mm -62.27 -30.42 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 62.31 111.067 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.643 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.6 tp -69.6 -51.73 32.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.04 110.892 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -37.16 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.03 110.884 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.71 HG23 ' O ' ' B' ' 160' ' ' GLY . 88.6 t -62.69 -59.74 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.17 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 161' ' ' ILE . 89.7 t -51.65 -47.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 74.02 111.116 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.689 ' O ' HG23 ' B' ' 170' ' ' VAL . 89.1 t -56.48 -39.1 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.082 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -50.03 70.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 53.35 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.62 -44.94 86.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.754 -0.736 . . . . 63.21 112.478 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.1 -48.92 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 52.4 111.174 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.689 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.7 t -58.94 -54.08 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 52.14 111.155 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -52.75 -53.91 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 75.35 110.865 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -58.68 10.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.708 -0.758 . . . . 51.41 112.499 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.22 -39.65 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 74.34 111.127 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.14 -60.32 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 42.01 110.94 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.548 HD11 ' CE2' ' B' ' 171' ' ' PHE . 77.0 mt -52.2 -35.15 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 61.14 111.128 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -68.2 -54.24 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 51.14 110.912 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 74.2 110.879 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 120.847 0.27 . . . . 62.13 112.369 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -37.87 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 72.44 110.932 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.559 HG23 ' HA ' ' B' ' 152' ' ' THR . 79.1 m -51.72 -32.16 29.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 72.21 111.144 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -67.46 -57.79 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 62.44 110.856 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 80.7 mt -51.4 -44.61 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 65.22 111.101 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.7 mm -67.24 -44.44 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 64.52 111.137 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.3 p -61.38 -41.68 97.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.21 110.897 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.01 77.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 71.12 111.047 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.3 t -54.63 -43.78 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 51.04 111.135 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 55' ' ' ILE . 85.6 t -61.38 -47.65 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 73.54 111.108 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.9 -50.1 71.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 72.34 112.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' HG23 ' A' ' 65' ' ' VAL . 72.4 mt -64.3 -33.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 72.31 111.146 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.3 tt -69.32 -49.18 58.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.978 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -57.94 -38.6 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 54.54 110.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.4 t -63.11 -58.23 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 64.34 111.151 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 61' ' ' ILE . 58.3 t -52.61 -47.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 72.55 111.132 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.723 ' O ' HG23 ' A' ' 70' ' ' VAL . 96.5 t -56.65 -38.27 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 75.14 111.168 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.36 -49.79 70.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 41.14 110.913 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.26 -44.19 89.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.789 -0.72 . . . . 65.25 112.462 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.55 -48.72 86.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 75.23 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.2 t -57.52 -54.03 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 71.04 111.108 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.84 -53.37 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.863 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.88 -58.06 11.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 64.05 112.478 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 64.11 111.127 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.231 0.137 0 CA-C-O 120.791 0.246 . . . . 74.41 112.354 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.88 -39.12 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 42.25 110.908 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.559 ' HA ' HG23 ' A' ' 52' ' ' THR . 86.2 m -52.57 -32.03 38.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 70.3 111.053 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 5.0 t -67.43 -57.63 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 53.14 110.87 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 80.8 mt -51.41 -44.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 75.01 111.12 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.8 mm -67.19 -44.39 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.098 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.5 p -61.37 -41.66 97.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 70.13 110.849 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.92 77.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 51.33 111.154 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.4 t -54.74 -43.74 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 63.41 111.113 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.0 t -61.43 -47.96 91.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.14 111.157 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.694 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -60.7 -49.08 82.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 71.12 112.44 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 165' ' ' VAL . 72.8 mt -64.43 -32.3 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 42.21 111.183 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.654 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.3 tt -69.85 -49.31 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 63.41 110.918 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.38 -38.53 77.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 52.14 110.938 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 160' ' ' GLY . 97.7 t -63.17 -58.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 63.4 111.07 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 161' ' ' ILE . 58.0 t -52.19 -48.27 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 73.45 111.156 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.683 ' O ' HG23 ' B' ' 170' ' ' VAL . 91.8 t -56.37 -39.03 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.01 111.081 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.49 -49.74 70.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 71.41 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.6 87.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.491 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.37 -49.12 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 74.42 111.159 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.683 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.9 t -59.22 -53.85 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 51.24 111.121 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.729 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.3 t80 -52.05 -53.43 42.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.1 -58.37 10.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 70.52 112.489 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.62 -40.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.838 0.351 . . . . 75.44 111.135 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.06 -59.57 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 51.15 110.91 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.729 HD11 ' CE2' ' B' ' 171' ' ' PHE . 75.5 mt -52.5 -35.32 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.32 111.163 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -66.99 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 75.14 110.858 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.33 110.858 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.465 -0.165 0 CA-C-O 120.864 0.277 . . . . 73.23 112.399 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 -38.67 58.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 75.02 110.896 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.575 HG21 ' CD1' ' B' ' 155' ' ' ILE . 22.2 m -62.42 -32.42 73.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 65.1 111.133 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.67 -57.38 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 72.15 110.839 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 72.5 mt -51.53 -44.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.085 -0.507 . . . . 75.3 111.138 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.576 ' CD1' HG21 ' B' ' 152' ' ' THR . 65.2 mt -67.59 -44.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.467 . . . . 71.34 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB2' HG21 ' B' ' 159' ' ' VAL . 59.5 p -61.14 -41.16 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.871 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.49 74.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 72.01 111.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.7 t -54.22 -44.37 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 71.15 111.15 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' ILE . 90.0 t -60.85 -48.36 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 71.11 111.098 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.56 -46.89 93.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 71.32 112.569 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 65' ' ' VAL . 80.7 mt -65.53 -31.18 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 70.24 111.146 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 66' ' ' VAL . 10.3 tp -69.55 -46.15 67.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 73.41 110.873 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD22 ' CG2' ' B' ' 164' ' ' VAL . 1.2 tt -62.89 -37.78 88.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 62.41 110.961 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.4 t -62.51 -57.1 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 61.33 111.164 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 61' ' ' ILE . 80.1 t -51.62 -50.28 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.115 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 70' ' ' VAL . 90.3 t -55.11 -39.35 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 51.4 111.156 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -49.64 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -45.15 85.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 71.24 112.512 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.5 t -59.1 -49.13 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.419 . . . . 62.23 111.137 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.5 t -60.09 -53.8 43.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 51.13 111.144 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.96 -53.71 38.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 71.34 110.896 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.84 -58.73 9.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 72.4 112.488 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 72.54 111.167 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.203 0 CA-C-O 120.821 0.259 . . . . 70.25 112.355 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.81 -38.77 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 60.13 110.871 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.576 HG21 ' CD1' ' A' ' 55' ' ' ILE . 22.9 m -61.52 -32.01 72.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 73.41 111.156 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -57.29 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.858 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 72.2 mt -51.5 -44.38 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 52.21 111.169 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.575 ' CD1' HG21 ' A' ' 52' ' ' THR . 65.6 mt -67.57 -44.93 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 71.2 111.175 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.405 ' HB2' HG21 ' A' ' 59' ' ' VAL . 59.6 p -61.13 -41.07 96.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 74.55 110.866 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.38 74.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 71.43 111.075 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.6 t -54.28 -44.34 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 62.03 111.159 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 155' ' ' ILE . 92.6 t -60.83 -48.78 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 63.42 111.129 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -61.8 -47.71 88.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 75.13 112.502 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 78.5 mt -66.26 -30.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 72.41 111.166 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.657 ' O ' HG23 ' B' ' 166' ' ' VAL . 10.4 tp -70.12 -46.09 65.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.973 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.19 -38.63 91.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 72.42 110.882 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.6 t -62.02 -57.15 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 45.42 111.117 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 161' ' ' ILE . 80.8 t -51.73 -49.8 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.11 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.687 ' O ' HG23 ' B' ' 170' ' ' VAL . 92.1 t -55.06 -39.47 50.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 64.53 111.166 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -49.9 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 61.43 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.75 87.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 65.01 112.477 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.09 -48.97 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.948 0.404 . . . . 53.43 111.145 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -58.57 -54.0 39.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 73.2 111.191 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.704 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.35 -53.84 39.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.873 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.25 -59.23 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.662 -0.78 . . . . 51.41 112.481 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -56.59 -39.76 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 61.42 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.75 -60.4 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.831 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.704 HD11 ' CE2' ' B' ' 171' ' ' PHE . 75.0 mt -52.25 -35.31 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 65.14 111.136 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -67.9 -59.02 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.14 110.923 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.851 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.84 0.267 . . . . 64.23 112.369 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HA ' HD12 ' A' ' 54' ' ' ILE . 9.1 mt -52.83 -36.68 59.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 72.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.607 ' HA ' HG23 ' B' ' 152' ' ' THR . 40.3 m -51.84 -35.16 43.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 62.12 111.179 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -56.93 10.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.13 110.934 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.717 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.0 mt -51.36 -46.51 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 64.12 111.099 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 59' ' ' VAL . 37.8 mm -65.98 -43.87 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.41 111.083 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 p -61.16 -43.07 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 71.54 110.822 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.7 80.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 73.41 111.138 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 54' ' ' ILE . 95.6 t -53.64 -47.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 72.33 111.13 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 55' ' ' ILE . 97.9 t -59.01 -47.03 91.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.106 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -58.75 -54.4 38.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 72.44 112.42 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 mm -61.56 -30.06 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 71.1 111.134 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.663 ' O ' HG23 ' A' ' 66' ' ' VAL . 11.9 tp -69.47 -49.72 52.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.23 110.906 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -37.52 79.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.932 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 60' ' ' GLY . 90.3 t -62.46 -58.78 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 61.31 111.147 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 61' ' ' ILE . 91.7 t -51.99 -47.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.5 111.123 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 70' ' ' VAL . 93.5 t -56.18 -38.83 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 52.41 111.195 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.89 -49.87 70.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 65.3 110.974 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.38 88.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 33.35 112.492 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -59.32 -48.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 72.14 111.179 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.4 t -57.69 -54.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 63.34 111.097 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -51.9 -53.32 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 71.44 110.917 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -57.89 11.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 65.4 112.502 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.89 0.376 . . . . 75.11 111.167 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.735 0.223 . . . . 74.33 112.311 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . 0.555 ' HA ' HD12 ' B' ' 154' ' ' ILE . 9.2 mt -52.86 -36.38 58.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 72.31 110.923 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 52' ' ' THR . 40.3 m -51.74 -35.17 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.173 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -56.95 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.41 110.834 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 4.0 mt -51.35 -46.55 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 63.12 111.123 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.419 ' O ' HG23 ' B' ' 159' ' ' VAL . 37.8 mm -65.88 -43.81 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 61.14 111.116 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 45.4 p -61.15 -43.1 99.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.921 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.6 80.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.518 . . . . 72.42 111.071 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 95.5 t -53.64 -47.8 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 64.32 111.132 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 155' ' ' ILE . 97.2 t -58.9 -47.1 90.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 53.54 111.101 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -58.53 -54.41 38.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 72.21 112.535 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.502 ' O ' HG23 ' B' ' 165' ' ' VAL . 30.4 mm -61.87 -30.83 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 72.34 111.198 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.647 ' O ' HG23 ' B' ' 166' ' ' VAL . 12.0 tp -70.21 -49.52 49.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.909 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -37.31 80.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.916 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.4 t -62.92 -59.06 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 65.25 111.098 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 161' ' ' ILE . 91.0 t -51.84 -48.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.144 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.662 ' O ' HG23 ' B' ' 170' ' ' VAL . 88.7 t -56.8 -38.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 72.44 111.135 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.62 -48.94 72.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.12 88.47 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 50.34 112.505 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.41 -49.17 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 74.45 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.4 t -60.67 -53.55 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 63.45 111.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -51.86 -53.13 44.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 64.02 110.866 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.99 -57.98 11.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 40.11 112.495 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.1 -41.04 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.372 . . . . 63.2 111.126 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.74 -61.44 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.23 110.874 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.5 mm -56.58 -30.98 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.33 111.114 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -68.9 -61.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.897 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 75.35 110.88 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.759 0.233 . . . . 70.33 112.336 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.13 -33.7 65.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.224 -0.444 . . . . 53.01 110.834 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.59 HG21 HD12 ' B' ' 155' ' ' ILE . 95.3 m -52.24 -32.17 35.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 72.32 111.144 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.6 m -67.8 -58.07 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.845 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.3 mm -51.28 -44.45 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.146 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.593 HD12 HG21 ' B' ' 152' ' ' THR . 73.7 mt -67.36 -44.38 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 60.23 111.135 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -61.61 -41.26 97.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 63.02 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.52 -48.04 76.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.51 111.094 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 99.3 t -54.77 -43.88 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.55 111.181 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 55' ' ' ILE . 87.3 t -61.16 -48.23 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 43.24 111.111 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.711 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.5 -48.0 87.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 70.12 112.467 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 65' ' ' VAL . 76.1 mt -66.38 -31.66 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.376 . . . . 70.5 111.18 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.2 tp -69.67 -44.84 69.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 72.24 110.957 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -38.74 92.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 62.13 110.871 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.2 t -62.03 -57.04 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 60.45 111.126 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 61' ' ' ILE . 79.7 t -51.82 -50.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 72.45 111.093 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 70' ' ' VAL . 93.6 t -54.98 -38.71 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 65.12 111.074 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tp -64.08 -50.16 69.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 74.41 110.936 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.91 86.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.831 -0.699 . . . . 63.41 112.418 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.01 -48.93 85.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 63.23 111.151 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.1 t -57.92 -54.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 75.31 111.185 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -52.0 -53.66 39.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 74.25 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.58 10.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 54.03 112.526 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.377 . . . . 64.44 111.085 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.827 0.261 . . . . 62.41 112.297 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.41 -33.94 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.25 110.962 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.593 HG21 HD12 ' A' ' 55' ' ' ILE . 95.5 m -52.69 -32.21 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 75.32 111.175 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -67.7 -58.05 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 65.34 110.813 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.712 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.3 mm -51.27 -44.53 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 74.12 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 52' ' ' THR . 73.5 mt -67.3 -44.37 87.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.5 111.157 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.2 p -61.68 -41.09 97.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 53.51 110.904 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.04 76.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 41.35 111.125 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.712 HG23 ' O ' ' B' ' 154' ' ' ILE . 99.3 t -54.77 -43.91 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 53.54 111.153 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.8 t -61.18 -48.37 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.11 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -61.84 -47.6 89.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.724 -0.75 . . . . 42.01 112.563 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.554 ' O ' HG23 ' B' ' 165' ' ' VAL . 76.8 mt -66.76 -30.97 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 72.42 111.12 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.657 ' O ' HG23 ' B' ' 166' ' ' VAL . 16.2 tp -69.97 -45.04 68.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.907 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 74.2 110.975 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 97.4 t -62.06 -56.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 65.24 111.144 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 161' ' ' ILE . 78.1 t -51.85 -50.4 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 62.23 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.71 ' O ' HG23 ' B' ' 170' ' ' VAL . 93.9 t -54.9 -38.83 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.3 111.112 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.98 -50.19 69.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.954 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.77 86.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 43.1 112.484 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.53 111.153 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.71 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -57.74 -53.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 54.12 111.128 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.69 -53.83 42.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 63.21 110.872 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -59.03 9.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 43.42 112.51 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.88 -39.71 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.952 0.406 . . . . 74.51 111.144 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.48 -61.37 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 73.3 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.44 -31.5 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 75.45 111.133 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -67.22 -56.95 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 65.43 110.943 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 63.24 110.856 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.86 0.275 . . . . 61.23 112.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.48 -26.03 40.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.869 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.508 HG23 HG23 ' B' ' 152' ' ' THR . 2.8 m -62.27 -32.37 73.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 52.01 111.079 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -57.94 5.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 41.24 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.7 mp -51.38 -44.5 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 64.11 111.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 59' ' ' VAL . 66.3 mt -67.01 -44.79 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 70.43 111.152 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 p -61.28 -42.1 98.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 63.3 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.57 80.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 73.53 111.13 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.7 t -54.81 -45.07 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.23 111.149 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 55' ' ' ILE . 98.7 t -60.12 -48.57 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.42 111.12 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.92 -48.09 87.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 65.32 112.474 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 65' ' ' VAL . 76.2 mt -62.91 -34.21 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 74.22 111.116 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.656 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.2 tp -69.76 -48.72 58.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.03 110.942 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -36.86 73.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 53.2 110.956 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.0 t -65.3 -58.0 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.184 -0.462 . . . . 64.13 111.123 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 61' ' ' ILE . 78.5 t -52.32 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 61.11 111.134 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 62' ' ' LEU . 98.9 t -57.53 -41.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 72.0 111.108 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.78 -46.33 90.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 64.23 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.38 -40.14 97.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 34.53 112.477 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 65' ' ' VAL . 88.3 t -62.31 -48.53 87.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 62.21 111.139 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.04 -52.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 72.43 111.163 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -52.65 -53.73 43.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.43 110.906 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.56 10.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 55.52 112.459 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 62.13 111.102 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.848 0.27 . . . . 64.12 112.36 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -26.24 38.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.967 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.508 HG23 HG23 ' A' ' 52' ' ' THR . 2.8 m -62.2 -32.33 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 75.51 111.186 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -57.94 5.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 51.4 110.893 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.706 ' O ' HG23 ' B' ' 158' ' ' VAL . 2.8 mp -51.37 -44.49 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 55.32 111.151 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.462 ' O ' HG23 ' B' ' 159' ' ' VAL . 66.5 mt -67.03 -44.83 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.16 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 58.5 p -61.19 -42.0 97.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 64.53 110.954 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.65 80.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 74.52 111.044 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.2 t -54.77 -45.06 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 74.33 111.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 155' ' ' ILE . 97.7 t -60.14 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 64.41 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.705 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.89 -48.11 87.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.49 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.518 ' O ' HG23 ' B' ' 165' ' ' VAL . 76.6 mt -62.41 -33.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 70.44 111.193 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.639 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.2 tp -70.14 -48.66 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 64.04 110.934 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.13 74.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.01 110.908 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 160' ' ' GLY . 88.3 t -64.99 -57.93 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.55 111.102 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 161' ' ' ILE . 79.1 t -52.04 -46.83 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 74.23 111.095 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.639 HG23 ' O ' ' B' ' 162' ' ' LEU . 95.3 t -57.18 -42.41 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 74.04 111.152 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.34 -46.04 91.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.91 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.82 96.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 44.44 112.443 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 165' ' ' VAL . 87.8 t -62.56 -48.56 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 73.35 111.189 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.1 -52.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 63.45 111.081 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -52.59 -53.64 43.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.14 110.897 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.39 -59.25 9.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 52.43 112.524 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 70.4 mt -56.79 -39.22 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 74.41 111.128 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.7 mt -58.51 -60.27 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 71.32 110.883 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 26.3 mm -55.97 -30.96 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 74.31 111.101 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -71.07 -60.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.34 110.829 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 65.14 110.825 -179.954 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.851 0.271 . . . . 71.41 112.339 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.17 -33.13 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 65.11 110.913 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.584 ' HA ' HG23 ' B' ' 152' ' ' THR . 28.3 m -51.81 -32.28 30.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 74.11 111.147 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -57.75 5.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.898 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 58' ' ' VAL . 61.6 mt -51.55 -44.71 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 61.13 111.104 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 59' ' ' VAL . 37.1 mm -67.0 -44.33 88.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 72.53 111.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -61.77 -41.53 97.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 70.43 110.884 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -47.51 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.02 111.045 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.4 t -55.01 -45.58 76.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 75.32 111.132 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' ILE . 85.0 t -59.71 -48.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 71.03 111.214 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.53 -48.36 86.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 64.51 112.516 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 65' ' ' VAL . 71.0 mt -63.83 -35.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.813 0.34 . . . . 74.13 111.107 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -68.78 -46.83 67.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 75.3 110.909 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.675 HD23 HG21 ' B' ' 164' ' ' VAL . 0.8 OUTLIER -59.35 -39.47 83.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 73.21 110.895 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.8 t -62.72 -55.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.078 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 61' ' ' ILE . 58.8 t -53.31 -46.98 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.121 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.696 ' O ' HG23 ' A' ' 70' ' ' VAL . 96.5 t -56.76 -40.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.117 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.92 -48.82 77.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.21 110.936 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.99 90.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 50.35 112.51 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.03 -48.69 85.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 74.34 111.117 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.1 t -57.23 -54.21 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 53.54 111.159 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -52.11 -53.84 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 73.32 110.93 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.87 -58.96 9.28 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.731 -0.747 . . . . 54.04 112.484 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 53.35 111.097 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.23 0.122 0 CA-C-O 120.815 0.256 . . . . 74.24 112.375 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.6 -34.57 51.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 54.12 110.937 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 52' ' ' THR . 28.4 m -52.93 -32.16 44.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 55.13 111.147 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.73 -57.32 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 60.43 110.799 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 61.3 mt -51.5 -45.07 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 62.3 111.187 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 159' ' ' VAL . 37.3 mm -66.87 -44.36 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 73.23 111.13 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.9 p -61.62 -41.58 97.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.25 110.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.63 78.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.23 111.159 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 97.8 t -54.73 -45.51 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 75.32 111.048 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 155' ' ' ILE . 84.7 t -59.96 -48.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 72.11 111.094 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.714 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.47 -48.69 84.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 73.41 112.482 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.584 ' O ' HG23 ' B' ' 165' ' ' VAL . 71.3 mt -63.62 -35.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 74.43 111.116 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . 0.66 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -68.76 -46.88 67.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.873 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.687 HD23 HG21 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -59.81 -38.98 83.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 71.21 110.822 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.4 t -62.76 -56.02 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 74.01 111.161 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 161' ' ' ILE . 57.2 t -53.05 -47.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 70.12 111.198 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.672 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.3 t -56.55 -40.56 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 62.44 111.131 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.04 -48.81 77.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.901 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.25 -45.19 88.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.15 -48.85 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 74.25 111.095 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.3 t -57.78 -54.05 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 52.32 111.154 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -52.1 -53.84 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.896 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -59.29 9.06 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 52.03 112.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.64 -39.72 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.375 . . . . 72.32 111.102 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -60.02 -60.63 3.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 64.42 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.3 mm -57.75 -31.63 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.01 111.085 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -68.14 -59.92 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.4 110.851 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.897 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.466 -0.254 . . . . 43.45 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.0 p -129.85 68.36 80.61 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.647 0.737 . . . . 72.32 110.921 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 102.89 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.669 2.246 . . . . 74.22 112.326 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.67 129.49 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 44.31 111.104 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.02 29.75 6.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 72.32 110.895 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.483 ' C ' HD13 ' B' ' 151' ' ' LEU . 0.0 OUTLIER 63.29 161.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.23 110.87 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.98 -179.89 5.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.902 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -176.11 34.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.4 111.098 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.67 160.57 44.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 72.05 110.852 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -42.65 3.23 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.671 2.247 . . . . 70.34 112.385 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD13 ' C ' ' B' ' 146' ' ' GLN . 26.0 mt -52.69 -29.37 26.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.886 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -62.76 -32.54 73.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 63.11 111.108 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -57.72 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.89 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.8 mm -51.31 -44.6 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 72.32 111.14 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 59' ' ' VAL . 63.7 mt -67.13 -44.88 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.2 111.17 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -61.16 -41.74 97.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 51.01 110.862 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.9 78.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.31 111.159 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.4 t -54.68 -45.01 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 61.41 111.099 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 55' ' ' ILE . 96.0 t -60.1 -48.25 88.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.53 111.075 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.71 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.82 -47.31 91.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.24 112.488 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 65' ' ' VAL . 81.2 mt -65.41 -30.54 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 75.22 111.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -70.17 -45.22 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.31 110.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.35 -37.55 87.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 65.41 110.928 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.3 t -62.8 -56.85 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 60.32 111.169 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 61' ' ' ILE . 84.8 t -52.06 -50.33 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.22 111.116 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' HG23 ' A' ' 70' ' ' VAL . 90.8 t -55.46 -38.72 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 53.13 111.151 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -49.6 70.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 64.41 110.904 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.9 -45.08 87.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.755 -0.736 . . . . 73.15 112.43 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.12 -48.95 85.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 71.31 111.124 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.8 t -60.57 -53.82 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 65.25 111.149 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.4 t80 -52.1 -53.32 44.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 74.12 110.888 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.9 -57.73 12.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 61.45 112.449 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.34 -40.49 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 72.11 111.138 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 74' ' ' LEU . 24.7 mt -57.88 -57.3 13.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 74.14 110.95 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.68 HD11 ' CE2' ' A' ' 71' ' ' PHE . 65.6 mt -58.83 -31.03 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.137 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -66.86 -51.12 59.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 75.2 110.926 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -64.59 -45.89 85.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.3 110.918 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.0 mtt-85 -63.5 -28.09 69.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.876 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.2 -175.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.939 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.98 167.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 53.12 110.929 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 mttt 60.33 85.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 74.24 110.853 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.75 66.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 72.02 111.126 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -177.09 78.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 63.33 110.902 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 63.31 110.89 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.466 -0.254 . . . . 74.25 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 7.9 p -129.8 68.41 80.62 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 73.03 110.86 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 102.93 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 62.42 112.383 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.52 129.21 5.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 74.0 111.067 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.21 29.83 6.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.905 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.479 ' C ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER 63.36 161.17 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.941 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . 0.406 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -129.71 179.55 5.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.11 110.856 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -176.79 34.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 74.05 111.089 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.33 160.55 45.14 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.69 0.757 . . . . 73.34 110.862 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -42.01 3.69 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.666 2.244 . . . . 62.4 112.366 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . 0.483 HD13 ' C ' ' A' ' 46' ' ' GLN . 26.4 mt -52.58 -29.71 27.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 45.45 110.867 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.7 m -62.25 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.221 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -57.73 5.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 52.33 110.868 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 158' ' ' VAL . 51.0 mm -51.38 -44.67 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.44 111.151 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.469 ' O ' HG23 ' B' ' 159' ' ' VAL . 64.0 mt -67.09 -44.79 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 74.22 111.128 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 59.3 p -61.15 -41.85 97.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 44.43 110.902 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.85 78.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 61.34 111.073 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 154' ' ' ILE . 97.1 t -54.58 -44.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 63.52 111.134 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 155' ' ' ILE . 96.7 t -60.16 -48.55 87.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.173 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.705 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -62.09 -47.29 90.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 52.54 112.436 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.54 ' O ' HG23 ' B' ' 165' ' ' VAL . 81.0 mt -66.22 -30.24 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 60.41 111.077 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.652 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -70.16 -45.32 66.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.929 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.2 -37.81 88.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 61.04 110.897 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 160' ' ' GLY . 93.7 t -62.67 -56.84 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 71.43 111.177 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 161' ' ' ILE . 84.7 t -52.22 -49.96 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 70.32 111.129 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.672 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.3 t -55.47 -38.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 75.35 111.117 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.29 -49.8 70.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 75.2 110.855 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.89 87.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 72.34 112.473 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.19 -48.89 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 25.3 111.095 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.4 t -59.71 -53.95 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.121 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -53.38 -53.86 45.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 74.51 110.862 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -57.91 12.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 54.21 112.485 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.93 -39.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 70.42 111.135 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.09 -58.41 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.42 110.877 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.601 HD11 ' CE2' ' B' ' 171' ' ' PHE . 64.6 mt -59.68 -31.54 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 73.24 111.081 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -67.62 -50.9 55.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.914 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -64.21 -45.93 86.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 75.42 110.896 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -63.51 -28.59 70.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.908 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.03 -175.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 64.42 110.896 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.48 167.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 74.23 110.939 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 1.4 mttt 60.4 86.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.911 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.6 66.45 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 73.34 111.144 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -176.94 78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 54.53 110.871 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.441 -0.263 . . . . 74.3 112.441 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 50.0 m 54.49 68.64 2.54 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 61.25 110.843 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -28.9 24.45 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.687 2.258 . . . . 75.34 112.291 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.63 177.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.51 111.086 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.08 81.05 1.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.4 110.896 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -128.88 33.2 4.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 45.13 110.901 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -165.43 133.81 3.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.14 110.831 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.06 101.29 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 75.13 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.43 160.61 25.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.699 0.762 . . . . 72.44 110.88 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -15.11 37.08 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.688 2.259 . . . . 74.33 112.333 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.19 -38.64 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 50.4 110.939 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.682 HG23 ' HA ' ' B' ' 152' ' ' THR . 19.3 m -52.3 -30.88 30.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 25.4 111.102 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -68.89 -57.5 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 60.41 110.844 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.9 mm -51.31 -44.62 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 60.23 111.157 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.5 mm -67.26 -45.07 86.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 73.21 111.118 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.3 p -60.88 -41.77 96.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 65.0 110.879 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -48.31 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 74.41 111.13 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.7 t -54.41 -43.56 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 72.42 111.083 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 55' ' ' ILE . 86.4 t -61.54 -47.49 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 72.33 111.16 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.694 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.24 -53.17 48.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 74.24 112.501 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 mm -61.94 -29.44 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 72.54 111.151 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.8 tp -70.51 -50.61 35.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.12 110.936 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD23 HG21 ' B' ' 164' ' ' VAL . 7.5 tp -60.1 -37.22 79.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 61.32 110.976 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 60' ' ' GLY . 93.4 t -62.74 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 72.41 111.163 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 61' ' ' ILE . 92.0 t -51.74 -48.96 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 65.43 111.188 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.697 ' O ' HG23 ' A' ' 70' ' ' VAL . 86.2 t -55.74 -39.05 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 72.11 111.122 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -49.8 70.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.896 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.76 -44.89 86.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 75.41 112.493 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.17 -49.02 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 74.14 111.165 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.9 t -58.51 -54.07 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 65.13 111.112 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.713 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.5 t80 -51.93 -53.54 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.891 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.8 -58.47 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 51.11 112.488 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.68 -40.11 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 74.32 111.184 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -58.81 -60.06 4.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 72.03 110.928 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.713 HD11 ' CE2' ' A' ' 71' ' ' PHE . 78.1 mt -51.87 -39.45 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.54 111.093 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -62.98 -48.1 80.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 72.43 110.872 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 -64.79 -47.01 79.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 73.12 110.878 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -31.04 71.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 74.14 110.86 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.0 -175.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 60.11 110.947 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.94 -68.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 74.25 110.936 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -167.23 143.25 4.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 72.15 110.901 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.54 66.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 70.03 111.124 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -126.39 105.27 8.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.926 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 44.24 110.916 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.423 -0.271 . . . . 62.43 112.423 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 50.4 m 54.48 68.62 2.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.581 0.705 . . . . 54.25 110.856 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -29.01 24.57 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.7 2.266 . . . . 44.14 112.312 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . 59.53 177.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 63.25 111.073 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.89 80.83 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 54.55 110.836 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -129.03 33.53 4.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 65.23 110.877 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -164.95 134.09 3.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 64.25 110.816 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -162.81 101.48 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 72.11 111.117 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.3 160.6 25.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.68 0.753 . . . . 63.12 110.822 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -13.77 35.09 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.701 2.267 . . . . 73.41 112.377 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.0 mt -51.74 -38.35 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 75.13 110.91 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.682 ' HA ' HG23 ' A' ' 52' ' ' THR . 18.9 m -51.96 -30.88 26.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 70.14 111.085 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.8 t -68.92 -57.57 5.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 54.21 110.87 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.9 mm -51.32 -44.65 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 70.02 111.139 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.495 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.6 mm -67.29 -45.05 86.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 65.41 111.125 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.3 p -60.89 -41.61 96.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.4 76.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 65.14 111.048 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.0 t -54.41 -43.46 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.02 111.116 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 155' ' ' ILE . 87.2 t -61.63 -47.71 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.44 111.127 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.676 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.58 -53.21 47.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 72.12 112.558 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.597 ' O ' HG23 ' B' ' 165' ' ' VAL . 29.8 mm -62.81 -28.03 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 64.12 111.115 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.624 ' O ' HG23 ' B' ' 166' ' ' VAL . 12.8 tp -70.0 -51.06 35.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.933 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 64' ' ' VAL . 7.5 tp -60.34 -37.59 81.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.953 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.676 HG23 ' O ' ' B' ' 160' ' ' GLY . 90.1 t -62.39 -58.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.23 111.129 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 161' ' ' ILE . 91.9 t -51.67 -48.68 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 73.13 111.144 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.707 ' O ' HG23 ' B' ' 170' ' ' VAL . 85.3 t -55.69 -39.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 71.01 111.155 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.07 -50.11 69.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.908 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.78 -44.47 86.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 70.34 112.536 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.29 -49.04 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 55.33 111.12 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.9 t -57.7 -53.93 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.31 111.14 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.7 t80 -52.69 -53.87 41.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.877 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.18 -58.95 9.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 51.34 112.462 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.96 -39.73 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 65.03 111.121 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.8 -61.1 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 61.4 110.903 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' B' ' 171' ' ' PHE . 78.4 mt -52.8 -39.09 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 72.23 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -62.39 -47.28 84.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 74.23 110.961 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 45.8 mtp85 -63.76 -47.29 81.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 70.52 110.886 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -31.4 72.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 64.15 110.893 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.99 -175.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.54 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -105.67 -69.03 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.926 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -167.25 143.43 4.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 72.51 110.863 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.3 mt -115.44 66.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 70.43 111.113 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -126.57 105.2 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 71.21 110.83 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 72.02 110.964 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.465 -0.254 . . . . 74.31 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.74 160.51 19.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.65 0.738 . . . . 72.13 110.937 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 124.83 11.48 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.245 . . . . 72.13 112.347 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.44 155.9 43.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.438 . . . . 73.41 111.115 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 175.73 5.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 64.44 110.876 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.04 174.86 10.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 73.43 110.939 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.99 -71.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 71.51 110.954 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.75 56.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.11 111.034 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -139.44 68.34 38.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.546 0.688 . . . . 73.24 110.883 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.64 -11.28 30.66 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.713 2.276 . . . . 64.41 112.353 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -23.47 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 61.33 110.918 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.653 HG21 HD12 ' B' ' 155' ' ' ILE . 31.6 m -55.91 -33.37 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 65.21 111.154 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -67.51 -57.97 5.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 35.25 110.87 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 58' ' ' VAL . 49.2 mm -51.46 -44.87 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.4 111.154 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.626 ' CD1' HG21 ' B' ' 152' ' ' THR . 79.0 mt -67.18 -43.48 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 64.33 111.171 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.698 ' HB3' HG21 ' B' ' 159' ' ' VAL . 3.8 m -62.27 -41.49 98.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 72.41 110.857 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.76 77.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 42.23 111.089 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 54' ' ' ILE . 94.9 t -55.64 -40.58 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.15 111.158 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' B' ' 156' ' ' SER . 92.3 t -63.92 -47.48 90.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 65.14 111.1 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.691 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.54 -46.25 92.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 62.22 112.474 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 65' ' ' VAL . 80.5 mt -66.81 -27.46 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.842 0.353 . . . . 71.53 111.038 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.658 ' O ' HG23 ' A' ' 66' ' ' VAL . 2.1 tt -71.13 -46.61 61.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 65.32 110.895 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -38.36 90.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.2 t -62.15 -55.15 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 64.53 111.15 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 61' ' ' ILE . 94.4 t -53.52 -48.94 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 75.3 111.093 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 70' ' ' VAL . 94.7 t -55.92 -38.67 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 63.31 111.104 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.21 -49.97 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.84 -44.66 87.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.843 -0.694 . . . . 74.15 112.45 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.31 -48.85 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 72.04 111.146 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.5 t -58.16 -54.04 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 75.43 111.152 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.4 t80 -51.93 -53.65 38.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.852 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.38 10.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.728 -0.749 . . . . 72.35 112.471 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.65 -40.12 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 62.21 111.149 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.5 mt -58.91 -59.36 5.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 54.14 110.921 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.718 HD11 ' CE2' ' A' ' 71' ' ' PHE . 76.7 mt -52.77 -44.76 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 72.4 111.081 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -60.73 -45.82 92.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 64.25 110.906 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -62.2 -44.89 95.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 65.11 110.84 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -65.33 -43.14 91.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 71.21 110.896 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.97 -35.99 36.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 61.45 110.868 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.83 102.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 72.23 110.874 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.31 148.07 30.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.903 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.46 66.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 73.53 111.097 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 52.45 80.38 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 64.15 110.838 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.865 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.576 -0.209 . . . . 65.23 112.576 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.64 160.54 18.64 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.621 0.724 . . . . 53.23 110.921 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 124.78 11.4 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.717 2.278 . . . . 73.13 112.328 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.65 155.9 43.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 72.21 111.066 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.31 175.17 5.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.871 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.76 175.43 9.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 70.54 110.904 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 -71.63 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.819 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -158.42 54.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 41.12 111.106 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 19.8 p -141.31 68.55 26.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.654 0.74 . . . . 70.21 110.81 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.65 -11.5 31.11 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.707 2.271 . . . . 74.2 112.434 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -23.27 36.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 52.52 110.92 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.626 HG21 ' CD1' ' A' ' 55' ' ' ILE . 30.8 m -58.11 -33.35 69.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.211 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -67.32 -57.71 6.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 65.11 110.873 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 158' ' ' VAL . 49.0 mm -51.52 -45.19 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 74.32 111.189 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.653 HD12 HG21 ' A' ' 52' ' ' THR . 79.3 mt -67.21 -43.32 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.133 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.725 ' HB3' HG21 ' A' ' 59' ' ' VAL . 3.8 m -62.05 -41.68 98.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.33 110.863 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 45.41 111.157 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.7 t -55.27 -40.62 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 70.21 111.135 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.698 HG21 ' HB3' ' A' ' 56' ' ' SER . 93.7 t -64.05 -47.57 89.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 61.34 111.136 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.704 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -63.6 -45.87 93.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 65.4 112.476 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.661 ' O ' HG23 ' B' ' 165' ' ' VAL . 81.0 mt -66.69 -26.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 64.22 111.144 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.65 ' O ' HG23 ' B' ' 166' ' ' VAL . 2.1 tt -70.93 -47.03 61.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.922 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.406 ' O ' HD13 ' B' ' 163' ' ' LEU . 0.2 OUTLIER -64.65 -38.32 90.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.902 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 160' ' ' GLY . 93.3 t -62.13 -54.86 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 64.33 111.189 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.661 HG23 ' O ' ' B' ' 161' ' ' ILE . 92.5 t -53.58 -48.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 73.03 111.164 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.706 ' O ' HG23 ' B' ' 170' ' ' VAL . 90.8 t -55.86 -39.43 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.157 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.49 -49.72 70.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 45.42 110.914 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.35 88.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 73.33 112.465 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.4 -49.07 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 51.15 111.133 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.0 t -58.42 -54.03 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 65.14 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.708 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.33 -53.61 42.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 73.15 110.871 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.14 -58.8 9.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 35.5 112.532 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.7 mm -57.21 -39.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 75.24 111.168 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.47 -59.88 4.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 75.03 110.943 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.708 HD11 ' CE2' ' B' ' 171' ' ' PHE . 76.4 mt -53.21 -44.16 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 72.33 111.111 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -59.72 -45.51 91.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 64.32 110.949 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -61.77 -45.43 93.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.862 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -66.09 -43.25 87.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 70.2 110.825 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -35.72 33.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 75.53 110.935 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.39 102.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 73.44 110.883 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 148.31 30.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 65.34 110.916 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.8 mt -115.35 66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 65.13 111.112 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 52.56 80.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.5 110.902 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 61.44 110.851 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.488 -0.245 . . . . 50.13 112.488 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.17 160.53 30.81 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.599 0.714 . . . . 75.53 110.888 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 120.61 7.37 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.703 2.269 . . . . 72.44 112.309 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.63 117.43 7.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 54.31 111.057 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.7 -51.08 5.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 74.21 110.939 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -98.99 105.26 17.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 63.22 110.938 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.89 122.43 7.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.895 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.87 81.38 2.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 55.02 111.151 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -135.85 70.52 64.49 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 73.25 110.868 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -31.32 20.5 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.681 2.254 . . . . 75.24 112.305 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.97 -33.66 38.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 42.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.788 HG21 HD12 ' B' ' 155' ' ' ILE . 14.2 m -52.38 -33.43 43.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.11 111.167 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -58.64 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.881 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.5 mm -51.46 -43.44 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 73.34 111.116 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.782 HD12 HG21 ' B' ' 152' ' ' THR . 80.2 mt -67.29 -44.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 71.33 111.098 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 p -62.08 -40.89 97.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 72.23 110.883 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.87 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 45.35 111.092 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.5 t -56.1 -47.43 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 72.5 111.135 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 55' ' ' ILE . 84.1 t -57.65 -48.17 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 44.15 111.104 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.706 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -60.17 -49.21 81.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 44.01 112.494 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 65' ' ' VAL . 78.3 mt -63.56 -31.87 54.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.378 . . . . 65.51 111.127 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.66 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -69.77 -47.12 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.969 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.93 -38.53 88.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 50.43 110.885 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.0 t -62.09 -57.25 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 62.3 111.07 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.8 t -51.63 -48.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 74.12 111.14 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 70' ' ' VAL . 92.9 t -55.53 -41.23 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.45 111.115 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.26 -49.54 73.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 54.52 110.894 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.25 -44.35 89.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.742 -0.742 . . . . 71.42 112.505 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 65' ' ' VAL . 83.9 t -59.28 -48.97 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 44.25 111.138 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.6 t -57.52 -54.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.22 111.148 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.3 t80 -52.06 -53.7 39.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 72.11 110.839 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.38 10.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.522 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.79 -39.96 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.13 111.112 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.8 mt -59.13 -55.16 38.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 70.44 110.974 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.632 HD11 ' CE2' ' A' ' 71' ' ' PHE . 73.0 mt -61.49 -50.01 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 55.25 111.19 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.81 -40.79 66.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 65.14 110.91 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -64.57 -51.58 62.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 61.52 110.841 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -62.13 -31.78 72.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.851 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 123.57 9.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.855 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.41 -172.13 1.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 64.25 110.889 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 164.37 2.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 75.35 110.977 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 mt -115.47 66.32 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 63.52 111.156 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.04 81.2 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 73.55 110.852 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.53 110.868 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.454 -0.258 . . . . 53.11 112.454 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.19 160.56 30.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.6 0.714 . . . . 74.14 110.921 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 120.73 7.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.622 2.215 . . . . 74.14 112.376 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -147.58 117.34 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 74.13 111.121 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.8 -51.08 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.54 110.884 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -98.93 105.22 17.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 71.54 110.887 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.91 122.45 7.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 75.14 110.829 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.94 81.51 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 64.2 111.114 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -135.92 70.56 63.96 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.679 0.752 . . . . 72.13 110.883 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -31.39 20.44 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.659 2.239 . . . . 63.32 112.283 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.53 37.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 63.03 110.96 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.782 HG21 HD12 ' A' ' 55' ' ' ILE . 14.4 m -52.31 -33.32 41.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 70.24 111.11 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -58.74 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 72.23 110.86 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.5 mm -51.43 -43.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 74.42 111.118 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.788 HD12 HG21 ' A' ' 52' ' ' THR . 80.4 mt -67.34 -44.88 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 70.12 111.078 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 34.8 p -62.2 -40.92 97.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 65.54 110.818 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.9 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 51.31 111.064 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.5 t -56.07 -47.41 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.13 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 155' ' ' ILE . 84.7 t -57.69 -48.19 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.109 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.714 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -60.23 -49.01 83.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.675 -0.774 . . . . 64.22 112.517 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.544 ' O ' HG23 ' B' ' 165' ' ' VAL . 78.3 mt -63.61 -32.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 74.43 111.101 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.651 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -70.05 -47.19 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 64.32 110.905 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 163' ' ' LEU . 1.7 tt -61.3 -38.59 87.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 64.3 110.941 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 160' ' ' GLY . 94.7 t -62.65 -57.34 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.43 111.101 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 161' ' ' ILE . 93.0 t -51.62 -48.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.13 111.163 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.686 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.7 t -55.67 -40.6 61.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 74.21 111.171 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.29 -49.25 74.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.95 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.17 -44.66 88.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.738 . . . . 41.13 112.472 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.27 -48.94 85.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 73.11 111.171 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.686 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -57.43 -54.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.44 111.125 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.587 ' CZ ' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.65 -53.83 41.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.8 9.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 53.21 112.482 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.11 -39.71 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 72.33 111.155 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.62 -55.38 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 51.43 110.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.587 HD11 ' CZ ' ' B' ' 171' ' ' PHE . 73.0 mt -61.67 -50.82 78.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.1 111.127 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -41.43 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.911 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -64.99 -51.57 60.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 73.31 110.935 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -61.84 -31.98 72.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.865 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.14 122.95 8.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 70.41 110.888 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.89 -172.21 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 61.32 110.874 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 164.5 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 63.22 110.999 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.3 mt -115.36 66.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 74.25 111.126 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.08 81.11 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 54.4 110.883 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.943 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.478 -0.249 . . . . 74.25 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -142.22 160.52 54.59 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.606 0.717 . . . . 54.52 110.888 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -179.74 3.11 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.733 2.289 . . . . 74.44 112.367 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.07 93.97 0.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 65.31 111.091 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -108.68 109.41 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 72.53 110.949 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.25 170.23 10.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.888 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 36.59 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 73.02 110.828 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.46 135.97 35.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.33 111.081 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m 63.15 72.66 0.56 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.632 0.73 . . . . 61.13 110.87 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -17.15 37.56 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.637 2.225 . . . . 72.02 112.314 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -36.22 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 74.02 110.88 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -51.63 -37.37 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.02 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -61.94 -59.37 5.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 55.25 110.907 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.678 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.3 mm -51.43 -47.55 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 74.11 111.124 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 59' ' ' VAL . 40.1 mm -64.23 -40.01 87.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.02 111.186 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.685 ' OG ' HG21 ' B' ' 159' ' ' VAL . 0.1 OUTLIER -58.38 -47.52 83.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 65.1 110.848 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.63 -49.62 68.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 64.2 111.035 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.9 t -50.69 -40.14 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.24 111.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 55' ' ' ILE . 62.0 t -69.31 -42.94 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 64.11 111.12 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.58 -50.16 63.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 60.32 112.523 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 65' ' ' VAL . 63.4 mt -66.02 -29.9 48.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.939 0.399 . . . . 71.14 111.184 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.665 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -69.71 -46.92 64.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 65.25 110.951 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -38.66 91.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 72.44 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.1 t -61.49 -56.72 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 53.22 111.122 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 61' ' ' ILE . 87.7 t -52.58 -48.73 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 64.24 111.133 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 70' ' ' VAL . 92.2 t -55.55 -38.59 50.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 75.53 111.156 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -50.47 68.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 64.53 110.866 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.59 85.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.755 -0.735 . . . . 71.33 112.452 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.06 -49.11 84.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 73.24 111.109 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.3 t -57.86 -54.21 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.23 111.112 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.4 t80 -52.09 -53.56 40.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.908 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -58.25 10.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.798 -0.715 . . . . 75.53 112.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.7 mt -57.96 -40.03 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.369 . . . . 65.21 111.129 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.6 mt -58.96 -59.05 6.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 70.21 110.912 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.722 HD11 ' CE2' ' A' ' 71' ' ' PHE . 76.7 mt -53.47 -39.98 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 70.31 111.183 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -65.12 -48.8 72.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 74.0 110.921 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -50.34 69.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 71.41 110.888 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.58 -39.39 93.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 75.15 110.879 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.89 134.19 25.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 70.13 110.939 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.54 -64.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 54.33 110.924 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.23 126.19 47.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 73.52 110.916 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.3 mt -115.58 66.38 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 75.55 111.096 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 60.17 98.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 72.32 110.892 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 mttp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 65.43 110.922 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.534 -0.226 . . . . 63.34 112.534 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -142.11 160.57 54.7 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.618 0.723 . . . . 74.11 110.876 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 -179.61 3.0 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.705 2.27 . . . . 71.41 112.388 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.9 94.04 0.45 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.44 . . . . 73.22 111.069 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -108.69 109.53 20.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 63.24 110.877 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.19 170.38 10.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 44.13 110.889 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.51 36.36 1.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 72.14 110.831 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.55 135.9 35.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 64.22 111.157 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 2.0 m 63.29 72.96 0.53 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 62.12 110.805 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -17.27 37.76 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.735 2.29 . . . . 74.4 112.373 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -36.49 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 71.12 110.908 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 13.3 m -51.57 -37.42 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.115 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -61.98 -59.24 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 45.1 110.888 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.687 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.1 mm -51.52 -47.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 73.14 111.092 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.692 ' O ' HG23 ' B' ' 159' ' ' VAL . 39.8 mm -64.32 -40.06 87.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -58.39 -47.53 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 60.42 110.801 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.57 68.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 51.14 111.088 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.6 t -50.83 -40.12 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 72.52 111.126 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.692 HG23 ' O ' ' B' ' 155' ' ' ILE . 62.1 t -69.25 -42.86 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.32 111.138 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.703 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -63.58 -50.21 63.58 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.668 -0.777 . . . . 75.24 112.513 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.548 ' O ' HG23 ' B' ' 165' ' ' VAL . 63.6 mt -66.05 -29.86 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 75.42 111.113 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.663 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -69.78 -46.93 64.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 63.33 110.967 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -38.6 91.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 73.42 110.903 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 160' ' ' GLY . 94.1 t -61.61 -56.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 55.43 111.088 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 161' ' ' ILE . 87.9 t -52.5 -48.87 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 75.55 111.091 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.685 ' O ' HG23 ' B' ' 170' ' ' VAL . 96.1 t -55.59 -38.67 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 61.35 111.102 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -50.42 68.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 62.14 110.915 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.47 -44.64 85.42 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.654 -0.784 . . . . 51.2 112.487 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.12 -49.3 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.371 . . . . 62.43 111.062 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.685 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.6 t -58.67 -54.03 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 70.11 111.148 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.649 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -52.72 -53.79 42.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.913 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.11 -58.66 10.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 64.51 112.427 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 69.9 mt -57.3 -39.84 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 74.23 111.166 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 174' ' ' LEU . 19.1 mt -59.11 -58.95 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.4 110.884 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.649 HD11 ' CE2' ' B' ' 171' ' ' PHE . 77.1 mt -53.29 -40.27 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.187 -0.46 . . . . 61.02 111.165 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -65.3 -49.69 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 71.41 110.886 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.08 -50.81 69.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.818 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.74 -39.42 94.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 64.45 110.875 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -50.87 133.8 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.43 110.895 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.83 -64.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.901 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.18 126.32 48.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 71.44 110.914 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.5 66.39 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 53.34 111.077 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 60.1 98.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 64.32 110.897 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.5 mttp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 63.12 110.855 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.496 -0.242 . . . . 73.05 112.496 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.9 m -141.49 70.88 26.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.607 0.718 . . . . 60.23 110.906 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.78 157.52 60.06 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.68 2.253 . . . . 64.24 112.315 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.87 90.12 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 72.41 111.075 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -133.86 178.59 6.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 72.35 110.919 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.25 -63.62 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.13 110.929 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 58.18 179.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.882 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.65 -175.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 65.0 111.063 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.09 160.53 42.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.656 0.741 . . . . 44.44 110.857 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -17.23 37.73 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.711 2.274 . . . . 62.43 112.342 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -51.93 -33.48 37.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 73.15 110.905 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.683 HG23 ' HA ' ' B' ' 152' ' ' THR . 18.7 m -51.75 -31.36 26.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.183 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.2 t -68.74 -57.5 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.875 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.1 mm -51.31 -44.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 62.4 111.104 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.6 mm -67.27 -44.97 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.142 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.5 p -60.9 -41.74 96.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.861 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.24 76.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 63.22 111.056 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.0 t -54.45 -43.39 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 71.24 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 55' ' ' ILE . 86.9 t -61.66 -47.62 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 51.44 111.082 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.712 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.12 -52.97 50.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 73.43 112.488 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 65' ' ' VAL . 29.8 mm -62.58 -30.78 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.84 0.352 . . . . 64.13 111.127 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.6 tp -69.54 -51.54 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 72.15 110.932 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -37.05 73.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.4 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 60' ' ' GLY . 93.8 t -63.09 -60.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.31 111.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.6 t -51.64 -47.37 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 74.32 111.141 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.68 ' O ' HG23 ' A' ' 70' ' ' VAL . 91.8 t -56.56 -38.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 64.31 111.16 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -49.94 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.922 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -44.92 86.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.818 -0.705 . . . . 72.42 112.482 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.08 -49.04 84.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 72.04 111.136 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.8 t -59.62 -54.09 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 50.45 111.091 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.729 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.4 t80 -52.03 -53.63 39.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.869 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.27 10.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.752 . . . . 32.21 112.469 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt -57.86 -40.2 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 75.34 111.122 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.6 mt -58.8 -60.06 4.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.912 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.729 HD11 ' CE2' ' A' ' 71' ' ' PHE . 76.8 mt -52.0 -35.17 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 64.11 111.137 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -68.28 -55.38 12.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.87 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.03 -36.32 77.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.876 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -65.45 -42.44 92.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.863 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 54.46 25.38 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 73.02 110.887 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.12 126.18 26.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 63.14 110.885 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -128.91 52.92 1.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 54.2 110.876 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.4 mt -115.48 66.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 72.14 111.066 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.29 66.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.924 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 72.32 110.852 179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.491 -0.244 . . . . 40.2 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 71.7 m -141.59 70.97 25.81 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.634 0.73 . . . . 73.12 110.864 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 157.28 60.95 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 63.01 112.343 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -126.05 90.17 3.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 71.2 111.083 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -133.57 178.18 7.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 43.42 110.904 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.73 -63.81 0.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 63.52 110.926 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 58.06 179.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 74.0 110.899 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . 62.89 -174.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 73.54 111.118 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.66 160.49 44.29 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.647 0.737 . . . . 74.21 110.858 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.41 37.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.738 2.292 . . . . 70.12 112.338 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.35 -34.84 59.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 64.32 110.884 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.683 ' HA ' HG23 ' A' ' 52' ' ' THR . 19.9 m -52.57 -31.23 35.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 64.23 111.138 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 45.0 t -68.7 -57.28 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 54.25 110.86 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.709 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.1 mm -51.43 -44.67 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 51.12 111.148 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.499 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.5 mm -67.34 -45.01 86.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 60.21 111.111 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.5 p -60.73 -41.91 96.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.851 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.36 76.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.101 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.709 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.3 t -54.3 -43.37 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 50.02 111.198 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.499 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.1 t -61.74 -47.52 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 53.34 111.082 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.71 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.14 -52.84 50.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 74.42 112.487 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.482 ' O ' HG23 ' B' ' 165' ' ' VAL . 30.2 mm -62.27 -30.42 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 62.31 111.067 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.643 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.6 tp -69.6 -51.73 32.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.04 110.892 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -37.16 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.03 110.884 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.71 HG23 ' O ' ' B' ' 160' ' ' GLY . 88.6 t -62.69 -59.74 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.17 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 161' ' ' ILE . 89.7 t -51.65 -47.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 74.02 111.116 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.689 ' O ' HG23 ' B' ' 170' ' ' VAL . 89.1 t -56.48 -39.1 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.082 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -50.03 70.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 53.35 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.62 -44.94 86.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.754 -0.736 . . . . 63.21 112.478 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.1 -48.92 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 52.4 111.174 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.689 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.7 t -58.94 -54.08 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 52.14 111.155 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.6 t80 -52.75 -53.91 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 75.35 110.865 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -58.68 10.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.708 -0.758 . . . . 51.41 112.499 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.22 -39.65 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 74.34 111.127 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.14 -60.32 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 42.01 110.94 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.548 HD11 ' CE2' ' B' ' 171' ' ' PHE . 77.0 mt -52.2 -35.15 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 61.14 111.128 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -68.2 -54.24 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 51.14 110.912 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -35.53 72.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 74.2 110.879 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -64.73 -42.59 95.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 72.21 110.824 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 54.28 25.53 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 72.55 110.841 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.7 125.75 25.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 70.54 110.928 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -129.22 53.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.889 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 27.3 mt -115.34 66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 71.1 111.109 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.31 66.83 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.31 110.847 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 62.21 110.869 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.488 -0.245 . . . . 42.4 112.488 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.6 p -148.62 156.53 41.79 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.591 0.71 . . . . 75.21 110.912 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 165.66 30.29 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.696 2.264 . . . . 53.23 112.34 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -167.24 168.02 13.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 70.32 111.15 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.82 140.12 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 72.24 110.929 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -119.23 176.35 5.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 64.54 110.884 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.61 136.59 57.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 71.51 110.798 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.33 122.48 6.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 50.54 111.08 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.5 p -127.15 73.31 77.05 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.621 0.724 . . . . 65.41 110.859 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -17.78 37.43 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.71 2.273 . . . . 62.13 112.369 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -37.87 59.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 72.44 110.932 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.559 HG23 ' HA ' ' B' ' 152' ' ' THR . 79.1 m -51.72 -32.16 29.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 72.21 111.144 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -67.46 -57.79 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 62.44 110.856 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 80.7 mt -51.4 -44.61 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 65.22 111.101 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 59' ' ' VAL . 36.7 mm -67.24 -44.44 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 64.52 111.137 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.3 p -61.38 -41.68 97.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.21 110.897 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.01 77.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 71.12 111.047 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.3 t -54.63 -43.78 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 51.04 111.135 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 55' ' ' ILE . 85.6 t -61.38 -47.65 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 73.54 111.108 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.9 -50.1 71.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 72.34 112.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' HG23 ' A' ' 65' ' ' VAL . 72.4 mt -64.3 -33.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 72.31 111.146 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.3 tt -69.32 -49.18 58.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.978 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tt -57.94 -38.6 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 54.54 110.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.4 t -63.11 -58.23 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 64.34 111.151 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 61' ' ' ILE . 58.3 t -52.61 -47.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 72.55 111.132 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.723 ' O ' HG23 ' A' ' 70' ' ' VAL . 96.5 t -56.65 -38.27 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 75.14 111.168 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.36 -49.79 70.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 41.14 110.913 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.26 -44.19 89.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.789 -0.72 . . . . 65.25 112.462 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.55 -48.72 86.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 75.23 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.2 t -57.52 -54.03 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 71.04 111.108 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.5 t80 -51.84 -53.37 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.863 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.88 -58.06 11.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 64.05 112.478 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -58.03 -40.32 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 64.11 111.127 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.3 mt -57.66 -59.19 5.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.54 110.889 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' A' ' 71' ' ' PHE . 75.5 mt -52.36 -37.26 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 71.31 111.142 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -68.95 -63.5 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 51.2 110.888 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.98 -31.21 28.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 73.31 110.89 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -63.4 -50.44 69.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 72.31 110.877 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.77 88.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.03 110.877 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.18 159.54 31.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 73.31 110.874 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.61 114.25 23.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 75.22 110.933 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 mt -114.3 65.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 75.14 111.139 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 55.33 84.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 63.51 110.879 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.8 mttt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 72.01 110.878 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.5 -0.24 . . . . 63.3 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 4.6 p -148.58 156.45 41.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.53 0.681 . . . . 75.12 110.879 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.65 165.62 30.23 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 74.41 112.363 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.33 167.96 13.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 51.14 111.112 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.95 140.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.442 . . . . 74.31 110.934 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -119.31 176.56 5.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.25 110.864 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.18 135.84 56.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 63.15 110.869 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.06 123.23 6.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 70.24 111.089 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 63.0 p -126.34 72.39 72.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 72.21 110.838 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -16.74 37.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.634 2.223 . . . . 74.41 112.354 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.88 -39.12 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 42.25 110.908 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.559 ' HA ' HG23 ' A' ' 52' ' ' THR . 86.2 m -52.57 -32.03 38.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 70.3 111.053 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 5.0 t -67.43 -57.63 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 53.14 110.87 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 80.8 mt -51.41 -44.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 75.01 111.12 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 159' ' ' VAL . 36.8 mm -67.19 -44.39 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.098 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.5 p -61.37 -41.66 97.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 70.13 110.849 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.92 77.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 51.33 111.154 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.4 t -54.74 -43.74 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 63.41 111.113 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.0 t -61.43 -47.96 91.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.14 111.157 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.694 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -60.7 -49.08 82.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 71.12 112.44 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 165' ' ' VAL . 72.8 mt -64.43 -32.3 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 42.21 111.183 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.654 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.3 tt -69.85 -49.31 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 63.41 110.918 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.38 -38.53 77.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 52.14 110.938 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 160' ' ' GLY . 97.7 t -63.17 -58.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 63.4 111.07 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 161' ' ' ILE . 58.0 t -52.19 -48.27 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 73.45 111.156 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.683 ' O ' HG23 ' B' ' 170' ' ' VAL . 91.8 t -56.37 -39.03 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.01 111.081 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.49 -49.74 70.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 71.41 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.6 87.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.491 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.37 -49.12 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 74.42 111.159 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.683 HG23 ' O ' ' B' ' 166' ' ' VAL . 45.9 t -59.22 -53.85 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 51.24 111.121 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.729 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.3 t80 -52.05 -53.43 42.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.1 -58.37 10.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 70.52 112.489 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.62 -40.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.838 0.351 . . . . 75.44 111.135 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.06 -59.57 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 51.15 110.91 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.729 HD11 ' CE2' ' B' ' 171' ' ' PHE . 75.5 mt -52.5 -35.32 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.32 111.163 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -66.99 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 75.14 110.858 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -35.0 61.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.33 110.858 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -67.22 -49.22 65.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.44 110.875 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.61 88.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.955 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.96 159.27 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 54.54 110.913 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.15 112.07 19.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 61.45 110.917 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 25.9 mt -115.75 64.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 53.2 111.181 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 54.0 84.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.873 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 40.6 mttt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.52 110.909 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.496 -0.241 . . . . 60.31 112.496 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.96 160.54 37.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.591 0.71 . . . . 73.51 110.901 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 94.07 0.53 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.716 2.277 . . . . 74.35 112.344 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.6 119.01 23.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 71.32 111.062 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HG3' HD21 ' B' ' 151' ' ' LEU . 40.5 tt0 -142.87 75.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.907 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -146.46 138.99 25.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.13 110.932 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HB3' HD13 ' B' ' 151' ' ' LEU . 0.0 OUTLIER -174.31 146.07 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 63.1 110.886 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.15 31.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 63.23 111.066 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -109.25 160.53 27.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.625 0.726 . . . . 64.3 110.821 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -17.64 37.24 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.708 2.272 . . . . 73.23 112.399 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 49' ' ' SER . 0.8 OUTLIER -52.27 -38.67 58.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 75.02 110.896 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.575 HG21 ' CD1' ' B' ' 155' ' ' ILE . 22.2 m -62.42 -32.42 73.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 65.1 111.133 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.67 -57.38 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 72.15 110.839 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 72.5 mt -51.53 -44.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.085 -0.507 . . . . 75.3 111.138 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.576 ' CD1' HG21 ' B' ' 152' ' ' THR . 65.2 mt -67.59 -44.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.467 . . . . 71.34 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB2' HG21 ' B' ' 159' ' ' VAL . 59.5 p -61.14 -41.16 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.871 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.49 74.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 72.01 111.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.7 t -54.22 -44.37 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 71.15 111.15 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' ILE . 90.0 t -60.85 -48.36 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 71.11 111.098 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.56 -46.89 93.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 71.32 112.569 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 65' ' ' VAL . 80.7 mt -65.53 -31.18 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 70.24 111.146 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 66' ' ' VAL . 10.3 tp -69.55 -46.15 67.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 73.41 110.873 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD22 ' CG2' ' B' ' 164' ' ' VAL . 1.2 tt -62.89 -37.78 88.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 62.41 110.961 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.4 t -62.51 -57.1 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 61.33 111.164 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 61' ' ' ILE . 80.1 t -51.62 -50.28 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.115 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 70' ' ' VAL . 90.3 t -55.11 -39.35 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 51.4 111.156 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -49.64 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.66 -45.15 85.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 71.24 112.512 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.5 t -59.1 -49.13 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.419 . . . . 62.23 111.137 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.5 t -60.09 -53.8 43.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 51.13 111.144 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.743 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.3 t80 -51.96 -53.71 38.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 71.34 110.896 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.84 -58.73 9.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 72.4 112.488 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.48 -39.75 70.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.886 0.374 . . . . 72.54 111.167 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.8 mt -59.62 -59.5 5.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 70.13 110.894 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.743 HD11 ' CE2' ' A' ' 71' ' ' PHE . 75.9 mt -51.72 -34.76 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 75.14 111.081 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -67.29 -59.97 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.12 110.916 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -55.64 -25.72 40.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 64.32 110.895 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -66.75 -22.88 66.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 72.34 110.893 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -50.56 146.31 5.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 61.2 110.96 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 63.34 44.93 5.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 64.31 110.91 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -68.25 165.44 18.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.894 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.4 mm -92.58 56.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 63.45 111.187 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -110.92 59.1 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 72.21 110.859 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 65.42 110.94 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.488 -0.245 . . . . 75.54 112.488 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.02 160.55 37.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.591 0.71 . . . . 64.35 110.914 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 94.05 0.53 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.716 2.277 . . . . 72.13 112.379 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -128.62 119.29 24.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 43.34 111.071 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . 0.475 ' HG3' HD21 ' A' ' 51' ' ' LEU . 40.5 tt0 -142.53 75.21 1.48 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.218 -0.446 . . . . 60.52 110.876 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -146.68 139.57 25.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.496 . . . . 72.12 110.913 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -173.83 145.88 1.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 53.43 110.858 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -173.4 31.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 72.45 111.077 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . 0.547 ' CB ' HD12 ' B' ' 151' ' ' LEU . 0.2 OUTLIER -109.25 160.58 27.06 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.679 0.752 . . . . 63.11 110.846 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -16.39 37.34 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.667 2.245 . . . . 70.25 112.355 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -51.81 -38.77 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 60.13 110.871 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.576 HG21 ' CD1' ' A' ' 55' ' ' ILE . 22.9 m -61.52 -32.01 72.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 73.41 111.156 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -57.29 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.858 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 72.2 mt -51.5 -44.38 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 52.21 111.169 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.575 ' CD1' HG21 ' A' ' 52' ' ' THR . 65.6 mt -67.57 -44.93 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 71.2 111.175 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.405 ' HB2' HG21 ' A' ' 59' ' ' VAL . 59.6 p -61.13 -41.07 96.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 74.55 110.866 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.38 74.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 71.43 111.075 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 98.6 t -54.28 -44.34 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 62.03 111.159 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 155' ' ' ILE . 92.6 t -60.83 -48.78 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 63.42 111.129 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -61.8 -47.71 88.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 75.13 112.502 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 78.5 mt -66.26 -30.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 72.41 111.166 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.657 ' O ' HG23 ' B' ' 166' ' ' VAL . 10.4 tp -70.12 -46.09 65.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.973 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.19 -38.63 91.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 72.42 110.882 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.6 t -62.02 -57.15 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 45.42 111.117 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 161' ' ' ILE . 80.8 t -51.73 -49.8 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.11 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.687 ' O ' HG23 ' B' ' 170' ' ' VAL . 92.1 t -55.06 -39.47 50.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 64.53 111.166 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -49.9 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 61.43 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.75 87.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 65.01 112.477 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.09 -48.97 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.948 0.404 . . . . 53.43 111.145 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -58.57 -54.0 39.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 73.2 111.191 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.704 ' CE2' HD11 ' B' ' 175' ' ' ILE . 5.5 t80 -52.35 -53.84 39.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.873 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.25 -59.23 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.662 -0.78 . . . . 51.41 112.481 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.5 mm -56.59 -39.76 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 61.42 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.75 -60.4 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.831 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.704 HD11 ' CE2' ' B' ' 171' ' ' PHE . 75.0 mt -52.25 -35.31 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 65.14 111.136 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -67.9 -59.02 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.14 110.923 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -55.57 -25.69 39.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.851 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -66.28 -23.39 66.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.872 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -50.65 146.29 5.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 70.22 110.918 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 63.22 45.55 5.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.915 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.7 165.58 16.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 71.22 110.856 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 20.7 mm -92.62 56.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 75.1 111.156 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -111.08 59.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.811 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.861 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.537 -0.225 . . . . 42.31 112.537 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 66.4 m 53.76 71.98 1.25 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 74.21 110.885 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 177.26 5.77 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.605 2.204 . . . . 71.52 112.345 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.91 149.75 34.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.077 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.21 138.71 19.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.914 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.87 148.74 50.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.839 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.59 82.46 6.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.902 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.12 40.67 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 71.25 111.107 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 p -134.28 72.03 71.58 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.693 0.758 . . . . 62.13 110.853 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -22.01 32.47 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.671 2.247 . . . . 64.23 112.369 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HA ' HD12 ' A' ' 54' ' ' ILE . 9.1 mt -52.83 -36.68 59.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 72.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.607 ' HA ' HG23 ' B' ' 152' ' ' THR . 40.3 m -51.84 -35.16 43.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 62.12 111.179 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -56.93 10.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.13 110.934 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.717 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.0 mt -51.36 -46.51 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 64.12 111.099 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 59' ' ' VAL . 37.8 mm -65.98 -43.87 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.41 111.083 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.4 p -61.16 -43.07 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 71.54 110.822 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.7 80.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 73.41 111.138 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 54' ' ' ILE . 95.6 t -53.64 -47.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 72.33 111.13 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 55' ' ' ILE . 97.9 t -59.01 -47.03 91.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.106 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -58.75 -54.4 38.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 72.44 112.42 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 mm -61.56 -30.06 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 71.1 111.134 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.663 ' O ' HG23 ' A' ' 66' ' ' VAL . 11.9 tp -69.47 -49.72 52.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.23 110.906 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -37.52 79.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.932 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 60' ' ' GLY . 90.3 t -62.46 -58.78 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 61.31 111.147 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 61' ' ' ILE . 91.7 t -51.99 -47.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.5 111.123 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 70' ' ' VAL . 93.5 t -56.18 -38.83 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 52.41 111.195 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.89 -49.87 70.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 65.3 110.974 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.1 -44.38 88.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 33.35 112.492 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -59.32 -48.61 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 72.14 111.179 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 66' ' ' VAL . 45.4 t -57.69 -54.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 63.34 111.097 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -51.9 -53.32 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 71.44 110.917 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -57.89 11.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 65.4 112.502 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -58.23 -40.3 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.89 0.376 . . . . 75.11 111.167 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.6 mt -57.71 -59.93 4.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.892 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 mm -56.34 -31.65 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.11 111.168 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -69.62 -58.55 3.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 70.41 110.901 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -55.16 -34.35 63.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.03 110.816 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -60.56 -41.44 94.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.845 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 51.76 88.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 70.2 110.886 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.04 126.32 8.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.931 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -129.26 38.41 3.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 73.14 110.913 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.9 mt -114.65 66.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 62.21 111.143 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.73 102.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 62.11 110.843 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 74.34 110.875 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.55 -0.22 . . . . 74.34 112.55 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 66.6 m 53.78 71.95 1.25 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.643 0.735 . . . . 73.55 110.867 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 177.13 5.85 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.778 2.319 . . . . 65.23 112.309 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -113.8 149.68 34.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 72.25 111.147 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.25 138.76 19.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 74.54 110.916 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.77 148.87 50.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 63.53 110.876 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -80.46 82.26 6.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.933 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.16 40.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 54.51 111.118 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 4.6 p -134.3 72.39 70.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.643 0.735 . . . . 74.34 110.798 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -22.21 32.28 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.67 2.247 . . . . 74.33 112.311 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . 0.555 ' HA ' HD12 ' B' ' 154' ' ' ILE . 9.2 mt -52.86 -36.38 58.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 72.31 110.923 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 52' ' ' THR . 40.3 m -51.74 -35.17 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.173 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -56.95 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.41 110.834 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 4.0 mt -51.35 -46.55 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 63.12 111.123 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.419 ' O ' HG23 ' B' ' 159' ' ' VAL . 37.8 mm -65.88 -43.81 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 61.14 111.116 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 45.4 p -61.15 -43.1 99.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.921 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.6 80.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.518 . . . . 72.42 111.071 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 95.5 t -53.64 -47.8 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 64.32 111.132 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 155' ' ' ILE . 97.2 t -58.9 -47.1 90.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 53.54 111.101 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -58.53 -54.41 38.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 72.21 112.535 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.502 ' O ' HG23 ' B' ' 165' ' ' VAL . 30.4 mm -61.87 -30.83 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 72.34 111.198 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.647 ' O ' HG23 ' B' ' 166' ' ' VAL . 12.0 tp -70.21 -49.52 49.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.909 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -37.31 80.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.916 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.4 t -62.92 -59.06 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 65.25 111.098 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 161' ' ' ILE . 91.0 t -51.84 -48.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.144 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.662 ' O ' HG23 ' B' ' 170' ' ' VAL . 88.7 t -56.8 -38.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 72.44 111.135 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.62 -48.94 72.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.12 88.47 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 50.34 112.505 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.41 -49.17 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 74.45 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.4 t -60.67 -53.55 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 63.45 111.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -51.86 -53.13 44.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 64.02 110.866 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.99 -57.98 11.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 40.11 112.495 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.1 -41.04 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.372 . . . . 63.2 111.126 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.74 -61.44 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.23 110.874 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.5 mm -56.58 -30.98 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.33 111.114 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -68.9 -61.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.897 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -58.66 -38.73 78.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 75.35 110.88 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -64.97 -40.57 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.839 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 51.78 88.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 73.44 110.916 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.53 127.1 7.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 74.04 110.934 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -128.67 37.28 4.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 71.05 110.929 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.0 mt -115.55 65.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 63.31 111.182 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.3 102.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 70.25 110.917 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 75.03 110.957 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.491 -0.243 . . . . 72.51 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 24.6 t -149.19 69.94 9.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 73.32 110.822 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 116.93 4.8 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 74.22 112.327 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.91 -34.75 59.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 60.23 111.086 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.7 35.91 22.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 70.23 110.839 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.27 -28.36 29.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 71.24 110.96 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 58.48 40.6 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 71.41 110.93 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.8 55.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 65.33 111.124 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.2 m -122.23 73.15 37.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.715 0.769 . . . . 74.42 110.889 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -22.43 31.94 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.684 2.256 . . . . 70.33 112.336 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.13 -33.7 65.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.224 -0.444 . . . . 53.01 110.834 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.59 HG21 HD12 ' B' ' 155' ' ' ILE . 95.3 m -52.24 -32.17 35.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 72.32 111.144 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.6 m -67.8 -58.07 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.845 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 58' ' ' VAL . 50.3 mm -51.28 -44.45 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.146 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.593 HD12 HG21 ' B' ' 152' ' ' THR . 73.7 mt -67.36 -44.38 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 60.23 111.135 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -61.61 -41.26 97.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 63.02 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.52 -48.04 76.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.51 111.094 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 54' ' ' ILE . 99.3 t -54.77 -43.88 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.55 111.181 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 55' ' ' ILE . 87.3 t -61.16 -48.23 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 43.24 111.111 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.711 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.5 -48.0 87.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 70.12 112.467 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 65' ' ' VAL . 76.1 mt -66.38 -31.66 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.376 . . . . 70.5 111.18 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.2 tp -69.67 -44.84 69.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 72.24 110.957 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -38.74 92.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 62.13 110.871 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.2 t -62.03 -57.04 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 60.45 111.126 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 61' ' ' ILE . 79.7 t -51.82 -50.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 72.45 111.093 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 70' ' ' VAL . 93.6 t -54.98 -38.71 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 65.12 111.074 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tp -64.08 -50.16 69.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 74.41 110.936 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.91 86.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.831 -0.699 . . . . 63.41 112.418 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.01 -48.93 85.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 63.23 111.151 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.1 t -57.92 -54.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 75.31 111.185 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -52.0 -53.66 39.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 74.25 110.871 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.86 -58.58 10.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 54.03 112.526 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.58 -39.97 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.377 . . . . 64.44 111.085 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.32 -60.21 4.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 71.23 110.94 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.4 mm -58.97 -31.21 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 43.23 111.093 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -67.19 -56.99 7.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 73.01 110.913 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -58.62 -41.94 87.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 72.22 110.876 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -63.35 -39.44 94.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 71.33 110.89 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -36.72 39.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 65.43 110.9 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -67.71 -55.64 12.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 55.2 110.897 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.23 158.97 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 63.42 110.919 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.36 66.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 75.12 111.135 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.83 56.76 6.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.54 110.821 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 53.14 110.864 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.479 -0.248 . . . . 61.02 112.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 24.4 t -149.11 69.91 9.91 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.571 0.7 . . . . 74.03 110.951 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 116.93 4.79 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.664 2.243 . . . . 60.53 112.329 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.9 -34.6 59.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 63.34 111.117 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.64 35.85 22.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 72.35 110.93 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.38 -28.39 28.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 74.52 110.884 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 58.28 40.54 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 74.33 110.859 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.85 54.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 73.12 111.105 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 7.3 m -122.56 72.89 41.09 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.683 0.754 . . . . 72.1 110.76 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -22.75 31.28 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.709 2.272 . . . . 62.41 112.297 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.5 mt -56.41 -33.94 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.25 110.962 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.593 HG21 HD12 ' A' ' 55' ' ' ILE . 95.5 m -52.69 -32.21 41.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 75.32 111.175 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -67.7 -58.05 5.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 65.34 110.813 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.712 ' O ' HG23 ' B' ' 158' ' ' VAL . 50.3 mm -51.27 -44.53 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 74.12 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 52' ' ' THR . 73.5 mt -67.3 -44.37 87.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.5 111.157 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 60.2 p -61.68 -41.09 97.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 53.51 110.904 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.04 76.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 41.35 111.125 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.712 HG23 ' O ' ' B' ' 154' ' ' ILE . 99.3 t -54.77 -43.91 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 53.54 111.153 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 155' ' ' ILE . 86.8 t -61.18 -48.37 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.11 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.707 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -61.84 -47.6 89.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.724 -0.75 . . . . 42.01 112.563 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.554 ' O ' HG23 ' B' ' 165' ' ' VAL . 76.8 mt -66.76 -30.97 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 72.42 111.12 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.657 ' O ' HG23 ' B' ' 166' ' ' VAL . 16.2 tp -69.97 -45.04 68.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.907 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 74.2 110.975 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 160' ' ' GLY . 97.4 t -62.06 -56.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 65.24 111.144 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 161' ' ' ILE . 78.1 t -51.85 -50.4 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 62.23 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.71 ' O ' HG23 ' B' ' 170' ' ' VAL . 93.9 t -54.9 -38.83 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.3 111.112 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.98 -50.19 69.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.954 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.65 -44.77 86.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 43.1 112.484 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.53 111.153 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.71 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.1 t -57.74 -53.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 54.12 111.128 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.69 -53.83 42.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 63.21 110.872 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -59.03 9.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 43.42 112.51 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 43.8 mm -56.88 -39.71 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.952 0.406 . . . . 74.51 111.144 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.48 -61.37 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 73.3 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 24.9 mm -59.44 -31.5 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 75.45 111.133 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -67.22 -56.95 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 65.43 110.943 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -58.5 -42.26 87.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 63.24 110.856 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -63.76 -39.87 95.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 71.55 110.895 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -37.06 42.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 62.44 110.922 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -67.9 -55.94 10.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 71.14 110.882 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.25 159.25 8.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 74.31 110.89 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.7 mt -115.34 66.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 63.23 111.121 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.95 56.54 6.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 73.1 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 75.12 110.892 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.479 -0.248 . . . . 74.53 112.479 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.7 m -137.41 72.41 51.37 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.483 0.659 . . . . 64.43 110.894 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -179.93 3.26 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.613 2.209 . . . . 75.45 112.377 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.42 92.72 8.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 74.43 111.083 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -158.06 127.0 5.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.916 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.46 112.44 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 61.54 110.916 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB2' HD13 ' B' ' 151' ' ' LEU . 0.0 OUTLIER -67.04 118.4 10.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 71.24 110.909 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.14 53.47 2.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 54.41 111.075 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.86 160.54 43.57 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.647 0.737 . . . . 74.33 110.908 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -47.11 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.693 2.262 . . . . 61.23 112.378 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD13 ' HB2' ' B' ' 147' ' ' ARG . 0.5 OUTLIER -55.48 -26.03 40.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.869 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.508 HG23 HG23 ' B' ' 152' ' ' THR . 2.8 m -62.27 -32.37 73.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 52.01 111.079 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -57.94 5.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 41.24 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.7 mp -51.38 -44.5 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 64.11 111.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 59' ' ' VAL . 66.3 mt -67.01 -44.79 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 70.43 111.152 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 p -61.28 -42.1 98.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 63.3 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.57 80.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 73.53 111.13 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 54' ' ' ILE . 96.7 t -54.81 -45.07 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.23 111.149 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 55' ' ' ILE . 98.7 t -60.12 -48.57 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.42 111.12 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.92 -48.09 87.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 65.32 112.474 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 65' ' ' VAL . 76.2 mt -62.91 -34.21 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 74.22 111.116 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.656 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.2 tp -69.76 -48.72 58.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 74.03 110.942 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -36.86 73.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 53.2 110.956 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 60' ' ' GLY . 94.0 t -65.3 -58.0 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.184 -0.462 . . . . 64.13 111.123 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 61' ' ' ILE . 78.5 t -52.32 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 61.11 111.134 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 62' ' ' LEU . 98.9 t -57.53 -41.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 72.0 111.108 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.78 -46.33 90.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 64.23 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.38 -40.14 97.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 34.53 112.477 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 65' ' ' VAL . 88.3 t -62.31 -48.53 87.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 62.21 111.139 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG12 ' CD1' ' A' ' 74' ' ' LEU . 56.9 t -65.04 -52.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 72.43 111.163 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -52.65 -53.73 43.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 71.43 110.906 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.79 -58.56 10.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 55.52 112.459 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.68 -39.71 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 62.13 111.102 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.405 ' CD1' HG12 ' A' ' 70' ' ' VAL . 24.8 mt -60.4 -61.18 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.23 110.936 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.4 mm -55.64 -31.22 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 75.41 111.111 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -71.58 -62.91 1.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 70.15 110.913 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -52.61 -30.96 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.849 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.31 -55.87 6.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 65.32 110.915 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 51.62 88.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 73.21 110.898 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -179.24 -173.13 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.54 110.911 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -79.06 -177.76 5.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 71.25 110.872 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.52 66.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 61.33 111.189 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 52.04 71.38 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 75.32 110.801 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 75.04 110.965 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.461 -0.255 . . . . 74.31 112.461 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 72.7 m -137.49 72.57 50.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.578 0.704 . . . . 61.53 110.861 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -179.95 3.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.728 2.285 . . . . 45.44 112.336 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.4 92.82 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 52.11 111.084 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -158.1 126.96 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.2 110.924 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.445 ' CA ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -171.36 112.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.877 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . 0.55 ' HB2' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -67.04 118.36 10.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 73.23 110.855 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.22 53.38 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 65.15 111.09 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.77 160.52 43.88 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.647 0.736 . . . . 41.03 110.884 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -46.96 1.05 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.688 2.259 . . . . 64.12 112.36 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -55.24 -26.24 38.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.967 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.508 HG23 HG23 ' A' ' 52' ' ' THR . 2.8 m -62.2 -32.33 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 75.51 111.186 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -57.94 5.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 51.4 110.893 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.706 ' O ' HG23 ' B' ' 158' ' ' VAL . 2.8 mp -51.37 -44.49 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 55.32 111.151 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.462 ' O ' HG23 ' B' ' 159' ' ' VAL . 66.5 mt -67.03 -44.83 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.16 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 58.5 p -61.19 -42.0 97.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 64.53 110.954 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.65 80.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 74.52 111.044 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 154' ' ' ILE . 96.2 t -54.77 -45.06 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 74.33 111.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 155' ' ' ILE . 97.7 t -60.14 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 64.41 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.705 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.89 -48.11 87.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.49 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.518 ' O ' HG23 ' B' ' 165' ' ' VAL . 76.6 mt -62.41 -33.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 70.44 111.193 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.639 ' O ' HG23 ' B' ' 166' ' ' VAL . 1.2 tp -70.14 -48.66 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 64.04 110.934 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.13 74.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.01 110.908 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 160' ' ' GLY . 88.3 t -64.99 -57.93 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.55 111.102 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 161' ' ' ILE . 79.1 t -52.04 -46.83 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 74.23 111.095 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.639 HG23 ' O ' ' B' ' 162' ' ' LEU . 95.3 t -57.18 -42.41 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 74.04 111.152 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.34 -46.04 91.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.91 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.82 96.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 44.44 112.443 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 165' ' ' VAL . 87.8 t -62.56 -48.56 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 73.35 111.189 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.1 -52.85 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 63.45 111.081 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -52.59 -53.64 43.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.14 110.897 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.39 -59.25 9.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 52.43 112.524 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 70.4 mt -56.79 -39.22 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 74.41 111.128 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.7 mt -58.51 -60.27 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 71.32 110.883 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 26.3 mm -55.97 -30.96 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 74.31 111.101 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -71.07 -60.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.34 110.829 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -52.01 -30.12 23.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 65.14 110.825 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.94 -56.32 6.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.875 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 51.77 88.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 73.01 110.878 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -178.46 -173.86 0.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 71.04 110.99 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -79.77 -178.24 6.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 55.11 110.975 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.4 mt -115.63 66.43 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 75.31 111.08 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 52.11 71.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 72.23 110.854 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 44.14 110.873 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.476 -0.25 . . . . 62.54 112.476 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.6 t -130.23 68.8 81.57 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.63 0.729 . . . . 70.2 110.901 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -45.4 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.697 2.265 . . . . 72.41 112.343 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.0 150.81 37.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 63.25 111.081 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -112.85 63.9 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 61.41 110.895 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.65 -177.69 6.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 62.04 110.915 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -158.61 80.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 65.52 110.912 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.74 141.5 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 70.33 111.106 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.55 160.54 37.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.749 0.785 . . . . 75.23 110.783 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -27.81 26.25 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.734 2.289 . . . . 71.41 112.339 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.17 -33.13 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 65.11 110.913 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.584 ' HA ' HG23 ' B' ' 152' ' ' THR . 28.3 m -51.81 -32.28 30.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 74.11 111.147 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -57.75 5.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.898 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 58' ' ' VAL . 61.6 mt -51.55 -44.71 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 61.13 111.104 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 59' ' ' VAL . 37.1 mm -67.0 -44.33 88.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 72.53 111.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -61.77 -41.53 97.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 70.43 110.884 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -47.51 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.02 111.045 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 54' ' ' ILE . 98.4 t -55.01 -45.58 76.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 75.32 111.132 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' ILE . 85.0 t -59.71 -48.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 71.03 111.214 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -59.53 -48.36 86.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 64.51 112.516 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 65' ' ' VAL . 71.0 mt -63.83 -35.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.813 0.34 . . . . 74.13 111.107 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -68.78 -46.83 67.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 75.3 110.909 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.675 HD23 HG21 ' B' ' 164' ' ' VAL . 0.8 OUTLIER -59.35 -39.47 83.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 73.21 110.895 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.8 t -62.72 -55.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.078 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 61' ' ' ILE . 58.8 t -53.31 -46.98 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.121 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.696 ' O ' HG23 ' A' ' 70' ' ' VAL . 96.5 t -56.76 -40.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.117 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.92 -48.82 77.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.21 110.936 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.99 90.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 50.35 112.51 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.03 -48.69 85.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 74.34 111.117 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 66' ' ' VAL . 46.1 t -57.23 -54.21 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 53.54 111.159 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -52.11 -53.84 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 73.32 110.93 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.87 -58.96 9.28 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.731 -0.747 . . . . 54.04 112.484 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.0 mm -57.22 -39.49 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 53.35 111.097 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 mt -60.44 -60.63 3.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.02 110.963 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.2 mm -57.69 -32.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 60.51 111.197 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -68.86 -60.24 2.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 71.0 110.965 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -52.59 -37.2 57.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 70.31 110.904 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -53.55 38.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.24 110.875 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.09 -175.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 75.42 110.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.92 -174.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 72.25 110.885 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt 58.64 95.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 64.13 110.9 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 mt -115.46 66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 62.42 111.135 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -174.57 55.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.24 110.833 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 73.35 110.921 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.458 -0.257 . . . . 35.5 112.458 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 2.6 t -130.27 68.73 81.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 72.13 110.935 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 -45.37 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.672 2.248 . . . . 72.12 112.363 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.09 150.63 37.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.11 111.084 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -113.03 64.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.881 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.43 -177.43 6.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.916 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -158.28 81.08 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 75.32 110.871 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -152.49 142.68 22.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 72.35 111.138 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.3 160.53 35.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.695 0.759 . . . . 72.52 110.877 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -28.27 25.68 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.714 2.276 . . . . 74.24 112.375 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -52.6 -34.57 51.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 54.12 110.937 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 52' ' ' THR . 28.4 m -52.93 -32.16 44.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 55.13 111.147 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.73 -57.32 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 60.43 110.799 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.711 ' O ' HG23 ' B' ' 158' ' ' VAL . 61.3 mt -51.5 -45.07 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 62.3 111.187 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 159' ' ' VAL . 37.3 mm -66.87 -44.36 88.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 73.23 111.13 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.9 p -61.62 -41.58 97.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.25 110.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.63 78.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.23 111.159 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 154' ' ' ILE . 97.8 t -54.73 -45.51 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 75.32 111.048 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 155' ' ' ILE . 84.7 t -59.96 -48.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 72.11 111.094 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.714 ' O ' HG23 ' B' ' 164' ' ' VAL . . . -59.47 -48.69 84.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 73.41 112.482 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.584 ' O ' HG23 ' B' ' 165' ' ' VAL . 71.3 mt -63.62 -35.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 74.43 111.116 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.66 ' O ' HG23 ' B' ' 166' ' ' VAL . 0.6 OUTLIER -68.76 -46.88 67.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.873 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.687 HD23 HG21 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -59.81 -38.98 83.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 71.21 110.822 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 160' ' ' GLY . 96.4 t -62.76 -56.02 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 74.01 111.161 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 161' ' ' ILE . 57.2 t -53.05 -47.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 70.12 111.198 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.672 ' O ' HG23 ' B' ' 170' ' ' VAL . 94.3 t -56.55 -40.56 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 62.44 111.131 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.04 -48.81 77.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.901 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.25 -45.19 88.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.15 -48.85 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 74.25 111.095 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 166' ' ' VAL . 46.3 t -57.78 -54.05 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 52.32 111.154 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -52.1 -53.84 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.896 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.19 -59.29 9.06 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 52.03 112.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.64 -39.72 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.375 . . . . 72.32 111.102 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 19.3 mt -60.02 -60.63 3.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 64.42 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 25.3 mm -57.75 -31.63 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.01 111.085 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -68.14 -59.92 2.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.4 110.851 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -52.98 -37.17 61.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.897 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -52.72 50.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 72.04 110.92 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 54.05 -175.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.879 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.42 -174.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 75.21 110.928 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt 58.57 95.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.893 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 26.8 mt -115.51 66.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 75.24 111.114 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -174.54 55.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 61.33 110.863 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.898 179.947 . . . . . . . . 1 1 . 1 stop_ save_